JohnLoh00的个人主页 - 老虎社区

JohnLoh00

暂无个人介绍

IP属地：未知

2关注

1粉丝

0主题

0勋章

2021-10-30

Ok

5 Stocks For Halloween: Will They Be Tricks Or Treats?

2021-10-15

Ok

抱歉，原内容已删除

2021-10-11

Ok

Here's How Wall Street Defines "Stagflation" And Why "Markets Could Be Massively Mispriced"

2021-10-09

Ok

抱歉，原内容已删除

2021-10-08

Ok

抱歉，原内容已删除

2021-10-05

Ok

SoFi Technologies stock dips after offering $1.1B of convertible notes

2021-10-04

Ok

抱歉，原内容已删除

2021-10-02

Ok

抱歉，原内容已删除

2021-09-30

Ok

2021 Global Market Outlook - Q4 Update: Growing Pains

2021-09-29

Ok

抱歉，原内容已删除

2021-09-28

Ok

抱歉，原内容已删除

2021-09-26

Ok

抱歉，原内容已删除

2021-09-25

Ok

抱歉，原内容已删除

2021-09-22

Ok

抱歉，原内容已删除

2021-09-21

Ok

Got $1,000? Buy These Hot Growth Stocks Before They Take Off

2021-09-20

Ok

3 Stocks to Add to Your Portfolio in a Market Pull-Back

2021-09-18

Ok

Pfizer Covid-19 shot's protection against hospitalisation wanes in study

2021-09-16

Ok

For GameStop Stock Investors, Perception May Be Reality That’s in the Way

2021-09-16

Ok

Procept BioRobotics spikes 40% on its first day of trading

2021-09-16

Ok

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3580436163482352","uuid":"3580436163482352","gmtCreate":1617342893541,"gmtModify":1617342893541,"name":"JohnLoh00","pinyin":"johnloh00","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":2,"tweetSize":21,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.08.23","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"80.52%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":840397995,"gmtCreate":1635585228408,"gmtModify":1635585228408,"author":{"id":"3580436163482352","authorId":"3580436163482352","name":"JohnLoh00","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580436163482352","authorIdStr":"3580436163482352"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/840397995","repostId":"1160516340","repostType":4,"repost":{"id":"1160516340","pubTimestamp":1635576015,"share":"https://www.laohu8.com/m/news/1160516340?lang=&edition=full","pubTime":"2021-10-30 14:40","market":"sh","language":"en","title":"5 Stocks For Halloween: Will They Be Tricks Or Treats?","url":"https://stock-news.laohu8.com/highlight/detail?id=1160516340","media":"Benzinga","summary":"Halloween will be celebrated on Sunday and could see significant changes from the 2020 event in the ","content":"<p>Halloween will be celebrated on Sunday and could see significant changes from the 2020 event&nbsp;in the middle of a COVID-19 pandemic that saw many cancel parties and plans to trick or treat.</p>\n<p>Here’s a look at what the data is pointing to for 2021 Halloween spending and five stocks to keep on the radar that could turn in strong quarters that include the holiday.</p>\n<p><b>Halloween Sales Expectations:</b>Consumers feel more comfortable resuming normal Halloween activities according to theNational Retail Federation.</p>\n<p>“This year, two-thirds (65%) of consumers plan to celebrate <a href=\"https://laohu8.com/S/AONE.U\">one</a> of America’s favorite holidays, up from 58% in 2020,” NRF said.</p>\n<p>The NRF sees consumers spending an average of $102.74 this year on Halloween, which would be the first time the figure has hit triple digits. Estimates last year were for spending of $92.12 by each consumer.</p>\n<p>Research points to candy and costumes as big winners by the return of Halloween activities along with decorations. Spending on decorations is expected to hit $3.3 billion, an all-time high.</p>\n<p>Is <a href=\"https://laohu8.com/S/KO\">Coca-Cola</a>'s Stock Overvalued OrUndervalued?</p>\n<p>Halloween 2021 will also see a higher number of people without kids celebrating than in 2020. Estimates call for 55% of homes without children to celebrate, compared to 49% in 2020. The figure falls in line with pre-pandemic levels of anticipated adult costume spending.</p>\n<p><b><a href=\"https://laohu8.com/S/TR\">Tootsie Roll</a>:</b>Candy company<b><a href=\"https://laohu8.com/S/TR\">Tootsie Roll</a> Industries Inc</b></p>\n<p>TR-0.47%is a popular option for anyone handing out candy to trick or treaters. If you’ve ever gone trick or treating, chances are you got a ton of tootsie rolls, given their lower cost for anyone buying for a large number of visitors.</p>\n<p>The companyreportedthird-quarter sales of $183.1 million, up 17% year-over-year. The company saw a dip in fourth-quarter revenue last year compared to the prior year. Look for Tootsie Roll to see a rebound in the fourth quarter.</p>\n<p><b><a href=\"https://laohu8.com/S/HSY\">Hershey</a>:The <a href=\"https://laohu8.com/S/HSY\">Hershey</a> Co</b></p>\n<p>HSY-2.28%has diversified its products to include several snack brands, but candy remains the big revenue driver. The company owns many of the popular brands that will be sought out by trick or treaters. Hershey’sthird-quarterrevenue of $2.4 billion was the highest it has seen in years on a quarterly basis.</p>\n<p>“Consumer demand for our brands has remained robust,” Hershey Company CEO<b>Michele Buck</b>said. The company raised full-year sales guidance and a strong Halloween could help meet or exceed the updated expectations.</p>\n<p><b><a href=\"https://laohu8.com/S/JAKK\">Jakks Pacific</a>:</b>Toy company<b><a href=\"https://laohu8.com/S/JAKK\">Jakks Pacific</a> Inc</b></p>\n<p>JAKK-4.38%finds itself on the Halloween list thanks to its ownership of Disguise, the world’s leading costume design and manufacturing company. With more adults dressing up and a return of trick or treat activities, the company could be in for a strong quarter.</p>\n<p>The company’sthird-quarterrevenue was $237&nbsp;million, which included $64&nbsp;million in revenue for the costumes segment. Costume sales were up 16.4% year-over-year and the fourth quarter could continue that trend. Jakks Pacific had revenue of $128.3 million in the fourth quarter last year, a decline from the prior year. Last year’s fourth quarter featured a 91% year-over-year increase in costumes segment revenue. The third and fourth quarters are the company’s two biggest quarters for revenue.</p>\n<p><b>Party <a href=\"https://laohu8.com/S/CHCO\">City</a>:</b>Retailer<b>$Party <a href=\"https://laohu8.com/S/CHCO\">City</a> Holdco(PRTY)$ Inc</b></p>\n<p>PRTY+2.97%could be a popular destination for Halloween costumes and decorations. The company ended thesecond quarterwith 749 locations and is also a provider of third-party products to other retailers.</p>\n<p>Second-quarter revenue was up 110% year-over-year for the company.</p>\n<p>“We saw sequential acceleration of the business as the economy opened up and restrictions subsided, driving increased consumer ability to celebrate,” Party City CEO<b>Brad Weston</b>said. The company will report third-quarter earnings on Nov. 9, which could provide a better look at how the Halloween shopping looked.</p>\n<p><b><a href=\"https://laohu8.com/S/AMCX\">AMC Networks</a>:</b>Media company<b><a href=\"https://laohu8.com/S/AMCX\">AMC Networks</a></b></p>\n<p>AMCX-2.04%finds itself on the Halloween stock list thanks to its ownership of “The Walking Dead” franchise, horror film programming and as owner of horror focused streaming platform Shudder. AMC isairing“FearFest” from Oct. 1 through Oct. 31 on its namesake AMC and AMC+ channels, which could turn into a subscriber boosting event.</p>\n<p>“The Walking Dead” returned to the network with its final season beginning Oct. 10, which could be another October event to watch. Shudder, which is the largest horror focused streaming platform, is available for $4.75 a month on major streaming platforms. The platformhitone million subscribers in 2020. Pizza Hut, a<b><a href=\"https://laohu8.com/S/YUM\">Yum</a> Brands Inc</b></p>\n<p>YUM-0.75%company,partneredwith Shudder to offer a promotion for 30 days free.</p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Stocks For Halloween: Will They Be Tricks Or Treats?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Stocks For Halloween: Will They Be Tricks Or Treats?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-30 14:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/small-cap/21/10/23762347/5-stocks-for-halloween-will-they-be-tricks-or-treats><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Halloween will be celebrated on Sunday and could see significant changes from the 2020 event in the middle of a COVID-19 pandemic that saw many cancel parties and plans to trick or treat.\nHere’s a ...</p>\n\n<a href=\"https://www.benzinga.com/news/small-cap/21/10/23762347/5-stocks-for-halloween-will-they-be-tricks-or-treats\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CHCO":"City Holding Company","JAKK":"杰克仕太平洋","HSY":"好时","AMCX":"AMC网络公司","TR":"Tootsie Roll Industries Inc"},"source_url":"https://www.benzinga.com/news/small-cap/21/10/23762347/5-stocks-for-halloween-will-they-be-tricks-or-treats","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160516340","content_text":"Halloween will be celebrated on Sunday and could see significant changes from the 2020 event in the middle of a COVID-19 pandemic that saw many cancel parties and plans to trick or treat.\nHere’s a look at what the data is pointing to for 2021 Halloween spending and five stocks to keep on the radar that could turn in strong quarters that include the holiday.\nHalloween Sales Expectations:Consumers feel more comfortable resuming normal Halloween activities according to theNational Retail Federation.\n“This year, two-thirds (65%) of consumers plan to celebrate one of America’s favorite holidays, up from 58% in 2020,” NRF said.\nThe NRF sees consumers spending an average of $102.74 this year on Halloween, which would be the first time the figure has hit triple digits. Estimates last year were for spending of $92.12 by each consumer.\nResearch points to candy and costumes as big winners by the return of Halloween activities along with decorations. Spending on decorations is expected to hit $3.3 billion, an all-time high.\nIs Coca-Cola's Stock Overvalued OrUndervalued?\nHalloween 2021 will also see a higher number of people without kids celebrating than in 2020. Estimates call for 55% of homes without children to celebrate, compared to 49% in 2020. The figure falls in line with pre-pandemic levels of anticipated adult costume spending.\nTootsie Roll:Candy companyTootsie Roll Industries Inc\nTR-0.47%is a popular option for anyone handing out candy to trick or treaters. If you’ve ever gone trick or treating, chances are you got a ton of tootsie rolls, given their lower cost for anyone buying for a large number of visitors.\nThe companyreportedthird-quarter sales of $183.1 million, up 17% year-over-year. The company saw a dip in fourth-quarter revenue last year compared to the prior year. Look for Tootsie Roll to see a rebound in the fourth quarter.\nHershey:The Hershey Co\nHSY-2.28%has diversified its products to include several snack brands, but candy remains the big revenue driver. The company owns many of the popular brands that will be sought out by trick or treaters. Hershey’sthird-quarterrevenue of $2.4 billion was the highest it has seen in years on a quarterly basis.\n“Consumer demand for our brands has remained robust,” Hershey Company CEOMichele Bucksaid. The company raised full-year sales guidance and a strong Halloween could help meet or exceed the updated expectations.\nJakks Pacific:Toy companyJakks Pacific Inc\nJAKK-4.38%finds itself on the Halloween list thanks to its ownership of Disguise, the world’s leading costume design and manufacturing company. With more adults dressing up and a return of trick or treat activities, the company could be in for a strong quarter.\nThe company’sthird-quarterrevenue was $237 million, which included $64 million in revenue for the costumes segment. Costume sales were up 16.4% year-over-year and the fourth quarter could continue that trend. Jakks Pacific had revenue of $128.3 million in the fourth quarter last year, a decline from the prior year. Last year’s fourth quarter featured a 91% year-over-year increase in costumes segment revenue. The third and fourth quarters are the company’s two biggest quarters for revenue.\nParty City:Retailer$Party City Holdco(PRTY)$ Inc\nPRTY+2.97%could be a popular destination for Halloween costumes and decorations. The company ended thesecond quarterwith 749 locations and is also a provider of third-party products to other retailers.\nSecond-quarter revenue was up 110% year-over-year for the company.\n“We saw sequential acceleration of the business as the economy opened up and restrictions subsided, driving increased consumer ability to celebrate,” Party City CEOBrad Westonsaid. The company will report third-quarter earnings on Nov. 9, which could provide a better look at how the Halloween shopping looked.\nAMC Networks:Media companyAMC Networks\nAMCX-2.04%finds itself on the Halloween stock list thanks to its ownership of “The Walking Dead” franchise, horror film programming and as owner of horror focused streaming platform Shudder. AMC isairing“FearFest” from Oct. 1 through Oct. 31 on its namesake AMC and AMC+ channels, which could turn into a subscriber boosting event.\n“The Walking Dead” returned to the network with its final season beginning Oct. 10, which could be another October event to watch. Shudder, which is the largest horror focused streaming platform, is available for $4.75 a month on major streaming platforms. The platformhitone million subscribers in 2020. Pizza Hut, aYum Brands Inc\nYUM-0.75%company,partneredwith Shudder to offer a promotion for 30 days free.","news_type":1},"isVote":1,"tweetType":1,"viewCount":875,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":824091842,"gmtCreate":1634260457197,"gmtModify":1634274406774,"author":{"id":"3580436163482352","authorId":"3580436163482352","name":"JohnLoh00","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580436163482352","authorIdStr":"3580436163482352"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/824091842","repostId":"1150327212","repostType":4,"isVote":1,"tweetType":1,"viewCount":1107,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":828250560,"gmtCreate":1633918243969,"gmtModify":1633918244063,"author":{"id":"3580436163482352","authorId":"3580436163482352","name":"JohnLoh00","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580436163482352","authorIdStr":"3580436163482352"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/828250560","repostId":"1199183279","repostType":4,"repost":{"id":"1199183279","pubTimestamp":1633914792,"share":"https://www.laohu8.com/m/news/1199183279?lang=&edition=full","pubTime":"2021-10-11 09:13","market":"us","language":"en","title":"Here's How Wall Street Defines \"Stagflation\" And Why \"Markets Could Be Massively Mispriced\"","url":"https://stock-news.laohu8.com/highlight/detail?id=1199183279","media":"zerohedge","summary":"It is easy to understand why Wall Street is increasingly worried about Stagflation: with the Citi gl","content":"<p>It is easy to understand why Wall Street is increasingly worried about Stagflation: with the Citi global inflation surprise index surging to the highest level ever (granted, it only captures the period since 1999 so it's unclear how it compares to the 1970s or early 1980s inflation shock periods)..</p>\n<p><img src=\"https://static.tigerbbs.com/168c3070fdc609f96adddbe87fc8da99\" tg-width=\"1738\" tg-height=\"866\" referrerpolicy=\"no-referrer\"></p>\n<p>... Citi's economic surprise index has turned negative and slumped to levels which historically have indicated an economic slowdown if not outright recession.</p>\n<p>As a result, it's also easy to understand why some of Wall Street's strategists have taken it upon themselves to ease investor concerns that another 1970s stagflationary shock may be coming, most notably Morgan Stanley earlier today, which admits that \"it’s not hard to see why one term seems to come up again and again in conversations with investors: stagflation\" but counters that in its view the surge in energy prices is temporary, and that the most comparable period to the current stagflationary scare is more comparable to 2005 when \"CPI hit 3.5%Y while the US manufacturing PMI had fallen to 52. 'Stagflation' graced the cover of The Economist. These fears eventually passed as growth rebounded and inflation moderated, but we think that 2005 may provide a useful reference point for a scare that comes far short of the 1970s. Equity multiples de-rated throughout 2004-05, consistent with the current forecasts for my colleague Mike Wilson and our US equity strategy team.\"</p>\n<p>Yet as Morgan Stanley also admits, while the \"market is focused on stagflation, it just hasn’t quite decided what that term really means.\"</p>\n<p>So to help shed some light on what most Wall Street professionals think when they hear the term \"Stagflation\", today we publish a second post on the topic of stagflation, in which we point readers to the latest monthly survey conducted by Deutsche Bank's Jim Reid who asked just this question and agrees with Morgan Stanley that \"one of the problems that the survey throws up is how we define “Stagflation”. It also shows the perceived elevated risks of it.\"</p>\n<p>Here's what the survey found:</p>\n<ul>\n <li><b>43% define Stagflation as “growth around zero or negative and inflation well above target”</b></li>\n <li><b>30% define Stagflation as “growth below trend and inflation comfortably above target”</b></li>\n <li><b>25% define Stagflation as “a strong slowdown in growth and strong pickup in inflation”</b></li>\n</ul>\n<p><img src=\"https://static.tigerbbs.com/5c1106e13503d4a8be89bb96fc1957fe\" tg-width=\"1312\" tg-height=\"640\" width=\"100%\" height=\"auto\"></p>\n<p>As Reid notes, although the top most negative definition is the most popular, there is a relatively even split of definitions out there.<b>\"This is important because there’s a huge potential difference in the impact of these scenarios on global markets over the next 12-18 months.</b>So when the term is used we have to be careful to understand the definition behind it.\"</p>\n<p>Reid also admits that he was very surprised how strong the consensus is now that stagflation of some kind is more likely than not over the next 12 months: for the most aggressively negative definition, the very high or high risk is still “only” 22% and 33% for the US and Europe.<b>It is a stunningly high 54% in the UK though.</b></p>\n<p>Surprisingly around 40% think the US is at risk of growth being below trend over the next year which given that consensus forecasts for GDP growth in 2022 is c.4%, feels quite aggressive.</p>\n<p>What this means in practical terms, is that if these numbers are proved correct, \"<b>markets could be massively mis-priced</b>\", according to the DB strategist. The silver lining to Reid, and here he is somewhat in agreement with Morgan Stanley, is that his \"gut feel\" is that while the risks are elevated, especially on the inflation side, \"the phrase “stagflation” is being used too aggressively at the moment.\"</p>\n<p>The next few months will prove if he is right.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's How Wall Street Defines \"Stagflation\" And Why \"Markets Could Be Massively Mispriced\"</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's How Wall Street Defines \"Stagflation\" And Why \"Markets Could Be Massively Mispriced\"\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-11 09:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.zerohedge.com/markets/heres-how-wall-street-defines-stagflation-and-why-markets-could-be-massively-mispriced?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohedge%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29><strong>zerohedge</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It is easy to understand why Wall Street is increasingly worried about Stagflation: with the Citi global inflation surprise index surging to the highest level ever (granted, it only captures the ...</p>\n\n<a href=\"https://www.zerohedge.com/markets/heres-how-wall-street-defines-stagflation-and-why-markets-could-be-massively-mispriced?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohedge%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯"},"source_url":"https://www.zerohedge.com/markets/heres-how-wall-street-defines-stagflation-and-why-markets-could-be-massively-mispriced?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+zerohedge%2Ffeed+%28zero+hedge+-+on+a+long+enough+timeline%2C+the+survival+rate+for+everyone+drops+to+zero%29","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1199183279","content_text":"It is easy to understand why Wall Street is increasingly worried about Stagflation: with the Citi global inflation surprise index surging to the highest level ever (granted, it only captures the period since 1999 so it's unclear how it compares to the 1970s or early 1980s inflation shock periods)..\n\n... Citi's economic surprise index has turned negative and slumped to levels which historically have indicated an economic slowdown if not outright recession.\nAs a result, it's also easy to understand why some of Wall Street's strategists have taken it upon themselves to ease investor concerns that another 1970s stagflationary shock may be coming, most notably Morgan Stanley earlier today, which admits that \"it’s not hard to see why one term seems to come up again and again in conversations with investors: stagflation\" but counters that in its view the surge in energy prices is temporary, and that the most comparable period to the current stagflationary scare is more comparable to 2005 when \"CPI hit 3.5%Y while the US manufacturing PMI had fallen to 52. 'Stagflation' graced the cover of The Economist. These fears eventually passed as growth rebounded and inflation moderated, but we think that 2005 may provide a useful reference point for a scare that comes far short of the 1970s. Equity multiples de-rated throughout 2004-05, consistent with the current forecasts for my colleague Mike Wilson and our US equity strategy team.\"\nYet as Morgan Stanley also admits, while the \"market is focused on stagflation, it just hasn’t quite decided what that term really means.\"\nSo to help shed some light on what most Wall Street professionals think when they hear the term \"Stagflation\", today we publish a second post on the topic of stagflation, in which we point readers to the latest monthly survey conducted by Deutsche Bank's Jim Reid who asked just this question and agrees with Morgan Stanley that \"one of the problems that the survey throws up is how we define “Stagflation”. It also shows the perceived elevated risks of it.\"\nHere's what the survey found:\n\n43% define Stagflation as “growth around zero or negative and inflation well above target”\n30% define Stagflation as “growth below trend and inflation comfortably above target”\n25% define Stagflation as “a strong slowdown in growth and strong pickup in inflation”\n\n\nAs Reid notes, although the top most negative definition is the most popular, there is a relatively even split of definitions out there.\"This is important because there’s a huge potential difference in the impact of these scenarios on global markets over the next 12-18 months.So when the term is used we have to be careful to understand the definition behind it.\"\nReid also admits that he was very surprised how strong the consensus is now that stagflation of some kind is more likely than not over the next 12 months: for the most aggressively negative definition, the very high or high risk is still “only” 22% and 33% for the US and Europe.It is a stunningly high 54% in the UK though.\nSurprisingly around 40% think the US is at risk of growth being below trend over the next year which given that consensus forecasts for GDP growth in 2022 is c.4%, feels quite aggressive.\nWhat this means in practical terms, is that if these numbers are proved correct, \"markets could be massively mis-priced\", according to the DB strategist. The silver lining to Reid, and here he is somewhat in agreement with Morgan Stanley, is that his \"gut feel\" is that while the risks are elevated, especially on the inflation side, \"the phrase “stagflation” is being used too aggressively at the moment.\"\nThe next few months will prove if he is right.","news_type":1},"isVote":1,"tweetType":1,"viewCount":431,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":821750357,"gmtCreate":1633794872595,"gmtModify":1633794872595,"author":{"id":"3580436163482352","authorId":"3580436163482352","name":"JohnLoh00","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580436163482352","authorIdStr":"3580436163482352"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/821750357","repostId":"1163103525","repostType":4,"isVote":1,"tweetType":1,"viewCount":735,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":823726999,"gmtCreate":1633664233140,"gmtModify":1633664233209,"author":{"id":"3580436163482352","authorId":"3580436163482352","name":"JohnLoh00","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580436163482352","authorIdStr":"3580436163482352"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/823726999","repostId":"1150824617","repostType":4,"isVote":1,"tweetType":1,"viewCount":815,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820579133,"gmtCreate":1633408441246,"gmtModify":1633408441318,"author":{"id":"3580436163482352","authorId":"3580436163482352","name":"JohnLoh00","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580436163482352","authorIdStr":"3580436163482352"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820579133","repostId":"1121300578","repostType":4,"repost":{"id":"1121300578","pubTimestamp":1633395123,"share":"https://www.laohu8.com/m/news/1121300578?lang=&edition=full","pubTime":"2021-10-05 08:52","market":"us","language":"en","title":"SoFi Technologies stock dips after offering $1.1B of convertible notes","url":"https://stock-news.laohu8.com/highlight/detail?id=1121300578","media":"Seekingalpha","summary":"SoFi Technologies(NASDAQ:SOFI)shares fall 5.2% since the fintech announced a convertible debt offeri","content":"<ul>\n <li>SoFi Technologies(NASDAQ:SOFI)shares fall 5.2% since the fintech announced a convertible debt offering last week.</li>\n <li>In today's trading alone, the stock&nbsp;dips 1.8%&nbsp;in early afternoon trading.</li>\n <li>On Sept. 29, the company boosted the size of its debt offering to $1.1B from $750M. The notes can be converted into SoFi (SOFI) shares on or after April 15, 2026 until the trading day preceding Oct. 15, 2026.</li>\n <li>Shares of companies that issue convertible debt often decline as the conversion of the debt to shares would increase the number of shares outstanding, potentially diluting existing stockholders' stakes.</li>\n <li>Previously (Sept. 29),SoFi Technologies prices $1.1B of convertible notes offering</li>\n</ul>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SoFi Technologies stock dips after offering $1.1B of convertible notes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSoFi Technologies stock dips after offering $1.1B of convertible notes\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-05 08:52 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3748268-sofi-technologies-stock-dips-after-offering-11b-of-convertible-notes><strong>Seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SoFi Technologies(NASDAQ:SOFI)shares fall 5.2% since the fintech announced a convertible debt offering last week.\nIn today's trading alone, the stock dips 1.8% in early afternoon trading.\nOn Sept. 29,...</p>\n\n<a href=\"https://seekingalpha.com/news/3748268-sofi-technologies-stock-dips-after-offering-11b-of-convertible-notes\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SOFI":"SoFi Technologies Inc."},"source_url":"https://seekingalpha.com/news/3748268-sofi-technologies-stock-dips-after-offering-11b-of-convertible-notes","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1121300578","content_text":"SoFi Technologies(NASDAQ:SOFI)shares fall 5.2% since the fintech announced a convertible debt offering last week.\nIn today's trading alone, the stock dips 1.8% in early afternoon trading.\nOn Sept. 29, the company boosted the size of its debt offering to $1.1B from $750M. The notes can be converted into SoFi (SOFI) shares on or after April 15, 2026 until the trading day preceding Oct. 15, 2026.\nShares of companies that issue convertible debt often decline as the conversion of the debt to shares would increase the number of shares outstanding, potentially diluting existing stockholders' stakes.\nPreviously (Sept. 29),SoFi Technologies prices $1.1B of convertible notes offering","news_type":1},"isVote":1,"tweetType":1,"viewCount":833,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820059025,"gmtCreate":1633329368514,"gmtModify":1633329368613,"author":{"id":"3580436163482352","authorId":"3580436163482352","name":"JohnLoh00","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580436163482352","authorIdStr":"3580436163482352"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/820059025","repostId":"1180397845","repostType":4,"isVote":1,"tweetType":1,"viewCount":483,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":864468714,"gmtCreate":1633139611877,"gmtModify":1633139611948,"author":{"id":"3580436163482352","authorId":"3580436163482352","name":"JohnLoh00","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580436163482352","authorIdStr":"3580436163482352"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/864468714","repostId":"2172618951","repostType":4,"isVote":1,"tweetType":1,"viewCount":687,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865816046,"gmtCreate":1632966833406,"gmtModify":1632966833521,"author":{"id":"3580436163482352","authorId":"3580436163482352","name":"JohnLoh00","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580436163482352","authorIdStr":"3580436163482352"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/865816046","repostId":"1104172212","repostType":4,"repost":{"id":"1104172212","pubTimestamp":1632965278,"share":"https://www.laohu8.com/m/news/1104172212?lang=&edition=full","pubTime":"2021-09-30 09:27","market":"us","language":"en","title":"2021 Global Market Outlook - Q4 Update: Growing Pains","url":"https://stock-news.laohu8.com/highlight/detail?id=1104172212","media":"seekingalpha","summary":"Summary\n\nThe post-lockdown recovery has been powerful, and most developed economies have seen double","content":"<p><b>Summary</b></p>\n<ul>\n <li>The post-lockdown recovery has been powerful, and most developed economies have seen double-digit gross domestic product (GDP) rebounds from 2020 lows.</li>\n <li>The reopening trade should resume in coming months. The cyclical stocks that comprise the value factor are reporting stronger earnings upgrades than technology-heavy growth stocks, and the value factor is cheap compared to the growth factor.</li>\n <li>The key risk is that the delta variant or similar proves resilient to vaccination or that infection rates escalate during the Northern Hemisphere winter.</li>\n</ul>\n<p>The COVID-19 delta variant, inflation and central bank tapering are unnerving investors. <b>We expect the pandemic-recovery trade to resume as inflation subsides, infection rates decline and tapering turns out to not equal tightening. Amid this backdrop, our outlook favors equities over bonds, the value factor over the growth factor and non-U.S. stocks over U.S. stocks.</b></p>\n<p><b>Introduction</b></p>\n<p>The post-lockdown recovery has transitioned from energetic youthfulness to awkward adolescence. It’s still growing, although at a slower pace, and there are worries about what happens next, particularly about monetary policy and the outlook for inflation. Theinflation spikehas been larger than expected, but we still think it istransitory, caused by base effects from when the U.S. consumer price index (CPI) fell during the lockdown last year and by temporary supply bottlenecks. Inflation may remain high over the remainder of 2021 but should decline in early 2022. This means that even though the U.S. Federal Reserve (Fed) is likely to begin tapering back on asset purchases before the end of the year, rate hikes are unlikely before the second half of 2023.</p>\n<p>Another worry is thehighly contagious COVID-19 delta variant. The evidence so far is that vaccines are effective in preventing serious COVID-19 infections. Vaccination rates are accelerating globally, and emerging economies are catching up with developed markets. Infection rates appear to have peaked globally in early September. This means the reopening of economies should continue over the remainder of 2021. The onset of winter in the northern hemisphere will be a test, but the rollout of booster vaccination shots should help prevent widescale renewed lockdowns.</p>\n<p>The conclusions from our cycle, value and sentiment (CVS) investment decision-making process are broadly unchanged from our previous quarterly report. Global equities remain expensive, with the very expensive U.S. market offsetting better value elsewhere. Sentiment is slightly overbought, but not close to dangerous levels of euphoria. The strong cycle delivers a preference for equities over bonds for at least the next 12 months, despite expensive valuations. It also reinforces our preference for thevalue equity factor over the growth factorand for non-U.S. equities to outperform the U.S. market.</p>\n<p><b>Cycle still in recovery phase</b></p>\n<p>The post-lockdown recovery has been powerful, and most developed economies have seen double-digit gross domestic product (GDP) rebounds from 2020 lows. Even so, we think the cycle is still in the recovery phase, although it is maturing. Despite strong growth, there is plenty of spare capacity. This can be seen in the employment-to-population ratio for prime-age workers in the United States. The chart below shows the ratio has recovered from the pandemic lows, but only to levels reached during the relatively mild recessions in the early 1990s and 2000s. We expect theU.S. labor-market recoveryshould still resemble a typical post-recession recovery over the next few quarters.</p>\n<p><b>U.S. EMPLOYMENT-POPULATION RATIO FOR PRIME-AGE WORKERS</b></p>\n<p><img src=\"https://static.tigerbbs.com/28a91fe2991463e2285879c32cb1b8c7\" tg-width=\"1280\" tg-height=\"982\" referrerpolicy=\"no-referrer\"></p>\n<p>The U.S. recovery, however, is more advanced than that of other developed economies. The following chart shows how far GDP has recovered, relative to the pre-COVID-19 peak in 2019. GDP is 0.8% higher in the U.S., although this level is still short relative to the pre-COVID-19 trend. GDP is 2.5% below 2019 levels in the euro area and 4.5% below in the United Kingdom. We expect more cyclical upside for economic growth outside the U.S., and this should allow market leadership to rotate toward the rest of the world.</p>\n<p><b>GDP IN Q2 2021 RELATIVE TO PRE-COVID-19 PEAK IN 2019</b></p>\n<p><img src=\"https://static.tigerbbs.com/577d1b96aef08b71c9bdb6665a21b2ac\" tg-width=\"1280\" tg-height=\"982\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Two key indicators</b></p>\n<p>Last quarter, we listed two indicators that should offer a guide to the Fed’s expected reaction to the inflation spike.</p>\n<p>The first is five-year/five-year breakeven inflation expectations, based on the pricing of Treasury Inflation Protected Securities (TIPS). This is the market’s forecast for average inflation over five years in five years’ time. It tells us that investors expect inflation will average 2.17% in the five years from late 2026 to late 2031. The TIPS yields are based on the CPI, while the Fed targets inflation as measured by the personal consumption expenditure (PCE) deflator. The two move together over time, but CPI inflation is generally around 0.25% higher than PCE inflation. A breakeven rate of 2.75% would suggest the market sees PCE inflation above 2.5% in five years’ time. Market inflation expectations are currently comfortably below the Fed’s worry point.</p>\n<p><b>WATCHPOINT INDICATOR #1: U.S. 5-YEAR/5-YEAR BREAKEVEN INFLATION RATE</b></p>\n<p><img src=\"https://static.tigerbbs.com/13f3cf57b58f600fe6681e9015779e85\" tg-width=\"1280\" tg-height=\"982\" referrerpolicy=\"no-referrer\"></p>\n<p>The second indicator is the Atlanta Fed’s Wage Growth Tracker, and this has a less-comforting message about inflation risks. It reached 3.9% in August, which isclose to the 4% thresholdwhere we judge that the Fed will become concerned about the inflationary impact on the growth of wages. A breakdown shows that the spike has been mostly driven by wages for low-skilled, young people in the leisure and hospitality industry. This suggests the surge has been caused by temporary labor supply shortages and that wage pressures should subside as economic activity normalizes. This indicator, however, will be an important watchpoint over the next few months.</p>\n<p><b>WATCHPOINT INDICATOR #2: ATLANTA FED WAGE GROWTH TRACKER</b></p>\n<p><img src=\"https://static.tigerbbs.com/a1d3ff1ca26f6d29a28f919c65531c9a\" tg-width=\"1280\" tg-height=\"982\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Reopening trade still makes sense</b></p>\n<p>The reopening trade, which lifts long-term interest rates and favors cyclical and value stocks over technology and growth stocks, worked well for several months following the vaccine announcement last November. Value outperformed growth and yield curves steepened. The trade has reversed in recent months, however, amid fears that the delta variant might derail the economic recovery. The impact has been magnified by short covering in bond markets as investors, who have been short or underweight, have been forced by the rally to buy back into the market, pushing bond yields even lower.</p>\n<p>The reopening trade should resume in coming months. The cyclical stocks that comprise the value factor are reporting stronger earnings upgrades than technology-heavy growth stocks, and the value factor is cheap compared to the growth factor. Financial stocks comprise the largest sector in the MSCI World Value Index, and they should benefit from further yield-curve steepening, which boosts the profitability of banks. Long-term interest rates should rise as global growth remains above trend, delta-variant fears fade, the short squeeze unwinds and central banks begin tapering back on bond purchases.</p>\n<p>The rotation in economic growth leadership away from the United States should also help the reopening trade. The rest of the world is overweight cyclical value stocks relative to the U.S., which has a higher weight to technology stocks.</p>\n<p>Emerging market (EM) equities have been poor performers since the vaccine announcement, but there are some encouraging signs. Initially, they were held back by the exposure to technology stocks in the MSCI Emerging Markets Index and the slow rollout of COVID-19 vaccines. More recently, they have come under pressure from the slowdown in the Chinese economy and theregulatory crackdown on Chinese tech companies. The vaccine rollout across emerging markets has accelerated and policy easing in China should soon improve the growth outlook. The path of Chinese regulation is harder to predict, but it is now largely priced in, with Chinese technology companies underperforming their global peers by nearly 50% from February 2021 through mid-September.</p>\n<p>The resumption of the reopening trade should also result in U.S. dollar weakness. The U.S. Dollar Index (DXY) has traded sideways since the vaccine announcement. It should weaken once investors have confidence that delta-variant risks are subsiding and realize that the Fed is likely to remain dovish as inflation risks decline. The dollar typically gains during global downturns and declines in the recovery phase. Dollar weakness should support the performance of non-U.S. markets, particularly emerging markets.</p>\n<p><b>Risks: variants, inflation, China weakness</b></p>\n<p>The key risk is that the delta variant or similar proves resilient to vaccination or that infection rates escalate during the Northern Hemisphere winter. The evidence so far is that vaccinations are highly effective in preventing serious illness. In Israel, booster shots appear to have slowed the rate of new cases.</p>\n<p>Another watchpoint is inflation and the response of central banks. Our expectation is that this year’s inflation spike is mostly transitory and that the major central banks, led by the Fed, are still two years from raising interest rates.</p>\n<p>Finally, there is the risk of a sharper-than-expected slowdown in China.Credit growth has slowed this yearand the purchasing managers’ indexes (PMI) have trended lower. Monetary and fiscal policy have been eased, however, and senior officials have signaled that more stimulus is on the way. China policy direction and credit trends will be an important watchpoint over coming months.</p>\n<p><b>Regional snapshotsUnited States</b></p>\n<p>The U.S. economy is likely to sustain above-trend growth into 2022. However, the easiest gains appear in the rear-view mirror at the end of the third quarter as the recovery phase of the business cycle matures. This is most visible for corporate earnings, where S&amp;P 500® Index earnings-per-share already sit 20% above their previous cyclical high.</p>\n<p>Strong fundamentals have helped power the stock market to new highs. Early evidence that the delta-variant wave may be fading and the potential for greater vaccine access for children are positives for a more complete recovery in the quarters ahead. The Fedlooks poised to start tapering its asset purchasesaround the end of 2021. The timing of the first rate hike will then hinge on what happens to inflation next year. Our models suggest that inflation is likely to drop back below the Fed’s 2% target in 2022. If that is correct, the Fed is likely to remain on hold into the second half of 2023.</p>\n<p>Wage inflation is a key risk to this view. It is running unusually strong for this stage of the cycle, and record hiring intentions from businesses could exhaust spare capacity in the year ahead. We expect the 10-year U.S. Treasury yield to rise moderately from 1.37% in mid-September to 1.75% in coming months.</p>\n<p>Fiscal stimulus negotiations continue to grab headlines in Washington, D.C. Thetax provisions in these billsare likely to be the most impactful for financial markets. We estimate thathigher corporate taxescould subtract about four percentage points from S&amp;P 500 earnings growth in 2022. This could create volatility and opportunity in markets. Given our strong cyclical outlook, our bias continues to be a<i>risk-on</i>preference for equities over bonds for the medium-term.</p>\n<p><b>Eurozone</b></p>\n<p>Euro area growthslowed through the third quarter but looks on track for a return to above-trend growth over the fourth quarter and into 2022. Vaccination rates are high, and the euro area has more catch-up potential than other major economies, particularly the United States. The euro area is also set to receive more fiscal support than other regions, with the European Union’s pandemic recovery fund only just starting to disburse stimulus, which will provide significant support in southern Europe. Polls in advance of Germany’s federal election on Sept. 26 suggested the electorate was moving toward the political left, which means the new government is likely to support expansionary fiscal policy and a continued dovish stance by the European Central Bank (ECB).</p>\n<p>The MSCI EMU Index, which reflects the European Economic and Monetary Union, has performed broadly in line with the S&amp;P 500 so far in 2021. We think it has potential to outperform in coming quarters. Europe’s exposure to financials and cyclically sensitive sectors such as industrials, materials and energy, and its relatively small exposure to technology, gives it the potential to outperform as delta-variant fears subside, economic activity picks up and yield curves in Europe steepen.</p>\n<p><b>United Kingdom</b></p>\n<p>As of mid-year, UK GDP was still nearly 4.5% below its pre-pandemic peak. We see plenty of scope for strong catch-up growth as borders are fully reopened and activity normalizes. Supply bottlenecks and labor shortages have triggered a sharp rise in underlying inflation and created concerns that the Bank of England (BoE) may start rate hikes in the first half of 2022. We think the BoE is unlikely to be that aggressive. We expect inflation to decline in early 2022 as supply constraints ease, which should convince the BoE to delay rate hikes.</p>\n<p>The FTSE 100 Index is the cheapest of the major developed equity markets in late 2021, and this should help it reflect higher returns than other markets over the next decade. Around 70% of UK corporate earnings come from offshore, so one near-term risk is that further strengthening of British sterling dampens earnings growth. The other risks are mostly around policy missteps, for example, early tightening by the Bank of England.</p>\n<p><b>Japan</b></p>\n<p>The Japanese economy is expected to get a shot in the arm as rising vaccination rates improve mobility and reduce the risk of further lockdowns, and as political leadership changes result in more fiscal stimulus: the Japanese election is due to be held before Nov. 28. Japanese equities look slightly more expensive than other regions such as the UK and Europe. We maintain our view that the Bank of Japan will significantly lag other central banks in normalizing policy.</p>\n<p><b>China</b></p>\n<p>We expect Chinese economic growth to berobust over the next 12 months, supported by a post-lockdown jump in consumer spending and incremental fiscal and monetary easing. Despite a big improvement in vaccination rates,COVID-19 outbreaks remain a riskgiven the Chinese government’s zero-tolerance approach. The major consumer technology companies have seen significant drops in stock prices recently due to more aggressive regulation. Some uncertainty remains around thepath of future regulation, especially as it relates to technology companies, and as a result we expect investors will remain cautious on Chinese equities in the coming months. The property market, particularly property developers as recently highlighted by Evergrande’s debt crisis, remains a risk that we are monitoring closely.</p>\n<p><b>Canada</b></p>\n<p>Canada leads the G71countries in terms of the vaccination rollout, which should minimize the risk of large-scale lockdowns over winter. The delta variant has taken an economic toll, however, with industry consensus projections now predicting 5% GDP growth in 2021 versus estimates of more than 6% just three months ago. Even so, growth remains above-trend and the odds of additional fiscal expenditures to support the economy have increased. This means that weaker growth due to COVID-19 is unlikely to change the Bank of Canada's (BoC) tightening bias.</p>\n<p>Tapering of asset purchasesshould be complete by the end of the first quarter of 2022. BoC Governor Tiff Macklem has indicated that the reinvestment phase of the bonds held by the central bank will commence once quantitative easing has ended. This should generate an estimated C$1 billion in weekly bond purchases, down from the current pace of C$2 billion. The BoC will likely only consider shrinking its balance sheet after it has started lifting interest rates. The BoC projects that the output gap will close sometime over the second half of 2022, and that rate hikes will be considered after economic slack has disappeared. We believe that the timeline may be a tad aggressive, and a delay to 2023 for liftoff is more likely. This would better align the Canadian central bank with its American counterpart.</p>\n<p><b>Australia/New Zealand</b></p>\n<p>The Australian economy is set to return to life, with lockdowns likely to be eased in October and November. Consumer and business balance sheets continue to look healthy, which should facilitate a strong recovery. The reopening of the international border in 2022 will provide a further boost. Fiscal policy has supported the economy through the downturn, and there is potential for further stimulus in the lead-up to the federal election, which is due before the end of 2022. The Reserve Bank of Australia has begun the process of tapering its bond-purchase program, but we expect that a rise in the cash rate is unlikely until at least the second half of 2023.</p>\n<p>New Zealand’s most recent lockdown will drag on Q3 GDP, but similar to Australia, we expect a solid rebound as the economy reopens. The government aims to provide a vaccine to all adults by the end of 2021, after which borders will gradually reopen. This will provide a boost, particularly to tourism-exposed sectors. Despite having recently put off hiking interest rates due to the recent lockdown, we expect the Reserve Bank of New Zealand will start raising rates this year. Even though they have significantly underperformed global equities this year, New Zealand equities still screen as relatively expensive compared to other regions.</p>\n<p><b>Asset-class preferences</b></p>\n<p>Our cycle, value and sentiment investment decision-making process in late September 2021 has a moderately positive medium-term view on global equities. Value is expensive across most markets except for UK equities, which are near fair value. The cycle is risk-asset supportive for the medium-term. The major economies still have spare capacity and inflation pressures appear transitory, caused by COVID-19-related supply shortages. Rate hikes by the U.S. Fed seem unlikely before the second half of 2023. Sentiment, after reaching overbought levels earlier in the year, has returned to more neutral levels.</p>\n<p><b>COMPOSITE CONTRARIAN INDICATOR: SENTIMENT SHIFTS TOWARD NEUTRAL</b></p>\n<p><img src=\"https://static.tigerbbs.com/5c527955abbc9e770d200c1d709f80d8\" tg-width=\"1280\" tg-height=\"982\" referrerpolicy=\"no-referrer\"></p>\n<ul>\n <li>We prefer<b>non-U.S. equities</b>to U.S. equities. Stronger economic growth and steeper yield curves after the third-quarter slowdown should favor undervalued cyclical value stocks over expensive technology and growth stocks. Relative to the U.S., the rest of the world is overweight cyclical value stocks.</li>\n <li><b>Emerging markets equities</b>have been relatively poor performers this year, but there are some encouraging signs. The vaccine rollout across EM has accelerated and policy easing in China should soon boost the economic growth outlook.China’s regulatory crackdownhas caused significant underperformance by Chinese technology companies, but this should be less of a headwind going forward now that it is priced in.</li>\n <li><b>High yield</b>and<b>investment grade credit</b>are expensive on a spread basis but have support from a positive cycle view that accommodates corporate profit growth and keeps default rates low. U.S. dollar-denominated<b>emerging markets debt</b>is close to fair value in spread terms and will gain support on U.S. dollar weakness.</li>\n <li><b>Government bonds</b>are expensive, and yields should come under upward pressure as output gaps close and central banks look to taper back asset purchases. We expect the 10-year U.S. Treasury yield to rise toward 1.75% in coming months.</li>\n <li><b>Real assets</b>: Real Estate Investment Trusts (REITs) have significantly outperformed Global Listed Infrastructure (GLI) so far this year, to the extent that REITS are now expensive relative to GLI. Both should benefit from the pandemic recovery, but GLI has some catch-up potential. GLI should benefit from the global re-opening boosting domestic and international travel.<b>Commodities</b>have been the best-performing asset class this year amid strong demand and supply bottlenecks. The gains have been led by industrial metals and energy. The pace of increase should ease as supply issues are resolved, butcommodities should retain supportfrom above-trend global demand.</li>\n <li>The<b>U.S. dollar</b>has been supported this year by expectations for early Fed tightening and U.S. economic growth leadership. It should weaken as global growth leadership rotates away from the U.S. and toward Europe and other developed economies. The dollar typically gains during global downturns and declines in the recovery phase. The main beneficiary is likely to be the<b>euro</b>, which is still undervalued. We also believe<b>British sterling</b>and the economically sensitive<i>commodity currencies</i>—the<b>Australian dollar</b>, the<b>New Zealand dollar</b>and the<b>Canadian dollar</b>—can make further gains, although these currencies are not undervalued from a longer-term perspective.</li>\n</ul>\n<p><b>ASSET PERFORMANCE SINCE THE BEGINNING OF 2021</b></p>\n<p><img src=\"https://static.tigerbbs.com/50e253becd38bd122d9fc211e7b0f583\" tg-width=\"1280\" tg-height=\"982\" referrerpolicy=\"no-referrer\"></p>\n<p>1The Group of Seven is an inter-governmental political forum consisting of Canada, France, Germany, Italy, Japan, the United Kingdom and the United States.</p>\n<p><b>Important Information</b></p>\n<p>The views in this Global Market Outlook report are subject to change at any time based upon market or other conditions and are current as of September 27, 2021. While all material is deemed to be reliable, accuracy and completeness cannot be guaranteed.</p>\n<p>Please remember that all investments carry some level of risk, including the potential loss of principal invested. They do not typically grow at an even rate of return and may experience negative growth. As with any type of portfolio structuring, attempting to reduce risk and increase return could, at certain times, unintentionally reduce returns.</p>\n<p>Keep in mind that, like all investing, multi-asset investing does not assure a profit or protect against loss.</p>\n<p>No model or group of models can offer a precise estimate of future returns available from capital markets. We remain cautious that rational analytical techniques cannot predict extremes in financial behavior, such as periods of financial euphoria or investor panic. Our models rest on the assumptions of normal and rational financial behavior. Forecasting models are inherently uncertain, subject to change at any time based on a variety of factors and can be inaccurate. Russell believes that the utility of this information is highest in evaluating the relative relationships of various components of a globally diversified portfolio. As such, the models may offer insights into the prudence of over or under weighting those components from time to time or under periods of extreme dislocation. The models are explicitly not intended as market timing signals.</p>\n<p>Forecasting represents predictions of market prices and/or volume patterns utilizing varying analytical data. It is not representative of a projection of the stock market, or of any specific investment.</p>\n<p>Investment in global, international or emerging markets may be significantly affected by political or economic conditions and regulatory requirements in a particular country. Investments in non-U.S. markets can involve risks of currency fluctuation, political and economic instability, different accounting standards and foreign taxation. Such securities may be less liquid and more volatile. Investments in emerging or developing markets involve exposure to economic structures that are generally less diverse and mature, and political systems with less stability than in more developed countries.</p>\n<p>Currency investing involves risks including fluctuations in currency values, whether the home currency or the foreign currency. They can either enhance or reduce the returns associated with foreign investments.</p>\n<p>Investments in non-U.S. markets can involve risks of currency fluctuation, political and economic instability, different accounting standards and foreign taxation.</p>\n<p>Bond investors should carefully consider risks such as interest rate, credit, default and duration risks. Greater risk, such as increased volatility, limited liquidity, prepayment, non-payment and increased default risk, is inherent in portfolios that invest in high yield (“junk”) bonds or mortgage-backed securities, especially mortgage-backed securities with exposure to sub-prime mortgages. Generally, when interest rates rise, prices of fixed income securities fall. Interest rates in the United States are at, or near, historic lows, which may increase a Fund’s exposure to risks associated with rising rates. Investment in non-U.S. and emerging market securities is subject to the risk of currency fluctuations and to economic and political risks associated with such foreign countries.</p>\n<p>Performance quoted represents past performance and should not be viewed as a guarantee of future results.</p>\n<p>The FTSE 100 Index is a market-capitalization weighted index of UK-listed blue chip companies.</p>\n<p>The S&amp;P 500® Index, or the Standard &amp; Poor’s 500, is a stock market index based on the market capitalizations of 500 large companies having common stock listed on the NYSE or NASDAQ.</p>\n<p>The MSCI EMU Index (European Economic and Monetary Union) captures large and mid cap representation across the 10 developed markets countries in the EMU. With 246 constituents, the index covers approximately 85% of the free float-adjusted market capitalization of the EMU.</p>\n<p>Indexes are unmanaged and cannot be invested in directly.</p>\n<p>Copyright © Russell Investments 2021. All rights reserved. This material is proprietary and may not be reproduced, transferred, or distributed in any form without prior written permission from Russell Investments. It is delivered on an “as is” basis without warranty.</p>\n<p>Frank Russell Company is the owner of the Russell trademarks contained in this material and all trademark rights related to the Russell trademarks, which the members of the Russell Investments group of companies are permitted to use under license from Frank Russell Company. The members of the Russell Investments group of companies are not affiliated in any manner with Frank Russell Company or any entity operating under the “FTSE RUSSELL” brand.</p>\n<p>Products and services described on this website are intended for<b>United States residents only</b>. Nothing contained in this material is intended to constitute legal, tax, securities, or investment advice, nor an opinion regarding the appropriateness of any investment, nor a solicitation of any type. The general information contained on this website should not be acted upon without obtaining specific legal, tax, and investment advice from a licensed professional. Persons outside the United States may find more information about products and services available within their jurisdictions by going to Russell Investments' Worldwide site.</p>\n<p>Russell Investments is committed to ensuring digital accessibility for people with disabilities. We are continually improving the user experience for everyone, and applying the relevant accessibility standards.</p>\n<p>Russell Investments' ownership is composed of a majority stake held by funds managed by TA Associates, with a significant minority stake held by funds managed by Reverence Capital Partners. Russell Investments' employees and Hamilton Lane Advisors, LLC also hold minority, non-controlling, ownership stakes.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2021 Global Market Outlook - Q4 Update: Growing Pains</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2021 Global Market Outlook - Q4 Update: Growing Pains\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-30 09:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4457651-2021-global-market-outlook-q4-update-growing-pains><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nThe post-lockdown recovery has been powerful, and most developed economies have seen double-digit gross domestic product (GDP) rebounds from 2020 lows.\nThe reopening trade should resume in ...</p>\n\n<a href=\"https://seekingalpha.com/article/4457651-2021-global-market-outlook-q4-update-growing-pains\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite","SPY":"标普500ETF",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"source_url":"https://seekingalpha.com/article/4457651-2021-global-market-outlook-q4-update-growing-pains","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1104172212","content_text":"Summary\n\nThe post-lockdown recovery has been powerful, and most developed economies have seen double-digit gross domestic product (GDP) rebounds from 2020 lows.\nThe reopening trade should resume in coming months. The cyclical stocks that comprise the value factor are reporting stronger earnings upgrades than technology-heavy growth stocks, and the value factor is cheap compared to the growth factor.\nThe key risk is that the delta variant or similar proves resilient to vaccination or that infection rates escalate during the Northern Hemisphere winter.\n\nThe COVID-19 delta variant, inflation and central bank tapering are unnerving investors. We expect the pandemic-recovery trade to resume as inflation subsides, infection rates decline and tapering turns out to not equal tightening. Amid this backdrop, our outlook favors equities over bonds, the value factor over the growth factor and non-U.S. stocks over U.S. stocks.\nIntroduction\nThe post-lockdown recovery has transitioned from energetic youthfulness to awkward adolescence. It’s still growing, although at a slower pace, and there are worries about what happens next, particularly about monetary policy and the outlook for inflation. Theinflation spikehas been larger than expected, but we still think it istransitory, caused by base effects from when the U.S. consumer price index (CPI) fell during the lockdown last year and by temporary supply bottlenecks. Inflation may remain high over the remainder of 2021 but should decline in early 2022. This means that even though the U.S. Federal Reserve (Fed) is likely to begin tapering back on asset purchases before the end of the year, rate hikes are unlikely before the second half of 2023.\nAnother worry is thehighly contagious COVID-19 delta variant. The evidence so far is that vaccines are effective in preventing serious COVID-19 infections. Vaccination rates are accelerating globally, and emerging economies are catching up with developed markets. Infection rates appear to have peaked globally in early September. This means the reopening of economies should continue over the remainder of 2021. The onset of winter in the northern hemisphere will be a test, but the rollout of booster vaccination shots should help prevent widescale renewed lockdowns.\nThe conclusions from our cycle, value and sentiment (CVS) investment decision-making process are broadly unchanged from our previous quarterly report. Global equities remain expensive, with the very expensive U.S. market offsetting better value elsewhere. Sentiment is slightly overbought, but not close to dangerous levels of euphoria. The strong cycle delivers a preference for equities over bonds for at least the next 12 months, despite expensive valuations. It also reinforces our preference for thevalue equity factor over the growth factorand for non-U.S. equities to outperform the U.S. market.\nCycle still in recovery phase\nThe post-lockdown recovery has been powerful, and most developed economies have seen double-digit gross domestic product (GDP) rebounds from 2020 lows. Even so, we think the cycle is still in the recovery phase, although it is maturing. Despite strong growth, there is plenty of spare capacity. This can be seen in the employment-to-population ratio for prime-age workers in the United States. The chart below shows the ratio has recovered from the pandemic lows, but only to levels reached during the relatively mild recessions in the early 1990s and 2000s. We expect theU.S. labor-market recoveryshould still resemble a typical post-recession recovery over the next few quarters.\nU.S. EMPLOYMENT-POPULATION RATIO FOR PRIME-AGE WORKERS\n\nThe U.S. recovery, however, is more advanced than that of other developed economies. The following chart shows how far GDP has recovered, relative to the pre-COVID-19 peak in 2019. GDP is 0.8% higher in the U.S., although this level is still short relative to the pre-COVID-19 trend. GDP is 2.5% below 2019 levels in the euro area and 4.5% below in the United Kingdom. We expect more cyclical upside for economic growth outside the U.S., and this should allow market leadership to rotate toward the rest of the world.\nGDP IN Q2 2021 RELATIVE TO PRE-COVID-19 PEAK IN 2019\n\nTwo key indicators\nLast quarter, we listed two indicators that should offer a guide to the Fed’s expected reaction to the inflation spike.\nThe first is five-year/five-year breakeven inflation expectations, based on the pricing of Treasury Inflation Protected Securities (TIPS). This is the market’s forecast for average inflation over five years in five years’ time. It tells us that investors expect inflation will average 2.17% in the five years from late 2026 to late 2031. The TIPS yields are based on the CPI, while the Fed targets inflation as measured by the personal consumption expenditure (PCE) deflator. The two move together over time, but CPI inflation is generally around 0.25% higher than PCE inflation. A breakeven rate of 2.75% would suggest the market sees PCE inflation above 2.5% in five years’ time. Market inflation expectations are currently comfortably below the Fed’s worry point.\nWATCHPOINT INDICATOR #1: U.S. 5-YEAR/5-YEAR BREAKEVEN INFLATION RATE\n\nThe second indicator is the Atlanta Fed’s Wage Growth Tracker, and this has a less-comforting message about inflation risks. It reached 3.9% in August, which isclose to the 4% thresholdwhere we judge that the Fed will become concerned about the inflationary impact on the growth of wages. A breakdown shows that the spike has been mostly driven by wages for low-skilled, young people in the leisure and hospitality industry. This suggests the surge has been caused by temporary labor supply shortages and that wage pressures should subside as economic activity normalizes. This indicator, however, will be an important watchpoint over the next few months.\nWATCHPOINT INDICATOR #2: ATLANTA FED WAGE GROWTH TRACKER\n\nReopening trade still makes sense\nThe reopening trade, which lifts long-term interest rates and favors cyclical and value stocks over technology and growth stocks, worked well for several months following the vaccine announcement last November. Value outperformed growth and yield curves steepened. The trade has reversed in recent months, however, amid fears that the delta variant might derail the economic recovery. The impact has been magnified by short covering in bond markets as investors, who have been short or underweight, have been forced by the rally to buy back into the market, pushing bond yields even lower.\nThe reopening trade should resume in coming months. The cyclical stocks that comprise the value factor are reporting stronger earnings upgrades than technology-heavy growth stocks, and the value factor is cheap compared to the growth factor. Financial stocks comprise the largest sector in the MSCI World Value Index, and they should benefit from further yield-curve steepening, which boosts the profitability of banks. Long-term interest rates should rise as global growth remains above trend, delta-variant fears fade, the short squeeze unwinds and central banks begin tapering back on bond purchases.\nThe rotation in economic growth leadership away from the United States should also help the reopening trade. The rest of the world is overweight cyclical value stocks relative to the U.S., which has a higher weight to technology stocks.\nEmerging market (EM) equities have been poor performers since the vaccine announcement, but there are some encouraging signs. Initially, they were held back by the exposure to technology stocks in the MSCI Emerging Markets Index and the slow rollout of COVID-19 vaccines. More recently, they have come under pressure from the slowdown in the Chinese economy and theregulatory crackdown on Chinese tech companies. The vaccine rollout across emerging markets has accelerated and policy easing in China should soon improve the growth outlook. The path of Chinese regulation is harder to predict, but it is now largely priced in, with Chinese technology companies underperforming their global peers by nearly 50% from February 2021 through mid-September.\nThe resumption of the reopening trade should also result in U.S. dollar weakness. The U.S. Dollar Index (DXY) has traded sideways since the vaccine announcement. It should weaken once investors have confidence that delta-variant risks are subsiding and realize that the Fed is likely to remain dovish as inflation risks decline. The dollar typically gains during global downturns and declines in the recovery phase. Dollar weakness should support the performance of non-U.S. markets, particularly emerging markets.\nRisks: variants, inflation, China weakness\nThe key risk is that the delta variant or similar proves resilient to vaccination or that infection rates escalate during the Northern Hemisphere winter. The evidence so far is that vaccinations are highly effective in preventing serious illness. In Israel, booster shots appear to have slowed the rate of new cases.\nAnother watchpoint is inflation and the response of central banks. Our expectation is that this year’s inflation spike is mostly transitory and that the major central banks, led by the Fed, are still two years from raising interest rates.\nFinally, there is the risk of a sharper-than-expected slowdown in China.Credit growth has slowed this yearand the purchasing managers’ indexes (PMI) have trended lower. Monetary and fiscal policy have been eased, however, and senior officials have signaled that more stimulus is on the way. China policy direction and credit trends will be an important watchpoint over coming months.\nRegional snapshotsUnited States\nThe U.S. economy is likely to sustain above-trend growth into 2022. However, the easiest gains appear in the rear-view mirror at the end of the third quarter as the recovery phase of the business cycle matures. This is most visible for corporate earnings, where S&P 500® Index earnings-per-share already sit 20% above their previous cyclical high.\nStrong fundamentals have helped power the stock market to new highs. Early evidence that the delta-variant wave may be fading and the potential for greater vaccine access for children are positives for a more complete recovery in the quarters ahead. The Fedlooks poised to start tapering its asset purchasesaround the end of 2021. The timing of the first rate hike will then hinge on what happens to inflation next year. Our models suggest that inflation is likely to drop back below the Fed’s 2% target in 2022. If that is correct, the Fed is likely to remain on hold into the second half of 2023.\nWage inflation is a key risk to this view. It is running unusually strong for this stage of the cycle, and record hiring intentions from businesses could exhaust spare capacity in the year ahead. We expect the 10-year U.S. Treasury yield to rise moderately from 1.37% in mid-September to 1.75% in coming months.\nFiscal stimulus negotiations continue to grab headlines in Washington, D.C. Thetax provisions in these billsare likely to be the most impactful for financial markets. We estimate thathigher corporate taxescould subtract about four percentage points from S&P 500 earnings growth in 2022. This could create volatility and opportunity in markets. Given our strong cyclical outlook, our bias continues to be arisk-onpreference for equities over bonds for the medium-term.\nEurozone\nEuro area growthslowed through the third quarter but looks on track for a return to above-trend growth over the fourth quarter and into 2022. Vaccination rates are high, and the euro area has more catch-up potential than other major economies, particularly the United States. The euro area is also set to receive more fiscal support than other regions, with the European Union’s pandemic recovery fund only just starting to disburse stimulus, which will provide significant support in southern Europe. Polls in advance of Germany’s federal election on Sept. 26 suggested the electorate was moving toward the political left, which means the new government is likely to support expansionary fiscal policy and a continued dovish stance by the European Central Bank (ECB).\nThe MSCI EMU Index, which reflects the European Economic and Monetary Union, has performed broadly in line with the S&P 500 so far in 2021. We think it has potential to outperform in coming quarters. Europe’s exposure to financials and cyclically sensitive sectors such as industrials, materials and energy, and its relatively small exposure to technology, gives it the potential to outperform as delta-variant fears subside, economic activity picks up and yield curves in Europe steepen.\nUnited Kingdom\nAs of mid-year, UK GDP was still nearly 4.5% below its pre-pandemic peak. We see plenty of scope for strong catch-up growth as borders are fully reopened and activity normalizes. Supply bottlenecks and labor shortages have triggered a sharp rise in underlying inflation and created concerns that the Bank of England (BoE) may start rate hikes in the first half of 2022. We think the BoE is unlikely to be that aggressive. We expect inflation to decline in early 2022 as supply constraints ease, which should convince the BoE to delay rate hikes.\nThe FTSE 100 Index is the cheapest of the major developed equity markets in late 2021, and this should help it reflect higher returns than other markets over the next decade. Around 70% of UK corporate earnings come from offshore, so one near-term risk is that further strengthening of British sterling dampens earnings growth. The other risks are mostly around policy missteps, for example, early tightening by the Bank of England.\nJapan\nThe Japanese economy is expected to get a shot in the arm as rising vaccination rates improve mobility and reduce the risk of further lockdowns, and as political leadership changes result in more fiscal stimulus: the Japanese election is due to be held before Nov. 28. Japanese equities look slightly more expensive than other regions such as the UK and Europe. We maintain our view that the Bank of Japan will significantly lag other central banks in normalizing policy.\nChina\nWe expect Chinese economic growth to berobust over the next 12 months, supported by a post-lockdown jump in consumer spending and incremental fiscal and monetary easing. Despite a big improvement in vaccination rates,COVID-19 outbreaks remain a riskgiven the Chinese government’s zero-tolerance approach. The major consumer technology companies have seen significant drops in stock prices recently due to more aggressive regulation. Some uncertainty remains around thepath of future regulation, especially as it relates to technology companies, and as a result we expect investors will remain cautious on Chinese equities in the coming months. The property market, particularly property developers as recently highlighted by Evergrande’s debt crisis, remains a risk that we are monitoring closely.\nCanada\nCanada leads the G71countries in terms of the vaccination rollout, which should minimize the risk of large-scale lockdowns over winter. The delta variant has taken an economic toll, however, with industry consensus projections now predicting 5% GDP growth in 2021 versus estimates of more than 6% just three months ago. Even so, growth remains above-trend and the odds of additional fiscal expenditures to support the economy have increased. This means that weaker growth due to COVID-19 is unlikely to change the Bank of Canada's (BoC) tightening bias.\nTapering of asset purchasesshould be complete by the end of the first quarter of 2022. BoC Governor Tiff Macklem has indicated that the reinvestment phase of the bonds held by the central bank will commence once quantitative easing has ended. This should generate an estimated C$1 billion in weekly bond purchases, down from the current pace of C$2 billion. The BoC will likely only consider shrinking its balance sheet after it has started lifting interest rates. The BoC projects that the output gap will close sometime over the second half of 2022, and that rate hikes will be considered after economic slack has disappeared. We believe that the timeline may be a tad aggressive, and a delay to 2023 for liftoff is more likely. This would better align the Canadian central bank with its American counterpart.\nAustralia/New Zealand\nThe Australian economy is set to return to life, with lockdowns likely to be eased in October and November. Consumer and business balance sheets continue to look healthy, which should facilitate a strong recovery. The reopening of the international border in 2022 will provide a further boost. Fiscal policy has supported the economy through the downturn, and there is potential for further stimulus in the lead-up to the federal election, which is due before the end of 2022. The Reserve Bank of Australia has begun the process of tapering its bond-purchase program, but we expect that a rise in the cash rate is unlikely until at least the second half of 2023.\nNew Zealand’s most recent lockdown will drag on Q3 GDP, but similar to Australia, we expect a solid rebound as the economy reopens. The government aims to provide a vaccine to all adults by the end of 2021, after which borders will gradually reopen. This will provide a boost, particularly to tourism-exposed sectors. Despite having recently put off hiking interest rates due to the recent lockdown, we expect the Reserve Bank of New Zealand will start raising rates this year. Even though they have significantly underperformed global equities this year, New Zealand equities still screen as relatively expensive compared to other regions.\nAsset-class preferences\nOur cycle, value and sentiment investment decision-making process in late September 2021 has a moderately positive medium-term view on global equities. Value is expensive across most markets except for UK equities, which are near fair value. The cycle is risk-asset supportive for the medium-term. The major economies still have spare capacity and inflation pressures appear transitory, caused by COVID-19-related supply shortages. Rate hikes by the U.S. Fed seem unlikely before the second half of 2023. Sentiment, after reaching overbought levels earlier in the year, has returned to more neutral levels.\nCOMPOSITE CONTRARIAN INDICATOR: SENTIMENT SHIFTS TOWARD NEUTRAL\n\n\nWe prefernon-U.S. equitiesto U.S. equities. Stronger economic growth and steeper yield curves after the third-quarter slowdown should favor undervalued cyclical value stocks over expensive technology and growth stocks. Relative to the U.S., the rest of the world is overweight cyclical value stocks.\nEmerging markets equitieshave been relatively poor performers this year, but there are some encouraging signs. The vaccine rollout across EM has accelerated and policy easing in China should soon boost the economic growth outlook.China’s regulatory crackdownhas caused significant underperformance by Chinese technology companies, but this should be less of a headwind going forward now that it is priced in.\nHigh yieldandinvestment grade creditare expensive on a spread basis but have support from a positive cycle view that accommodates corporate profit growth and keeps default rates low. U.S. dollar-denominatedemerging markets debtis close to fair value in spread terms and will gain support on U.S. dollar weakness.\nGovernment bondsare expensive, and yields should come under upward pressure as output gaps close and central banks look to taper back asset purchases. We expect the 10-year U.S. Treasury yield to rise toward 1.75% in coming months.\nReal assets: Real Estate Investment Trusts (REITs) have significantly outperformed Global Listed Infrastructure (GLI) so far this year, to the extent that REITS are now expensive relative to GLI. Both should benefit from the pandemic recovery, but GLI has some catch-up potential. GLI should benefit from the global re-opening boosting domestic and international travel.Commoditieshave been the best-performing asset class this year amid strong demand and supply bottlenecks. The gains have been led by industrial metals and energy. The pace of increase should ease as supply issues are resolved, butcommodities should retain supportfrom above-trend global demand.\nTheU.S. dollarhas been supported this year by expectations for early Fed tightening and U.S. economic growth leadership. It should weaken as global growth leadership rotates away from the U.S. and toward Europe and other developed economies. The dollar typically gains during global downturns and declines in the recovery phase. The main beneficiary is likely to be theeuro, which is still undervalued. We also believeBritish sterlingand the economically sensitivecommodity currencies—theAustralian dollar, theNew Zealand dollarand theCanadian dollar—can make further gains, although these currencies are not undervalued from a longer-term perspective.\n\nASSET PERFORMANCE SINCE THE BEGINNING OF 2021\n\n1The Group of Seven is an inter-governmental political forum consisting of Canada, France, Germany, Italy, Japan, the United Kingdom and the United States.\nImportant Information\nThe views in this Global Market Outlook report are subject to change at any time based upon market or other conditions and are current as of September 27, 2021. While all material is deemed to be reliable, accuracy and completeness cannot be guaranteed.\nPlease remember that all investments carry some level of risk, including the potential loss of principal invested. They do not typically grow at an even rate of return and may experience negative growth. As with any type of portfolio structuring, attempting to reduce risk and increase return could, at certain times, unintentionally reduce returns.\nKeep in mind that, like all investing, multi-asset investing does not assure a profit or protect against loss.\nNo model or group of models can offer a precise estimate of future returns available from capital markets. We remain cautious that rational analytical techniques cannot predict extremes in financial behavior, such as periods of financial euphoria or investor panic. Our models rest on the assumptions of normal and rational financial behavior. Forecasting models are inherently uncertain, subject to change at any time based on a variety of factors and can be inaccurate. Russell believes that the utility of this information is highest in evaluating the relative relationships of various components of a globally diversified portfolio. As such, the models may offer insights into the prudence of over or under weighting those components from time to time or under periods of extreme dislocation. The models are explicitly not intended as market timing signals.\nForecasting represents predictions of market prices and/or volume patterns utilizing varying analytical data. It is not representative of a projection of the stock market, or of any specific investment.\nInvestment in global, international or emerging markets may be significantly affected by political or economic conditions and regulatory requirements in a particular country. Investments in non-U.S. markets can involve risks of currency fluctuation, political and economic instability, different accounting standards and foreign taxation. Such securities may be less liquid and more volatile. Investments in emerging or developing markets involve exposure to economic structures that are generally less diverse and mature, and political systems with less stability than in more developed countries.\nCurrency investing involves risks including fluctuations in currency values, whether the home currency or the foreign currency. They can either enhance or reduce the returns associated with foreign investments.\nInvestments in non-U.S. markets can involve risks of currency fluctuation, political and economic instability, different accounting standards and foreign taxation.\nBond investors should carefully consider risks such as interest rate, credit, default and duration risks. Greater risk, such as increased volatility, limited liquidity, prepayment, non-payment and increased default risk, is inherent in portfolios that invest in high yield (“junk”) bonds or mortgage-backed securities, especially mortgage-backed securities with exposure to sub-prime mortgages. Generally, when interest rates rise, prices of fixed income securities fall. Interest rates in the United States are at, or near, historic lows, which may increase a Fund’s exposure to risks associated with rising rates. Investment in non-U.S. and emerging market securities is subject to the risk of currency fluctuations and to economic and political risks associated with such foreign countries.\nPerformance quoted represents past performance and should not be viewed as a guarantee of future results.\nThe FTSE 100 Index is a market-capitalization weighted index of UK-listed blue chip companies.\nThe S&P 500® Index, or the Standard & Poor’s 500, is a stock market index based on the market capitalizations of 500 large companies having common stock listed on the NYSE or NASDAQ.\nThe MSCI EMU Index (European Economic and Monetary Union) captures large and mid cap representation across the 10 developed markets countries in the EMU. With 246 constituents, the index covers approximately 85% of the free float-adjusted market capitalization of the EMU.\nIndexes are unmanaged and cannot be invested in directly.\nCopyright © Russell Investments 2021. All rights reserved. This material is proprietary and may not be reproduced, transferred, or distributed in any form without prior written permission from Russell Investments. It is delivered on an “as is” basis without warranty.\nFrank Russell Company is the owner of the Russell trademarks contained in this material and all trademark rights related to the Russell trademarks, which the members of the Russell Investments group of companies are permitted to use under license from Frank Russell Company. The members of the Russell Investments group of companies are not affiliated in any manner with Frank Russell Company or any entity operating under the “FTSE RUSSELL” brand.\nProducts and services described on this website are intended forUnited States residents only. Nothing contained in this material is intended to constitute legal, tax, securities, or investment advice, nor an opinion regarding the appropriateness of any investment, nor a solicitation of any type. The general information contained on this website should not be acted upon without obtaining specific legal, tax, and investment advice from a licensed professional. Persons outside the United States may find more information about products and services available within their jurisdictions by going to Russell Investments' Worldwide site.\nRussell Investments is committed to ensuring digital accessibility for people with disabilities. We are continually improving the user experience for everyone, and applying the relevant accessibility standards.\nRussell Investments' ownership is composed of a majority stake held by funds managed by TA Associates, with a significant minority stake held by funds managed by Reverence Capital Partners. Russell Investments' employees and Hamilton Lane Advisors, LLC also hold minority, non-controlling, ownership stakes.","news_type":1},"isVote":1,"tweetType":1,"viewCount":771,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":862668854,"gmtCreate":1632876185869,"gmtModify":1632876185869,"author":{"id":"3580436163482352","authorId":"3580436163482352","name":"JohnLoh00","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580436163482352","authorIdStr":"3580436163482352"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/862668854","repostId":"1120355916","repostType":4,"isVote":1,"tweetType":1,"viewCount":826,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":866577311,"gmtCreate":1632793917233,"gmtModify":1632797572773,"author":{"id":"3580436163482352","authorId":"3580436163482352","name":"JohnLoh00","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580436163482352","authorIdStr":"3580436163482352"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/866577311","repostId":"1199853438","repostType":4,"isVote":1,"tweetType":1,"viewCount":277,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":868143094,"gmtCreate":1632623252318,"gmtModify":1632650711674,"author":{"id":"3580436163482352","authorId":"3580436163482352","name":"JohnLoh00","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580436163482352","authorIdStr":"3580436163482352"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/868143094","repostId":"2170614921","repostType":4,"isVote":1,"tweetType":1,"viewCount":294,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":868965488,"gmtCreate":1632578047444,"gmtModify":1632655733823,"author":{"id":"3580436163482352","authorId":"3580436163482352","name":"JohnLoh00","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580436163482352","authorIdStr":"3580436163482352"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/868965488","repostId":"1117076176","repostType":4,"isVote":1,"tweetType":1,"viewCount":237,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":869838777,"gmtCreate":1632271331099,"gmtModify":1632801612990,"author":{"id":"3580436163482352","authorId":"3580436163482352","name":"JohnLoh00","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580436163482352","authorIdStr":"3580436163482352"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/869838777","repostId":"2169637141","repostType":4,"isVote":1,"tweetType":1,"viewCount":143,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":860401147,"gmtCreate":1632193476289,"gmtModify":1632802148971,"author":{"id":"3580436163482352","authorId":"3580436163482352","name":"JohnLoh00","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580436163482352","authorIdStr":"3580436163482352"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/860401147","repostId":"1159687756","repostType":4,"repost":{"id":"1159687756","pubTimestamp":1632190724,"share":"https://www.laohu8.com/m/news/1159687756?lang=&edition=full","pubTime":"2021-09-21 10:18","market":"us","language":"en","title":"Got $1,000? Buy These Hot Growth Stocks Before They Take Off","url":"https://stock-news.laohu8.com/highlight/detail?id=1159687756","media":"Motley Fool","summary":"You don't need a lot of money to make a difference with the right growth stocks.","content":"<p><b>Key Points</b></p>\n<ul>\n <li>A little money can go a long way when volatility turns stocks you want to buy into even bigger bargains.</li>\n <li>Crocs is a name on this list, a surprising winner that is still sneaking up on investors with its masterful turnaround.</li>\n <li>The other two names are growing fast in a booming streaming video market.</li>\n</ul>\n<p>The market's off to a shaky start this week, but there's opportunity in the volatility. Now is a good time to size up some of the stocks on your shopping to list, asking yourself if the stories are getting better even as the stocks are going nowhere.</p>\n<p>You don't need a lot of money to take advantage of the ups and downs of Wall Street. Just $1,000 can go a long way if you are buying the right growth stocks, and right now I like&nbsp;<b>Crocs</b>&nbsp;(NASDAQ:CROX),<b>fuboTV</b>(NYSE:FUBO), and&nbsp;<b>Roku</b>(NASDAQ:ROKU). The first one is a surprising winner in 2021. The other two are surprising laggards. Even though $1,000 will buy you just a couple of shares in some of these names, let's get into why I see these as growth stocks that are about to take off.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5eb5fb95534102c76d3a38d3bea8ad5b\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"><span>IMAGE SOURCE: GETTY IMAGES.</span></p>\n<p><b>1. Crocs</b></p>\n<p>If you haven't been following Crocs lately you may be surprised at how well the stock has been doing. The maker of hole-filled resin shoes has more than doubled in 2021, nearly quadrupling since the start of last year.</p>\n<p>Crocs has had its ups and downs over the years, but it's clearly on an upswing now. The revival started in 2017 when a new CEO came in just as the maker of unique footwear was posting its third straight year of declining sales. Revenue growth turned slightly positive in 2018 with a 6% increase, followed by back-to-back years of 13% top-line upticks. This year Crocs is running on an entirely different level.</p>\n<p>Back in February Crocs was targeting 20% to 25% revenue gains for all of 2021, a great achievement as it would be nearly doubling its growth from the prior year. In late April the guidance was bumped to 40% to 50% in top-line growth, and this summer it got boosted again. Crocs now sees a 60% to 65% increase in revenue in 2021.</p>\n<p>The pandemic made us appreciate Crocs again. We chose comfort over fashion during the shelter-in-place phase of the pandemic. Now that we're out and about again we're not giving up our Crocs. We're seeing celebrities strutting in Crocs at media events and out in the wild. Crocs are showing up in movies like this summer's&nbsp;<i>Suicide Squad</i>. The stock may have hit&nbsp;an all-time high last week, but with a lot of people still skeptical on the turnaround the bullish argument here is that the rally is just beginning.</p>\n<p><b>2. fuboTV</b></p>\n<p>When you size up the IPO class of 2020, fuboTV should be the teacher's pet. Some debutantes appear to be peaking just before their stock offerings, but the live TV streaming service is&nbsp;stepping on the gas. Let's just go over the top-line performance in fuboTV's first four quarters as a public company.</p>\n<ul>\n <li>Q3 2020: 71% revenue growth.</li>\n <li>Q4 2020: 98% revenue growth.</li>\n <li>Q1 2021: 135% revenue growth.</li>\n <li>Q2 2021: 196% revenue growth.</li>\n</ul>\n<p>A 138% increase in subscribers over the past year coupled with a 30% pop in average revenue per user is why fuboTV's revenue has nearly tripled. The near-term outlook is even more exciting. As a sports-minded streaming service -- with more than three dozen of its over 100 channels dedicated to live sporting events -- it knows its audience. It introduced free-to-play predictive games and live layered stats this summer, and it expects to roll out a sportsbook to allow viewers to place cash bets on the games they're watching before the end of the year.</p>\n<p>Despite the perpetual improvement at fuboTV the stock is roughly where it was when the year began. With sports season heating up, fuboTV's engaged audience will help it win this game.</p>\n<p><b>3. Roku</b></p>\n<p>There are worse things than standing in place, and right now Roku is trading slightly lower in 2021. It doesn't seem fair. Roku continues to be the platform of choice for folks streaming from home, with 38% of all smart TVs rolling out with Roku's operating system as the default factory-installed operating system. If you don't happen to buy a Roku-ready TV you can buy a dongle for as little as $20 to $30 that will plug into one of your TV's HDMI ports.</p>\n<p>This is a growing market, and even if viewing hours slipped this summer as we began to venture outside again the long-term trend is undeniable. We love streaming video entertainment from home. Sunday's Emmy Awards is another reminder that the best shows on TV these days are largely on premium streaming services.</p>\n<p>Despite the slight dip in sequential consumption in its latest quarter and the&nbsp;recent challenge&nbsp;of a competitor introducing its own TVs, Roku has never been better. The record 55.1 million active accounts on the platform at the end of June was a 28% increase from where it was a year ago, and like fuboTV we're seeing average revenue per user advance at a double-digit percentage clip. Roku is a worthy leader among&nbsp;streaming service stocks. The stock taking a small step back in 2021 at a time when the fundamentals continue to move forward makes this a strong candidate to take off once the dust settles.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Got $1,000? Buy These Hot Growth Stocks Before They Take Off</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGot $1,000? Buy These Hot Growth Stocks Before They Take Off\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-21 10:18 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/20/got-1000-buy-these-hot-growth-stocks-before-they-t/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Key Points\n\nA little money can go a long way when volatility turns stocks you want to buy into even bigger bargains.\nCrocs is a name on this list, a surprising winner that is still sneaking up on ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/20/got-1000-buy-these-hot-growth-stocks-before-they-t/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"FUBO":"fuboTV Inc.","CROX":"卡骆驰","ROKU":"Roku Inc"},"source_url":"https://www.fool.com/investing/2021/09/20/got-1000-buy-these-hot-growth-stocks-before-they-t/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159687756","content_text":"Key Points\n\nA little money can go a long way when volatility turns stocks you want to buy into even bigger bargains.\nCrocs is a name on this list, a surprising winner that is still sneaking up on investors with its masterful turnaround.\nThe other two names are growing fast in a booming streaming video market.\n\nThe market's off to a shaky start this week, but there's opportunity in the volatility. Now is a good time to size up some of the stocks on your shopping to list, asking yourself if the stories are getting better even as the stocks are going nowhere.\nYou don't need a lot of money to take advantage of the ups and downs of Wall Street. Just $1,000 can go a long way if you are buying the right growth stocks, and right now I like Crocs (NASDAQ:CROX),fuboTV(NYSE:FUBO), and Roku(NASDAQ:ROKU). The first one is a surprising winner in 2021. The other two are surprising laggards. Even though $1,000 will buy you just a couple of shares in some of these names, let's get into why I see these as growth stocks that are about to take off.\nIMAGE SOURCE: GETTY IMAGES.\n1. Crocs\nIf you haven't been following Crocs lately you may be surprised at how well the stock has been doing. The maker of hole-filled resin shoes has more than doubled in 2021, nearly quadrupling since the start of last year.\nCrocs has had its ups and downs over the years, but it's clearly on an upswing now. The revival started in 2017 when a new CEO came in just as the maker of unique footwear was posting its third straight year of declining sales. Revenue growth turned slightly positive in 2018 with a 6% increase, followed by back-to-back years of 13% top-line upticks. This year Crocs is running on an entirely different level.\nBack in February Crocs was targeting 20% to 25% revenue gains for all of 2021, a great achievement as it would be nearly doubling its growth from the prior year. In late April the guidance was bumped to 40% to 50% in top-line growth, and this summer it got boosted again. Crocs now sees a 60% to 65% increase in revenue in 2021.\nThe pandemic made us appreciate Crocs again. We chose comfort over fashion during the shelter-in-place phase of the pandemic. Now that we're out and about again we're not giving up our Crocs. We're seeing celebrities strutting in Crocs at media events and out in the wild. Crocs are showing up in movies like this summer's Suicide Squad. The stock may have hit an all-time high last week, but with a lot of people still skeptical on the turnaround the bullish argument here is that the rally is just beginning.\n2. fuboTV\nWhen you size up the IPO class of 2020, fuboTV should be the teacher's pet. Some debutantes appear to be peaking just before their stock offerings, but the live TV streaming service is stepping on the gas. Let's just go over the top-line performance in fuboTV's first four quarters as a public company.\n\nQ3 2020: 71% revenue growth.\nQ4 2020: 98% revenue growth.\nQ1 2021: 135% revenue growth.\nQ2 2021: 196% revenue growth.\n\nA 138% increase in subscribers over the past year coupled with a 30% pop in average revenue per user is why fuboTV's revenue has nearly tripled. The near-term outlook is even more exciting. As a sports-minded streaming service -- with more than three dozen of its over 100 channels dedicated to live sporting events -- it knows its audience. It introduced free-to-play predictive games and live layered stats this summer, and it expects to roll out a sportsbook to allow viewers to place cash bets on the games they're watching before the end of the year.\nDespite the perpetual improvement at fuboTV the stock is roughly where it was when the year began. With sports season heating up, fuboTV's engaged audience will help it win this game.\n3. Roku\nThere are worse things than standing in place, and right now Roku is trading slightly lower in 2021. It doesn't seem fair. Roku continues to be the platform of choice for folks streaming from home, with 38% of all smart TVs rolling out with Roku's operating system as the default factory-installed operating system. If you don't happen to buy a Roku-ready TV you can buy a dongle for as little as $20 to $30 that will plug into one of your TV's HDMI ports.\nThis is a growing market, and even if viewing hours slipped this summer as we began to venture outside again the long-term trend is undeniable. We love streaming video entertainment from home. Sunday's Emmy Awards is another reminder that the best shows on TV these days are largely on premium streaming services.\nDespite the slight dip in sequential consumption in its latest quarter and the recent challenge of a competitor introducing its own TVs, Roku has never been better. The record 55.1 million active accounts on the platform at the end of June was a 28% increase from where it was a year ago, and like fuboTV we're seeing average revenue per user advance at a double-digit percentage clip. Roku is a worthy leader among streaming service stocks. The stock taking a small step back in 2021 at a time when the fundamentals continue to move forward makes this a strong candidate to take off once the dust settles.","news_type":1},"isVote":1,"tweetType":1,"viewCount":74,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":860067721,"gmtCreate":1632108948463,"gmtModify":1632802775095,"author":{"id":"3580436163482352","authorId":"3580436163482352","name":"JohnLoh00","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580436163482352","authorIdStr":"3580436163482352"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/860067721","repostId":"2168505605","repostType":4,"repost":{"id":"2168505605","pubTimestamp":1632107672,"share":"https://www.laohu8.com/m/news/2168505605?lang=&edition=full","pubTime":"2021-09-20 11:14","market":"us","language":"en","title":"3 Stocks to Add to Your Portfolio in a Market Pull-Back","url":"https://stock-news.laohu8.com/highlight/detail?id=2168505605","media":"Motley Fool","summary":"These great stocks are just a little too expensive to be perfect investments right now.","content":"<p>Stocks are expensive right now, with the <b>S&amp;P 500</b> price-to-earnings ratio at its highest level since the dot-com bubble. That doesn't mean that investors should be selling all their stocks and waiting for the next crash. It could be a while until a correction occurs, and that sort of strategy would have caused you to miss out on the past year of market growth.</p>\n<p>Still, some shrewd investors have built more defensive portfolios and are waiting for a pull-back to scoop up great companies that happen to have aggressive valuations right now. These three stocks are great opportunities that you should consider if they get any cheaper.</p>\n<h2>Nvidia</h2>\n<p><b>Nvidia</b> (NASDAQ:NVDA) is a rockstar tech stock with outstanding growth catalysts, and it's returned more than 230% since the pandemic market bottom in March 2020.</p>\n<p class=\"t-img-caption\"><img src=\"https://media.ycharts.com/charts/e4d03dae188b51897bf508dc9b12336c.png\" tg-width=\"720\" tg-height=\"387\" width=\"100%\" height=\"auto\"><span>NVDA data by YCharts</span></p>\n<p>Nvidia is the global market leader in PC graphics processor units (GPU), with 83% market share. The company supplies microchips that are essential for gaming, high-performance video, and other applications that require more advanced visual hardware. The global video game market is expected to grow more than 12% annually over the next five years, and high-resolution video content continues to become a preferred media for consumers. Those factors alone provide catalysts for Nvidia for the foreseeable future.</p>\n<p>However, Nvidia's opportunity isn't limited to gaming and personal computing. The company's chips have important applications in data centers, the automotive and autonomous vehicle industry, artificial intelligence and automation technology, and 5G network infrastructure. Connection to those trends provides an even more enticing growth opportunity.</p>\n<p>What's the catch here? Nvidia is expensive. Its forward price-to-earnings ratio of 55 is high relative to most other semiconductor stocks, and it's substantially higher than Nvidia's own recent historical levels. Even the PEG ratio, which takes into account the company's bullish growth forecast, indicates an expensive-looking stock.</p>\n<p class=\"t-img-caption\"><img src=\"https://media.ycharts.com/charts/a51764bc0c3216578fb6c349d060cc6d.png\" tg-width=\"720\" tg-height=\"387\" width=\"100%\" height=\"auto\"><span>NVDA P/E Ratio (Forward 1y) data by YCharts</span></p>\n<p>Overall, it seems that Nvidia is a great stock to own, but there might be less expensive alternatives that can deliver better fundamentals for the price. If there's a market pull-back anytime soon, Nvidia should be <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the first stocks to consider at a lower price.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/32358a5a70714295cef5e46d939c1d3e\" tg-width=\"700\" tg-height=\"404\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Chipotle</h2>\n<p><b>Chipotle Mexican Grill</b> (NYSE:CMG) is a chain of well-known, fast-casual restaurants. The company has managed to endure a handful of scandals and an unprecedented pandemic, and it just keeps on growing. The chain's perceived value, nutrition, quality, and convenience clearly resonate with consumers. With double-digit growth forecast for this year and next, it doesn't seem like there's any reason to expect Chipotle to falter soon.</p>\n<p>Chipotle has plenty of avenues for continued growth that excite investors. It has fewer than 2,900 locations, less than half of its sales are from its digital channel, and delivery services only produce 1% of total revenue. The company produces substantial cash flow, and the only debt on its balance sheet is related to operating lease obligations, not loans. That limits financial risk and means that Chipotle could easily source capital for growth if the need arose.</p>\n<p>Once again, the issue here is really about valuation. Chipotle has often attracted aggressive valuation multiples, and its 56 forward P/E ratio seems more characteristic of a tech company than an established restaurant chain. Its enterprise-value-to-EBITDA ratio of 50 indicates that it's not a situation in which earnings per share misrepresent true profits. Chipotle is simply expensive to own. If the market gives you an opportunity to scoop up some shares at a more attractive price, it's worth consideration.</p>\n<h2><a href=\"https://laohu8.com/S/V\">Visa</a></h2>\n<p><b>Visa</b> (NYSE:V) is a household name with a brand that's nearly synonymous with credit and debit cards. People see that logo every day, and it's also featured on the front doors of countless restaurants and retailers that accept Visa cards. There's more going on under the surface here, too, and this company offers some exposure to a wider fintech revolution that's been occurring.</p>\n<p>Visa is really a payment processing network with global reach, rather than a credit card supplier. This is a rapidly evolving landscape with the likes of <b>Square</b> (NYSE:SQ), <b><a href=\"https://laohu8.com/S/PYPL\">PayPal</a></b> (NASDAQ:PYPL), countless ambitious start-ups, and various blockchain solutions springing up to bring efficiency and security to digital payments and transfers.</p>\n<p>Visa remains competitive by making acquisitions and creating partnerships with innovators that might otherwise turn into competitors. Regulators blocked its acquisition of Plaid, and Visa pivoted by purchasing the B2B cross-border payment platform Currencycloud and Tink, a European open-banking platform for consumers.</p>\n<p>Visa offers a compelling business narrative, but its value as an investment is a bit less straightforward. It's hard to consider this a value stock with a forward P/E ratio of 30.6 and a 0.6% dividend yield. Like many other stocks, Visa is near the high end of its recent range for the P/E ratio.</p>\n<p class=\"t-img-caption\"><img src=\"https://media.ycharts.com/charts/e6f09aebc95eb66f909e97fb08b12336.png\" tg-width=\"720\" tg-height=\"387\" width=\"100%\" height=\"auto\"><span>V Normalized PE Ratio (Annual) data by YCharts</span></p>\n<p>On the other hand, Visa is mature compared to other fintech stocks and doesn't have quite the same growth prospects. It's also in a tough spot as the incumbent power in an industry that's undergoing rapid evolution. If we have a market correction, Visa would suddenly look a lot better as a value investment with more upside than most. If the stock's price dips around 15%, its PEG ratio would creep toward 1.5. At that valuation, I would buy Visa hand over fist as a cash flow generator with uncommon growth potential.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks to Add to Your Portfolio in a Market Pull-Back</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks to Add to Your Portfolio in a Market Pull-Back\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-20 11:14 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/19/3-stocks-to-add-to-your-portfolio-in-a-market-pull/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Stocks are expensive right now, with the S&P 500 price-to-earnings ratio at its highest level since the dot-com bubble. That doesn't mean that investors should be selling all their stocks and waiting ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/19/3-stocks-to-add-to-your-portfolio-in-a-market-pull/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CMG":"墨式烧烤","NVDA":"英伟达","V":"Visa"},"source_url":"https://www.fool.com/investing/2021/09/19/3-stocks-to-add-to-your-portfolio-in-a-market-pull/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2168505605","content_text":"Stocks are expensive right now, with the S&P 500 price-to-earnings ratio at its highest level since the dot-com bubble. That doesn't mean that investors should be selling all their stocks and waiting for the next crash. It could be a while until a correction occurs, and that sort of strategy would have caused you to miss out on the past year of market growth.\nStill, some shrewd investors have built more defensive portfolios and are waiting for a pull-back to scoop up great companies that happen to have aggressive valuations right now. These three stocks are great opportunities that you should consider if they get any cheaper.\nNvidia\nNvidia (NASDAQ:NVDA) is a rockstar tech stock with outstanding growth catalysts, and it's returned more than 230% since the pandemic market bottom in March 2020.\nNVDA data by YCharts\nNvidia is the global market leader in PC graphics processor units (GPU), with 83% market share. The company supplies microchips that are essential for gaming, high-performance video, and other applications that require more advanced visual hardware. The global video game market is expected to grow more than 12% annually over the next five years, and high-resolution video content continues to become a preferred media for consumers. Those factors alone provide catalysts for Nvidia for the foreseeable future.\nHowever, Nvidia's opportunity isn't limited to gaming and personal computing. The company's chips have important applications in data centers, the automotive and autonomous vehicle industry, artificial intelligence and automation technology, and 5G network infrastructure. Connection to those trends provides an even more enticing growth opportunity.\nWhat's the catch here? Nvidia is expensive. Its forward price-to-earnings ratio of 55 is high relative to most other semiconductor stocks, and it's substantially higher than Nvidia's own recent historical levels. Even the PEG ratio, which takes into account the company's bullish growth forecast, indicates an expensive-looking stock.\nNVDA P/E Ratio (Forward 1y) data by YCharts\nOverall, it seems that Nvidia is a great stock to own, but there might be less expensive alternatives that can deliver better fundamentals for the price. If there's a market pull-back anytime soon, Nvidia should be one of the first stocks to consider at a lower price.\nImage source: Getty Images.\nChipotle\nChipotle Mexican Grill (NYSE:CMG) is a chain of well-known, fast-casual restaurants. The company has managed to endure a handful of scandals and an unprecedented pandemic, and it just keeps on growing. The chain's perceived value, nutrition, quality, and convenience clearly resonate with consumers. With double-digit growth forecast for this year and next, it doesn't seem like there's any reason to expect Chipotle to falter soon.\nChipotle has plenty of avenues for continued growth that excite investors. It has fewer than 2,900 locations, less than half of its sales are from its digital channel, and delivery services only produce 1% of total revenue. The company produces substantial cash flow, and the only debt on its balance sheet is related to operating lease obligations, not loans. That limits financial risk and means that Chipotle could easily source capital for growth if the need arose.\nOnce again, the issue here is really about valuation. Chipotle has often attracted aggressive valuation multiples, and its 56 forward P/E ratio seems more characteristic of a tech company than an established restaurant chain. Its enterprise-value-to-EBITDA ratio of 50 indicates that it's not a situation in which earnings per share misrepresent true profits. Chipotle is simply expensive to own. If the market gives you an opportunity to scoop up some shares at a more attractive price, it's worth consideration.\nVisa\nVisa (NYSE:V) is a household name with a brand that's nearly synonymous with credit and debit cards. People see that logo every day, and it's also featured on the front doors of countless restaurants and retailers that accept Visa cards. There's more going on under the surface here, too, and this company offers some exposure to a wider fintech revolution that's been occurring.\nVisa is really a payment processing network with global reach, rather than a credit card supplier. This is a rapidly evolving landscape with the likes of Square (NYSE:SQ), PayPal (NASDAQ:PYPL), countless ambitious start-ups, and various blockchain solutions springing up to bring efficiency and security to digital payments and transfers.\nVisa remains competitive by making acquisitions and creating partnerships with innovators that might otherwise turn into competitors. Regulators blocked its acquisition of Plaid, and Visa pivoted by purchasing the B2B cross-border payment platform Currencycloud and Tink, a European open-banking platform for consumers.\nVisa offers a compelling business narrative, but its value as an investment is a bit less straightforward. It's hard to consider this a value stock with a forward P/E ratio of 30.6 and a 0.6% dividend yield. Like many other stocks, Visa is near the high end of its recent range for the P/E ratio.\nV Normalized PE Ratio (Annual) data by YCharts\nOn the other hand, Visa is mature compared to other fintech stocks and doesn't have quite the same growth prospects. It's also in a tough spot as the incumbent power in an industry that's undergoing rapid evolution. If we have a market correction, Visa would suddenly look a lot better as a value investment with more upside than most. If the stock's price dips around 15%, its PEG ratio would creep toward 1.5. At that valuation, I would buy Visa hand over fist as a cash flow generator with uncommon growth potential.","news_type":1},"isVote":1,"tweetType":1,"viewCount":113,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":887097920,"gmtCreate":1631940583860,"gmtModify":1632805171963,"author":{"id":"3580436163482352","authorId":"3580436163482352","name":"JohnLoh00","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580436163482352","authorIdStr":"3580436163482352"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/887097920","repostId":"2168574191","repostType":4,"repost":{"id":"2168574191","pubTimestamp":1631928823,"share":"https://www.laohu8.com/m/news/2168574191?lang=&edition=full","pubTime":"2021-09-18 09:33","market":"us","language":"en","title":"Pfizer Covid-19 shot's protection against hospitalisation wanes in study","url":"https://stock-news.laohu8.com/highlight/detail?id=2168574191","media":"The Straits Times","summary":"WASHINGTON (BLOOMBERG) - Pfizer's Covid-19 vaccine declined in protection against hospitalisation af","content":"<div>\n<p>WASHINGTON (BLOOMBERG) - Pfizer's Covid-19 vaccine declined in protection against hospitalisation after four months, while Moderna's remained stable, US researchers found in an analysis of data from ...</p>\n\n<a href=\"http://www.straitstimes.com/world/united-states/pfizer-covid-19-shots-protection-against-hospitalisation-wanes-in-study\">Web Link</a>\n\n</div>\n","source":"straits_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Covid-19 shot's protection against hospitalisation wanes in study</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Covid-19 shot's protection against hospitalisation wanes in study\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-18 09:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://www.straitstimes.com/world/united-states/pfizer-covid-19-shots-protection-against-hospitalisation-wanes-in-study><strong>The Straits Times</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>WASHINGTON (BLOOMBERG) - Pfizer's Covid-19 vaccine declined in protection against hospitalisation after four months, while Moderna's remained stable, US researchers found in an analysis of data from ...</p>\n\n<a href=\"http://www.straitstimes.com/world/united-states/pfizer-covid-19-shots-protection-against-hospitalisation-wanes-in-study\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"http://www.straitstimes.com/world/united-states/pfizer-covid-19-shots-protection-against-hospitalisation-wanes-in-study","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2168574191","content_text":"WASHINGTON (BLOOMBERG) - Pfizer's Covid-19 vaccine declined in protection against hospitalisation after four months, while Moderna's remained stable, US researchers found in an analysis of data from 21 US hospitals across 18 states.\nTwo doses of either vaccine provided more protection against hospitalisation than the one-dose Johnson & Johnson vaccine, the study found, though Pfizer's advantage over J&J narrowed over time, according to the study published on Friday (Sept 17) by the Centres for Disease Control and Prevention with collaborators across the country.\nAll three vaccines provided substantial protection after four months - Moderna's was 92 per cent effective against hospitalisation by then, with Pfizer's at 77 per cent and J&J at 68 per cent.\nThe data, published on Friday, may influence the debate over whether Americans should receive a third dose of vaccine to ward off the virus.\nAdvisers to the Food and Drug Administration are expected to vote on Friday on whether to recommend a booster shot, and they've mostly had to rely on data from Israel and the UK on whether the shots' effectiveness wanes over time.\nThe US is facing a surge of Covid-19 infections fuelled by the highly transmissible Delta variant, particularly among unvaccinated parts of the country, and breakthrough infections among vaccinated people have become more common.\nThe CDC study looked at 3,689 non-immunocompromised adults from March to August. The researchers noted that the vaccine effectiveness differences between Moderna and Pfizer's shots, which both use a mechanism called messenger RNA, could be due to differences in timings between doses.\nThe second dose of the Pfizer vaccine is typically delivered after three weeks, while Moderna patients wait four weeks.\nThey also noted several limitations to the study, including the fact that a relatively small number of patients had received the J&J vaccine compared with the mRNA vaccines.\nPrevious studies have found that Moderna's vaccine appears to generate more antibodies than Pfizer's, though it's not clear if antibodies are even the most important component in immunity over the long term.","news_type":1},"isVote":1,"tweetType":1,"viewCount":120,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":885045807,"gmtCreate":1631748395909,"gmtModify":1632806492193,"author":{"id":"3580436163482352","authorId":"3580436163482352","name":"JohnLoh00","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580436163482352","authorIdStr":"3580436163482352"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/885045807","repostId":"1121883775","repostType":4,"repost":{"id":"1121883775","pubTimestamp":1631719213,"share":"https://www.laohu8.com/m/news/1121883775?lang=&edition=full","pubTime":"2021-09-15 23:20","market":"us","language":"en","title":"For GameStop Stock Investors, Perception May Be Reality That’s in the Way","url":"https://stock-news.laohu8.com/highlight/detail?id=1121883775","media":"InvestorPlace","summary":"Now a leaner company, GME stock may be whatever investors want it to be","content":"<p>There are few things more powerful than your own beliefs. This is playing out in a big way with the meme stock trade, particularly with the original,<b>GameStop</b>&nbsp;(NYSE:<b><u>GME</u></b>). And eight months after trading for over $500 per share, GME stock remains one of the most intriguing.</p>\n<p>Did I just say put “GME stock” and “intriguing” in the same sentence? I did, but probably not for the reason you may think. The company has made a smart pivot to e-commerce. And retail investors have helped fund this transition as evidenced by the $1.1 billion at-the-market offering the company conducted in June.</p>\n<p>As a result of that transition, GameStop is emerging as a leaner company. On the second-quarter&nbsp;earnings call, CEO Matt Furlong remarked that GameStop’s year-over-year debt level was down $424.7 million. He also remarked that the company’s only long-term debt is a $47.5 million low-interest unsecured term loan.</p>\n<p><b>Difficult ComparisonsChallenge GME Stock</b></p>\n<p>However, while revenue is trending in the right direction, the comparisons become difficult. GameStop’s fiscal year runs from February through January. And for the first two quarters of this year, GameStop delivered revenue of $1.28 billion and $1.18 billion. That is higher than in FY2020 when the company reported revenue of $1.02 billion and $942 million in the respective quarters.</p>\n<p>But that may not be a fair comparison. So I looked back to FY2019. And the revenue for the first two quarters of that year came in at $1.55 billion and $1.29 billion, respectively. That’s a 13% decline.</p>\n<p>I know that GME bulls will say that I’m not comparing apples to apples. In 2019, the company was relying on revenue from its brick-and-mortar business. Now the company is focused on e-commerce. And investors would be quick to point out that hardware sales are being affected by the global chip shortage. Except they’re not. In fact, hardware sales were up on a year-over-year basis.</p>\n<p>The more alarming trend is software sales, which continue to be in free fall. And with more and more gamers opting for digital downloads, it’s unlikely that the company will be able to reverse this trend.</p>\n<p>Plus the company is not completely reliant on e-commerce at this time. On the earnings call, Furlong noted that the company reported a 9% reduction in its “global store fleet.” This is a good move, but the transition will still take time.</p>\n<p><b>What Comes Next?</b></p>\n<p>This is where things become more problematic. Specifically because GameStop is not offering investors any forward guidance. However, the company did reiterate that they “believe total net sales is the most appropriate metric to evaluate performance at this time.”</p>\n<p>This is why&nbsp;I believe that the perception of GameStop may be all that matters.</p>\n<p>GME stock bulls will say the analyst community unfairly is stuck in the past and fails to see the e-commerce opportunity that exists. However, GME skeptics will point out that GameStop is attempting to compete in a hyper-competitive market.</p>\n<p><b>GME Stock is Developing a Pattern</b></p>\n<p>They say when something happens three times,it becomes a pattern. So I find it intriguing that for the third-straight earnings report, GME stock has gapped down after earnings. When this happened in March, the stock recovered its former share price and, in fact, closed as high as $300 before the company’s June earnings.</p>\n<p>However, since then the stock has been on a steady downtrend. And that’s why I’m still of the mindset that GameStop has a heavy lift.</p>\n<p>I think&nbsp;<i>InvestorPlace</i>&nbsp;contributor Thomas Niel summarized my feelings best when discussing therisk/reward scenariofor GME stock. Simply put, it’s more likely that over time (those are critical words), the likelihood for the stock to take a large move down appears to be greater than the possibility that the stock will soar higher.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>For GameStop Stock Investors, Perception May Be Reality That’s in the Way</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFor GameStop Stock Investors, Perception May Be Reality That’s in the Way\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-15 23:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/09/gme-stock-remains-question-perception-versus-reality/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>There are few things more powerful than your own beliefs. This is playing out in a big way with the meme stock trade, particularly with the original,GameStop (NYSE:GME). And eight months after trading...</p>\n\n<a href=\"https://investorplace.com/2021/09/gme-stock-remains-question-perception-versus-reality/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GME":"游戏驿站"},"source_url":"https://investorplace.com/2021/09/gme-stock-remains-question-perception-versus-reality/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1121883775","content_text":"There are few things more powerful than your own beliefs. This is playing out in a big way with the meme stock trade, particularly with the original,GameStop (NYSE:GME). And eight months after trading for over $500 per share, GME stock remains one of the most intriguing.\nDid I just say put “GME stock” and “intriguing” in the same sentence? I did, but probably not for the reason you may think. The company has made a smart pivot to e-commerce. And retail investors have helped fund this transition as evidenced by the $1.1 billion at-the-market offering the company conducted in June.\nAs a result of that transition, GameStop is emerging as a leaner company. On the second-quarter earnings call, CEO Matt Furlong remarked that GameStop’s year-over-year debt level was down $424.7 million. He also remarked that the company’s only long-term debt is a $47.5 million low-interest unsecured term loan.\nDifficult ComparisonsChallenge GME Stock\nHowever, while revenue is trending in the right direction, the comparisons become difficult. GameStop’s fiscal year runs from February through January. And for the first two quarters of this year, GameStop delivered revenue of $1.28 billion and $1.18 billion. That is higher than in FY2020 when the company reported revenue of $1.02 billion and $942 million in the respective quarters.\nBut that may not be a fair comparison. So I looked back to FY2019. And the revenue for the first two quarters of that year came in at $1.55 billion and $1.29 billion, respectively. That’s a 13% decline.\nI know that GME bulls will say that I’m not comparing apples to apples. In 2019, the company was relying on revenue from its brick-and-mortar business. Now the company is focused on e-commerce. And investors would be quick to point out that hardware sales are being affected by the global chip shortage. Except they’re not. In fact, hardware sales were up on a year-over-year basis.\nThe more alarming trend is software sales, which continue to be in free fall. And with more and more gamers opting for digital downloads, it’s unlikely that the company will be able to reverse this trend.\nPlus the company is not completely reliant on e-commerce at this time. On the earnings call, Furlong noted that the company reported a 9% reduction in its “global store fleet.” This is a good move, but the transition will still take time.\nWhat Comes Next?\nThis is where things become more problematic. Specifically because GameStop is not offering investors any forward guidance. However, the company did reiterate that they “believe total net sales is the most appropriate metric to evaluate performance at this time.”\nThis is why I believe that the perception of GameStop may be all that matters.\nGME stock bulls will say the analyst community unfairly is stuck in the past and fails to see the e-commerce opportunity that exists. However, GME skeptics will point out that GameStop is attempting to compete in a hyper-competitive market.\nGME Stock is Developing a Pattern\nThey say when something happens three times,it becomes a pattern. So I find it intriguing that for the third-straight earnings report, GME stock has gapped down after earnings. When this happened in March, the stock recovered its former share price and, in fact, closed as high as $300 before the company’s June earnings.\nHowever, since then the stock has been on a steady downtrend. And that’s why I’m still of the mindset that GameStop has a heavy lift.\nI think InvestorPlace contributor Thomas Niel summarized my feelings best when discussing therisk/reward scenariofor GME stock. Simply put, it’s more likely that over time (those are critical words), the likelihood for the stock to take a large move down appears to be greater than the possibility that the stock will soar higher.","news_type":1},"isVote":1,"tweetType":1,"viewCount":47,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":885045088,"gmtCreate":1631748377144,"gmtModify":1632806492621,"author":{"id":"3580436163482352","authorId":"3580436163482352","name":"JohnLoh00","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580436163482352","authorIdStr":"3580436163482352"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/885045088","repostId":"2167559884","repostType":4,"repost":{"id":"2167559884","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1631721822,"share":"https://www.laohu8.com/m/news/2167559884?lang=&edition=full","pubTime":"2021-09-16 00:03","market":"us","language":"en","title":"Procept BioRobotics spikes 40% on its first day of trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2167559884","media":"Dow Jones","summary":"Procept BioRobotics spikes 40% on its first day of trading.\n\nProcept BioRobotics Corp. is set to go ","content":"<p>Procept BioRobotics spikes 40% on its first day of trading.</p>\n<p><img src=\"https://static.tigerbbs.com/70f6e6c88567a43f408cd96f913f6476\" tg-width=\"1404\" tg-height=\"888\" width=\"100%\" height=\"auto\"></p>\n<p>Procept BioRobotics Corp.&nbsp;is set to go public Wednesday, as the California-based surgical robotics company's upsized initial public offering priced above the expected range at $25.00 per share. The company sold 6.56 million shares in the IPO to raise $163.9 million. Procept had previously expected to offer 5.5 million shares in the IPO, which was projected to price between $22 and $24 per share. The stock is expected to begin trading Wednesday on the Nasdaq under the ticker symbol \"PRCT.\" With 41.21 million shares outstanding after the IPO, the pricing values Procept at $1.03 billion. BofA Securities and Goldman Sachs are the joint lead bookrunning managers. The company had recorded a net loss of $27.4 million on revenue of $15.7 million in the six months ended June 30, after a loss of $25.7 million on revenue of $2.4 million in the same period a year ago. The company is going public at a time that the <a href=\"https://laohu8.com/S/IPO\">Renaissance IPO ETF</a>&nbsp;has gained 7.4% over the past three months while the S&amp;P 500 has tacked on 4.6%.</p>\n<p><b>Company and Technology</b></p>\n<p>Redwood City, California-based Procept was founded to develop advanced surgical robotic devices for use in minimally invasive procedures.</p>\n<p>Management is headed by President and CEO Reza Zadno, Ph.D., who has been with the firm since February 2020 and was previously president and CEO of Avedro, a healthcare company.</p>\n<p>The company's first instrument is the AquaBeam Robotic System for use in urologic surgery with an initial focus on treating benign prostate hyperplasia.</p>\n<p>Procept has received at least $328 million in equity investment from investors including CPMG, Viking Global, Fidelity and individuals.</p>\n<p>Customer Acquisition</p>\n<p>The firm sells its product to hospitals who in turn charge various third party payors for each service rendered.</p>\n<p>The company is targeting 860 high-volume hospitals which account for 70% of all hospital-based resective procedures.</p>\n<p>Selling, G&amp;A expenses as a percentage of total revenue have dropped substantially as revenues have increased, as the figures below indicate:</p>\n<table>\n <colgroup></colgroup>\n <tbody>\n  <tr>\n   <td><p><b>Selling, G&amp;A</b></p></td>\n   <td><p><b>Expenses vs. Revenue</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Percentage</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>144.5%</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>392.3%</p></td>\n  </tr>\n  <tr>\n   <td><p>2019</p></td>\n   <td><p>462.3%</p></td>\n  </tr>\n </tbody>\n</table>\n<p>The Selling, G&amp;A efficiency rate, defined as how many dollars of additional new revenue are generated by each dollar of Selling, G&amp;A spend, rose to 0.6x in the most recent reporting period, as shown in the table below:</p>\n<table>\n <colgroup></colgroup>\n <tbody>\n  <tr>\n   <td><p><b>Selling, G&amp;A</b></p></td>\n   <td><p><b>Efficiency Rate</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Multiple</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>0.6</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>0.1</p></td>\n  </tr>\n </tbody>\n</table>\n<p><b>Market &amp; Competition</b></p>\n<p>According to a 2018 marketresearch reportby Allied Market Research, the global market for treating benign prostatic hyperplasia was an estimated $10.7 billion in 2017 and is forecast to reach $20.1 billion by 2025.</p>\n<p>This represents a forecast CAGR of 8.1% from 2018 to 2025.</p>\n<p>The main drivers for this expected growth are an increase in disease incidence to the aging of the global population of males.</p>\n<p>Also, alpha-blocker drugs are likely to be a major competitor, as they help in relaxing the muscle of the prostate and the bladder neck, allowing urination to occur more easily.</p>\n<p>Major competitive or other industry participants include:</p>\n<ul>\n <li>Boehringer Ingelheim</li>\n <li>Allergan</li>\n <li>GlaxoSmithKline(NYSE:GSK)</li>\n <li>Merck(NYSE:MRK)</li>\n <li>Teleflex(NYSE:TFX)</li>\n <li>Boston Scientific(NYSE:BSX)</li>\n <li>Others</li>\n</ul>\n<p><b>Financial Performance</b></p>\n<p>Procept’s recent financial results can be summarized as follows:</p>\n<ul>\n <li>Sharply growing top-line revenue from a small base</li>\n <li>A swing to gross profit and positive gross margin</li>\n <li>High and increasing operating losses</li>\n <li>High and increasing cash used in operations</li>\n</ul>\n<p>Below are relevant financial results derived from the firm’s registration statement:</p>\n<p><img src=\"https://static.tigerbbs.com/6fb31b91e96ed681b39c952c72b32105\" tg-width=\"904\" tg-height=\"439\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/94b04bc1fd096b33535887c4c77d17a5\" tg-width=\"906\" tg-height=\"442\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/72b3c6e00fbb7d021141642eb8f69104\" tg-width=\"907\" tg-height=\"441\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/43410c6bd6487d96c4424db32f9c94e7\" tg-width=\"907\" tg-height=\"438\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/0457da194f7ee652bf4bad3deb6fbf40\" tg-width=\"908\" tg-height=\"441\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/12ac204e8226347ff04eb9ca845142aa\" tg-width=\"902\" tg-height=\"439\" referrerpolicy=\"no-referrer\"></p>\n<p>As of June 30, 2021, Procept had $159.2 million in cash and $68.3 million in total liabilities.</p>\n<p>Free cash flow during the twelve months ended June 30, 2021, was negative ($52.7 million).</p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Procept BioRobotics spikes 40% on its first day of trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nProcept BioRobotics spikes 40% on its first day of trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-09-16 00:03</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Procept BioRobotics spikes 40% on its first day of trading.</p>\n<p><img src=\"https://static.tigerbbs.com/70f6e6c88567a43f408cd96f913f6476\" tg-width=\"1404\" tg-height=\"888\" width=\"100%\" height=\"auto\"></p>\n<p>Procept BioRobotics Corp.&nbsp;is set to go public Wednesday, as the California-based surgical robotics company's upsized initial public offering priced above the expected range at $25.00 per share. The company sold 6.56 million shares in the IPO to raise $163.9 million. Procept had previously expected to offer 5.5 million shares in the IPO, which was projected to price between $22 and $24 per share. The stock is expected to begin trading Wednesday on the Nasdaq under the ticker symbol \"PRCT.\" With 41.21 million shares outstanding after the IPO, the pricing values Procept at $1.03 billion. BofA Securities and Goldman Sachs are the joint lead bookrunning managers. The company had recorded a net loss of $27.4 million on revenue of $15.7 million in the six months ended June 30, after a loss of $25.7 million on revenue of $2.4 million in the same period a year ago. The company is going public at a time that the <a href=\"https://laohu8.com/S/IPO\">Renaissance IPO ETF</a>&nbsp;has gained 7.4% over the past three months while the S&amp;P 500 has tacked on 4.6%.</p>\n<p><b>Company and Technology</b></p>\n<p>Redwood City, California-based Procept was founded to develop advanced surgical robotic devices for use in minimally invasive procedures.</p>\n<p>Management is headed by President and CEO Reza Zadno, Ph.D., who has been with the firm since February 2020 and was previously president and CEO of Avedro, a healthcare company.</p>\n<p>The company's first instrument is the AquaBeam Robotic System for use in urologic surgery with an initial focus on treating benign prostate hyperplasia.</p>\n<p>Procept has received at least $328 million in equity investment from investors including CPMG, Viking Global, Fidelity and individuals.</p>\n<p>Customer Acquisition</p>\n<p>The firm sells its product to hospitals who in turn charge various third party payors for each service rendered.</p>\n<p>The company is targeting 860 high-volume hospitals which account for 70% of all hospital-based resective procedures.</p>\n<p>Selling, G&amp;A expenses as a percentage of total revenue have dropped substantially as revenues have increased, as the figures below indicate:</p>\n<table>\n <colgroup></colgroup>\n <tbody>\n  <tr>\n   <td><p><b>Selling, G&amp;A</b></p></td>\n   <td><p><b>Expenses vs. Revenue</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Percentage</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>144.5%</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>392.3%</p></td>\n  </tr>\n  <tr>\n   <td><p>2019</p></td>\n   <td><p>462.3%</p></td>\n  </tr>\n </tbody>\n</table>\n<p>The Selling, G&amp;A efficiency rate, defined as how many dollars of additional new revenue are generated by each dollar of Selling, G&amp;A spend, rose to 0.6x in the most recent reporting period, as shown in the table below:</p>\n<table>\n <colgroup></colgroup>\n <tbody>\n  <tr>\n   <td><p><b>Selling, G&amp;A</b></p></td>\n   <td><p><b>Efficiency Rate</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Multiple</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>0.6</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>0.1</p></td>\n  </tr>\n </tbody>\n</table>\n<p><b>Market &amp; Competition</b></p>\n<p>According to a 2018 marketresearch reportby Allied Market Research, the global market for treating benign prostatic hyperplasia was an estimated $10.7 billion in 2017 and is forecast to reach $20.1 billion by 2025.</p>\n<p>This represents a forecast CAGR of 8.1% from 2018 to 2025.</p>\n<p>The main drivers for this expected growth are an increase in disease incidence to the aging of the global population of males.</p>\n<p>Also, alpha-blocker drugs are likely to be a major competitor, as they help in relaxing the muscle of the prostate and the bladder neck, allowing urination to occur more easily.</p>\n<p>Major competitive or other industry participants include:</p>\n<ul>\n <li>Boehringer Ingelheim</li>\n <li>Allergan</li>\n <li>GlaxoSmithKline(NYSE:GSK)</li>\n <li>Merck(NYSE:MRK)</li>\n <li>Teleflex(NYSE:TFX)</li>\n <li>Boston Scientific(NYSE:BSX)</li>\n <li>Others</li>\n</ul>\n<p><b>Financial Performance</b></p>\n<p>Procept’s recent financial results can be summarized as follows:</p>\n<ul>\n <li>Sharply growing top-line revenue from a small base</li>\n <li>A swing to gross profit and positive gross margin</li>\n <li>High and increasing operating losses</li>\n <li>High and increasing cash used in operations</li>\n</ul>\n<p>Below are relevant financial results derived from the firm’s registration statement:</p>\n<p><img src=\"https://static.tigerbbs.com/6fb31b91e96ed681b39c952c72b32105\" tg-width=\"904\" tg-height=\"439\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/94b04bc1fd096b33535887c4c77d17a5\" tg-width=\"906\" tg-height=\"442\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/72b3c6e00fbb7d021141642eb8f69104\" tg-width=\"907\" tg-height=\"441\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/43410c6bd6487d96c4424db32f9c94e7\" tg-width=\"907\" tg-height=\"438\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/0457da194f7ee652bf4bad3deb6fbf40\" tg-width=\"908\" tg-height=\"441\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/12ac204e8226347ff04eb9ca845142aa\" tg-width=\"902\" tg-height=\"439\" referrerpolicy=\"no-referrer\"></p>\n<p>As of June 30, 2021, Procept had $159.2 million in cash and $68.3 million in total liabilities.</p>\n<p>Free cash flow during the twelve months ended June 30, 2021, was negative ($52.7 million).</p>\n<p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PRCT":"PROCEPT BioRobotics"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2167559884","content_text":"Procept BioRobotics spikes 40% on its first day of trading.\n\nProcept BioRobotics Corp. is set to go public Wednesday, as the California-based surgical robotics company's upsized initial public offering priced above the expected range at $25.00 per share. The company sold 6.56 million shares in the IPO to raise $163.9 million. Procept had previously expected to offer 5.5 million shares in the IPO, which was projected to price between $22 and $24 per share. The stock is expected to begin trading Wednesday on the Nasdaq under the ticker symbol \"PRCT.\" With 41.21 million shares outstanding after the IPO, the pricing values Procept at $1.03 billion. BofA Securities and Goldman Sachs are the joint lead bookrunning managers. The company had recorded a net loss of $27.4 million on revenue of $15.7 million in the six months ended June 30, after a loss of $25.7 million on revenue of $2.4 million in the same period a year ago. The company is going public at a time that the Renaissance IPO ETF has gained 7.4% over the past three months while the S&P 500 has tacked on 4.6%.\nCompany and Technology\nRedwood City, California-based Procept was founded to develop advanced surgical robotic devices for use in minimally invasive procedures.\nManagement is headed by President and CEO Reza Zadno, Ph.D., who has been with the firm since February 2020 and was previously president and CEO of Avedro, a healthcare company.\nThe company's first instrument is the AquaBeam Robotic System for use in urologic surgery with an initial focus on treating benign prostate hyperplasia.\nProcept has received at least $328 million in equity investment from investors including CPMG, Viking Global, Fidelity and individuals.\nCustomer Acquisition\nThe firm sells its product to hospitals who in turn charge various third party payors for each service rendered.\nThe company is targeting 860 high-volume hospitals which account for 70% of all hospital-based resective procedures.\nSelling, G&A expenses as a percentage of total revenue have dropped substantially as revenues have increased, as the figures below indicate:\n\n\n\n\nSelling, G&A\nExpenses vs. Revenue\n\n\nPeriod\nPercentage\n\n\nSix Mos. Ended June 30, 2021\n144.5%\n\n\n2020\n392.3%\n\n\n2019\n462.3%\n\n\n\nThe Selling, G&A efficiency rate, defined as how many dollars of additional new revenue are generated by each dollar of Selling, G&A spend, rose to 0.6x in the most recent reporting period, as shown in the table below:\n\n\n\n\nSelling, G&A\nEfficiency Rate\n\n\nPeriod\nMultiple\n\n\nSix Mos. Ended June 30, 2021\n0.6\n\n\n2020\n0.1\n\n\n\nMarket & Competition\nAccording to a 2018 marketresearch reportby Allied Market Research, the global market for treating benign prostatic hyperplasia was an estimated $10.7 billion in 2017 and is forecast to reach $20.1 billion by 2025.\nThis represents a forecast CAGR of 8.1% from 2018 to 2025.\nThe main drivers for this expected growth are an increase in disease incidence to the aging of the global population of males.\nAlso, alpha-blocker drugs are likely to be a major competitor, as they help in relaxing the muscle of the prostate and the bladder neck, allowing urination to occur more easily.\nMajor competitive or other industry participants include:\n\nBoehringer Ingelheim\nAllergan\nGlaxoSmithKline(NYSE:GSK)\nMerck(NYSE:MRK)\nTeleflex(NYSE:TFX)\nBoston Scientific(NYSE:BSX)\nOthers\n\nFinancial Performance\nProcept’s recent financial results can be summarized as follows:\n\nSharply growing top-line revenue from a small base\nA swing to gross profit and positive gross margin\nHigh and increasing operating losses\nHigh and increasing cash used in operations\n\nBelow are relevant financial results derived from the firm’s registration statement:\n\nAs of June 30, 2021, Procept had $159.2 million in cash and $68.3 million in total liabilities.\nFree cash flow during the twelve months ended June 30, 2021, was negative ($52.7 million).","news_type":1},"isVote":1,"tweetType":1,"viewCount":144,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":885042243,"gmtCreate":1631748359982,"gmtModify":1632806492946,"author":{"id":"3580436163482352","authorId":"3580436163482352","name":"JohnLoh00","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580436163482352","authorIdStr":"3580436163482352"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/885042243","repostId":"2167559884","repostType":4,"isVote":1,"tweetType":1,"viewCount":45,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":820059025,"gmtCreate":1633329368514,"gmtModify":1633329368613,"author":{"id":"3580436163482352","authorId":"3580436163482352","name":"JohnLoh00","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580436163482352","authorIdStr":"3580436163482352"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/820059025","repostId":"1180397845","repostType":4,"isVote":1,"tweetType":1,"viewCount":483,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":828250560,"gmtCreate":1633918243969,"gmtModify":1633918244063,"author":{"id":"3580436163482352","authorId":"3580436163482352","name":"JohnLoh00","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580436163482352","authorIdStr":"3580436163482352"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/828250560","repostId":"1199183279","repostType":4,"isVote":1,"tweetType":1,"viewCount":431,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":840397995,"gmtCreate":1635585228408,"gmtModify":1635585228408,"author":{"id":"3580436163482352","authorId":"3580436163482352","name":"JohnLoh00","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580436163482352","authorIdStr":"3580436163482352"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/840397995","repostId":"1160516340","repostType":4,"isVote":1,"tweetType":1,"viewCount":875,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":862668854,"gmtCreate":1632876185869,"gmtModify":1632876185869,"author":{"id":"3580436163482352","authorId":"3580436163482352","name":"JohnLoh00","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580436163482352","authorIdStr":"3580436163482352"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/862668854","repostId":"1120355916","repostType":4,"repost":{"id":"1120355916","pubTimestamp":1632875501,"share":"https://www.laohu8.com/m/news/1120355916?lang=&edition=full","pubTime":"2021-09-29 08:31","market":"sg","language":"en","title":"What are the four catalysts to an influx of business deals?","url":"https://stock-news.laohu8.com/highlight/detail?id=1120355916","media":"Singapore Business","summary":"Deal volumes and sizes are the highest since Q4 2019.\n\nAccording to a report by Maybank Kim Eng, fou","content":"<blockquote>\n <b>Deal volumes and sizes are the highest since Q4 2019.</b>\n</blockquote>\n<p>According to a report by Maybank Kim Eng, four key drivers were seen as catalysts for business deals in Singapore.</p>\n<p>These four catalysts lie in the pandemic-aided acceleration of structural shifts, distressed business models, integration of green business strategies, and government initiatives.</p>\n<p>\"Underlying trends of digitalization and hybrid-work have accelerated due to COVID restrictions, and this is forcing businesses to adopt fresh strategies of service and product delivery,\" MayBank Kim Eng said.</p>\n<p>Also included in this restructuring is the movement to reach climate goals and de-risk their environmental, social, and governance exposures.</p>\n<p>Singapore’s government has also introduced initiatives, which include a special purpose acquisition company framework, funding for late-stage and initial public offering capital raisins to further support the ecosystem going forward.</p>\n<p>This is on the back of deal volumes and sizes reaching a peak since the fourth quarter of 2019. Currently, privatizations of Singapore Stock Exchange listings are 71% higher than the whole year 2020.</p>\n<p>Deal volumes are notable in real estate in technology, so far this year. Meanwhile, US$20b of mergers and acquisitions transactions are still pending—an amount double of the deals that have already been completed. \"This indicates an acceleration of deal-related activity in [the second half], MayBank said.</p>","source":"lsy1618986048053","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What are the four catalysts to an influx of business deals?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat are the four catalysts to an influx of business deals?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-29 08:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://sbr.com.sg/economy/in-focus/what-are-four-catalysts-influx-business-deals><strong>Singapore Business</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Deal volumes and sizes are the highest since Q4 2019.\n\nAccording to a report by Maybank Kim Eng, four key drivers were seen as catalysts for business deals in Singapore.\nThese four catalysts lie in ...</p>\n\n<a href=\"https://sbr.com.sg/economy/in-focus/what-are-four-catalysts-influx-business-deals\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数","S68.SI":"新加坡交易所"},"source_url":"https://sbr.com.sg/economy/in-focus/what-are-four-catalysts-influx-business-deals","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1120355916","content_text":"Deal volumes and sizes are the highest since Q4 2019.\n\nAccording to a report by Maybank Kim Eng, four key drivers were seen as catalysts for business deals in Singapore.\nThese four catalysts lie in the pandemic-aided acceleration of structural shifts, distressed business models, integration of green business strategies, and government initiatives.\n\"Underlying trends of digitalization and hybrid-work have accelerated due to COVID restrictions, and this is forcing businesses to adopt fresh strategies of service and product delivery,\" MayBank Kim Eng said.\nAlso included in this restructuring is the movement to reach climate goals and de-risk their environmental, social, and governance exposures.\nSingapore’s government has also introduced initiatives, which include a special purpose acquisition company framework, funding for late-stage and initial public offering capital raisins to further support the ecosystem going forward.\nThis is on the back of deal volumes and sizes reaching a peak since the fourth quarter of 2019. Currently, privatizations of Singapore Stock Exchange listings are 71% higher than the whole year 2020.\nDeal volumes are notable in real estate in technology, so far this year. Meanwhile, US$20b of mergers and acquisitions transactions are still pending—an amount double of the deals that have already been completed. \"This indicates an acceleration of deal-related activity in [the second half], MayBank said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":826,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":866577311,"gmtCreate":1632793917233,"gmtModify":1632797572773,"author":{"id":"3580436163482352","authorId":"3580436163482352","name":"JohnLoh00","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580436163482352","authorIdStr":"3580436163482352"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/866577311","repostId":"1199853438","repostType":4,"repost":{"id":"1199853438","pubTimestamp":1632790562,"share":"https://www.laohu8.com/m/news/1199853438?lang=&edition=full","pubTime":"2021-09-28 08:56","market":"us","language":"en","title":"U.S. Bank Stocks Surge Toward Best Year Since 1997 on Fed Shift","url":"https://stock-news.laohu8.com/highlight/detail?id=1199853438","media":"Bloomberg","summary":"U.S. bank stocks are on track for the biggest annual gain in more than two decades as traders increa","content":"<p>U.S. bank stocks are on track for the biggest annual gain in more than two decades as traders increase bets that the Federal Reserve will start raising interest rates as soon as late next year, promising to boost lenders’ profits.</p>\n<p>The KBW Bank Index jumped 2.9% on Monday after 10-year Treasury yields touched the highest level since June on expectations that the Fed is moving closer toward tightening monetary policy as the economy recovers from the pandemic. The advance pushed the index to a gain of 37% this year, the most since 1997.</p>\n<p>READ: Treasury 10-Year Yield Tops 1.5% for <a href=\"https://laohu8.com/S/FBNC\">First</a> <a href=\"https://laohu8.com/S/TIME\">Time</a> Since June</p>\n<p><a href=\"https://laohu8.com/S/ISBC\">Investors</a> began piling back into bank shares last week after the Fed’s latest dot plot showed 9 of 18 officials anticipate a rate hike next year, up from seven in June, and Chair Jerome <a href=\"https://laohu8.com/S/POWL\">Powell</a> said the central bank may soon begin scaling back its massive bond purchases.</p>\n<p>Higher interest rates would provide a boost to banks’ bottom lines by increasing earnings on long-term loans.</p>\n<p>“Recent commentary about both tapering and a potential 2022 rate hike prove positive tailwinds” for asset sensitive banks, Hovde Group analysts include Brett Rabatin wrote in a note.</p>\n<p>All 24 members of the KBW Bank Index have gained at least 3.5% since the Fed’s Sept. 22 meeting, with half of shares rising 10% or more over the four-day rally. Dallas-based <a href=\"https://laohu8.com/S/CMA\">Comerica</a> Inc. has been the best performer, jumping about 15%.</p>\n<p>But <a href=\"https://laohu8.com/S/WFC\">Wells Fargo</a> &amp; Co. has lagged its peers and was the lone decliner on Monday after the bank reached a settlement with the U.S. Justice Department over claims it overcharged commercial customers who used its foreign exchange services.</p>\n<p>While the Fed’s next meeting is not until November, the next major catalyst for banks is just over two weeks away, with <a href=\"https://laohu8.com/S/JPM\">JPMorgan Chase</a> &amp; Co. scheduled to kick off the third-quarter earnings season on Oct. 13.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. Bank Stocks Surge Toward Best Year Since 1997 on Fed Shift</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. Bank Stocks Surge Toward Best Year Since 1997 on Fed Shift\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-28 08:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/u-bank-stocks-surge-toward-173655393.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>U.S. bank stocks are on track for the biggest annual gain in more than two decades as traders increase bets that the Federal Reserve will start raising interest rates as soon as late next year, ...</p>\n\n<a href=\"https://finance.yahoo.com/news/u-bank-stocks-surge-toward-173655393.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BAC":"美国银行"},"source_url":"https://finance.yahoo.com/news/u-bank-stocks-surge-toward-173655393.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1199853438","content_text":"U.S. bank stocks are on track for the biggest annual gain in more than two decades as traders increase bets that the Federal Reserve will start raising interest rates as soon as late next year, promising to boost lenders’ profits.\nThe KBW Bank Index jumped 2.9% on Monday after 10-year Treasury yields touched the highest level since June on expectations that the Fed is moving closer toward tightening monetary policy as the economy recovers from the pandemic. The advance pushed the index to a gain of 37% this year, the most since 1997.\nREAD: Treasury 10-Year Yield Tops 1.5% for First Time Since June\nInvestors began piling back into bank shares last week after the Fed’s latest dot plot showed 9 of 18 officials anticipate a rate hike next year, up from seven in June, and Chair Jerome Powell said the central bank may soon begin scaling back its massive bond purchases.\nHigher interest rates would provide a boost to banks’ bottom lines by increasing earnings on long-term loans.\n“Recent commentary about both tapering and a potential 2022 rate hike prove positive tailwinds” for asset sensitive banks, Hovde Group analysts include Brett Rabatin wrote in a note.\nAll 24 members of the KBW Bank Index have gained at least 3.5% since the Fed’s Sept. 22 meeting, with half of shares rising 10% or more over the four-day rally. Dallas-based Comerica Inc. has been the best performer, jumping about 15%.\nBut Wells Fargo & Co. has lagged its peers and was the lone decliner on Monday after the bank reached a settlement with the U.S. Justice Department over claims it overcharged commercial customers who used its foreign exchange services.\nWhile the Fed’s next meeting is not until November, the next major catalyst for banks is just over two weeks away, with JPMorgan Chase & Co. scheduled to kick off the third-quarter earnings season on Oct. 13.","news_type":1},"isVote":1,"tweetType":1,"viewCount":277,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":868965488,"gmtCreate":1632578047444,"gmtModify":1632655733823,"author":{"id":"3580436163482352","authorId":"3580436163482352","name":"JohnLoh00","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580436163482352","authorIdStr":"3580436163482352"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/868965488","repostId":"1117076176","repostType":4,"repost":{"id":"1117076176","pubTimestamp":1632530515,"share":"https://www.laohu8.com/m/news/1117076176?lang=&edition=full","pubTime":"2021-09-25 08:41","market":"us","language":"en","title":"Cathie Wood Knows Something About Zoom That You Don’t","url":"https://stock-news.laohu8.com/highlight/detail?id=1117076176","media":"investorplace","summary":"ZM stock is down about 20% YTD, but there are reasons to still favor this video-conferencing pick\nEd","content":"<p>ZM stock is down about 20% YTD, but there are reasons to still favor this video-conferencing pick</p>\n<p><i>Editor’s Note: This article is part ofJoanna’s Top Trades</i>—<i>a weekly feature dedicated toward making you money within a specific space. Joanna’s pick for this week is</i><b><i>Zoom</i></b><i>(NASDAQ:</i><i><b><u>ZM</u></b></i><i>) as the top stock to trade this week.</i></p>\n<p>We all know video-calling software maker<b>Zoom</b>&nbsp;(NASDAQ:<b><u>ZM</u></b>). The pandemic high-flier capitalized on a stay-at-home workforce, growing itsusage from 10 million daily meeting participants one year ago to over 200 million.ZM stock enjoyed a meteoric 400% rise in 2020.</p>\n<p><img src=\"https://static.tigerbbs.com/320cf0858628ccaaed68980cabbaefec\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\">Source: Michael Vi / Shutterstock.com</p>\n<p>However, Zoom knows firsthand — like a lot of last year’s tech gainers — that 2021 has been much less forgiving. As the world returns to normalcy, the company’s growth has naturally slowed. Investors have cooled on the story. ZM stock is down about 20% year-to-date (YTD). Plus, adding salt to the wound, the company ishaving trouble closing its recentlyproposed acquisitionof<b>Five9</b>(NASDAQ:<b><u>FIVN</u></b>).</p>\n<p>I love a stock with some good controversy. Zoom fits that bill. The shares are volatile, reflecting investor uncertainty around whether it has enough gas in the tank for a second growth wave.But add a celebrity investor to the mix and things get<i>even more intriguing</i>. Enter Cathie Wood, who’s been scooping up Zoom shares on the dip.</p>\n<p>Is it over for ZM stock? Or is it just the beginning? Here’s a place to start.</p>\n<p><b>ZM Stock: What a Difference a Year Makes</b></p>\n<p>We all know how well Zoom did last year. But investors have very short memories. So, when it comes to analyzing ZM stock, let’s focus our conversation on the present (and future potential).</p>\n<p>Business is still good at Zoom, but it’s slowing relative to last year. Fiscal second-quarter earnings were a mixed bag. The good news is the company beat expectations. The bad news? Year-over-year (YOY) comparisons are down. For example, revenueincreased 54%YOY — an impressive number — butdown from 191%in Q1. Now for Q3, growth is expected to taper further to 31%. No doubt, these are still impressive growth numbers. But they’re not a raise inguidance for the second half of the fiscal year.</p>\n<p>Wall Street doesn’t like slowing growth. That’s why negative comparisons almost always translate into declines in stock prices.</p>\n<p>There’s another thing Wall Street doesn’t like: competition. Zoom enjoyed wild success last year. But going forward, the company isn’t the only video-conference software maker in town. There are plenty of other options:<b>Microsoft</b>(NASDAQ:<b><u>MSFT</u></b>) has Skype and Teams,<b>Cisco</b>(NASDAQ:<b><u>CSCO</u></b>) offers Webex,<b>Adobe</b>(NASDAQ:<b><u>ADBE</u></b>) has Connect and<b>LogMeIn</b>has GoToMeeting, among others. This list of giant competitors also includes<b>Facebook</b>(NASDAQ:<b><u>FB</u></b>), which recently introduced a feature called Messenger Rooms.</p>\n<p>For these much larger tech companies, online meetings are just one of many software offerings. This leaves ZM stock vulnerable if one of these companies finds a competitive advantage.</p>\n<p><b>Looking for Growth</b></p>\n<p>With growth slowing and the company facing an increasingly crowded enterprise communications market,Zoom is naturally looking for its next leg of growth. In July, the company announced its&nbsp;intent to acquirecloud contact-center software providerFive9for $14.7 billion in stock. The deal terms were that Zoom would pay $200.28 for each share of Five9.</p>\n<p>However, the market has since soured on the deal, for two reasons. First: valuation. Sure, the deal terms sounded good to shareholders when it was initially announced (ZM stock was trading for over $350 at the time). But on the heels of a mixed quarter, the stock started sliding — and quickly. Investors then had more reason to question the lofty proposed purchase price.</p>\n<p>Last week, things came to a head. With Zoom shares down almost 20% from the deal announcement, proxy-analysis firm Institutional Shareholder Services (ISS) sounded the alarm bells. The firmadvised Five9 shareholders toreject the deal. ISS said that Five9 investors would be exposed to a more-volatile stock with a less-than-rosy outlook as economies reopen following the pandemic.</p>\n<p>Secondly, though, there’s the Justice Department and the Federal Communications Commission (FCC). Both agencies are looking into whether Zoom’s ties to China could make the deal a national-security risk. Still, Zoomsaid it expects to receive regulatory approvals by the first half of 2022. That could leave it on track to close the deal as originally planned.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood Knows Something About Zoom That You Don’t</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood Knows Something About Zoom That You Don’t\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-25 08:41 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/09/cathie-wood-knows-something-about-zm-stock-that-you-dont/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>ZM stock is down about 20% YTD, but there are reasons to still favor this video-conferencing pick\nEditor’s Note: This article is part ofJoanna’s Top Trades—a weekly feature dedicated toward making you...</p>\n\n<a href=\"https://investorplace.com/2021/09/cathie-wood-knows-something-about-zm-stock-that-you-dont/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://investorplace.com/2021/09/cathie-wood-knows-something-about-zm-stock-that-you-dont/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1117076176","content_text":"ZM stock is down about 20% YTD, but there are reasons to still favor this video-conferencing pick\nEditor’s Note: This article is part ofJoanna’s Top Trades—a weekly feature dedicated toward making you money within a specific space. Joanna’s pick for this week isZoom(NASDAQ:ZM) as the top stock to trade this week.\nWe all know video-calling software makerZoom (NASDAQ:ZM). The pandemic high-flier capitalized on a stay-at-home workforce, growing itsusage from 10 million daily meeting participants one year ago to over 200 million.ZM stock enjoyed a meteoric 400% rise in 2020.\nSource: Michael Vi / Shutterstock.com\nHowever, Zoom knows firsthand — like a lot of last year’s tech gainers — that 2021 has been much less forgiving. As the world returns to normalcy, the company’s growth has naturally slowed. Investors have cooled on the story. ZM stock is down about 20% year-to-date (YTD). Plus, adding salt to the wound, the company ishaving trouble closing its recentlyproposed acquisitionofFive9(NASDAQ:FIVN).\nI love a stock with some good controversy. Zoom fits that bill. The shares are volatile, reflecting investor uncertainty around whether it has enough gas in the tank for a second growth wave.But add a celebrity investor to the mix and things geteven more intriguing. Enter Cathie Wood, who’s been scooping up Zoom shares on the dip.\nIs it over for ZM stock? Or is it just the beginning? Here’s a place to start.\nZM Stock: What a Difference a Year Makes\nWe all know how well Zoom did last year. But investors have very short memories. So, when it comes to analyzing ZM stock, let’s focus our conversation on the present (and future potential).\nBusiness is still good at Zoom, but it’s slowing relative to last year. Fiscal second-quarter earnings were a mixed bag. The good news is the company beat expectations. The bad news? Year-over-year (YOY) comparisons are down. For example, revenueincreased 54%YOY — an impressive number — butdown from 191%in Q1. Now for Q3, growth is expected to taper further to 31%. No doubt, these are still impressive growth numbers. But they’re not a raise inguidance for the second half of the fiscal year.\nWall Street doesn’t like slowing growth. That’s why negative comparisons almost always translate into declines in stock prices.\nThere’s another thing Wall Street doesn’t like: competition. Zoom enjoyed wild success last year. But going forward, the company isn’t the only video-conference software maker in town. There are plenty of other options:Microsoft(NASDAQ:MSFT) has Skype and Teams,Cisco(NASDAQ:CSCO) offers Webex,Adobe(NASDAQ:ADBE) has Connect andLogMeInhas GoToMeeting, among others. This list of giant competitors also includesFacebook(NASDAQ:FB), which recently introduced a feature called Messenger Rooms.\nFor these much larger tech companies, online meetings are just one of many software offerings. This leaves ZM stock vulnerable if one of these companies finds a competitive advantage.\nLooking for Growth\nWith growth slowing and the company facing an increasingly crowded enterprise communications market,Zoom is naturally looking for its next leg of growth. In July, the company announced its intent to acquirecloud contact-center software providerFive9for $14.7 billion in stock. The deal terms were that Zoom would pay $200.28 for each share of Five9.\nHowever, the market has since soured on the deal, for two reasons. First: valuation. Sure, the deal terms sounded good to shareholders when it was initially announced (ZM stock was trading for over $350 at the time). But on the heels of a mixed quarter, the stock started sliding — and quickly. Investors then had more reason to question the lofty proposed purchase price.\nLast week, things came to a head. With Zoom shares down almost 20% from the deal announcement, proxy-analysis firm Institutional Shareholder Services (ISS) sounded the alarm bells. The firmadvised Five9 shareholders toreject the deal. ISS said that Five9 investors would be exposed to a more-volatile stock with a less-than-rosy outlook as economies reopen following the pandemic.\nSecondly, though, there’s the Justice Department and the Federal Communications Commission (FCC). Both agencies are looking into whether Zoom’s ties to China could make the deal a national-security risk. Still, Zoomsaid it expects to receive regulatory approvals by the first half of 2022. That could leave it on track to close the deal as originally planned.","news_type":1},"isVote":1,"tweetType":1,"viewCount":237,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":824091842,"gmtCreate":1634260457197,"gmtModify":1634274406774,"author":{"id":"3580436163482352","authorId":"3580436163482352","name":"JohnLoh00","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580436163482352","authorIdStr":"3580436163482352"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/824091842","repostId":"1150327212","repostType":4,"repost":{"id":"1150327212","pubTimestamp":1634259107,"share":"https://www.laohu8.com/m/news/1150327212?lang=&edition=full","pubTime":"2021-10-15 08:51","market":"us","language":"en","title":"Morgan Stanley Leads Big Banks in Selling Bonds Post Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=1150327212","media":"Bloomberg","summary":"(Bloomberg) -- Morgan Stanley became the first big Wall Street bank to bring a new bond deal after r","content":"<p>(Bloomberg) -- Morgan Stanley became the first big Wall Street bank to bring a new bond deal after reporting third-quarter earnings, setting the stage for other banks to follow.</p>\n<p>The lender borrowed $5 billion in a two-part bond sale on Thursday, according to a person with knowledge of the matter. The longest maturity, an 11-year portion, yields 1 percentage point above Treasuries, after initial discussions of around 1.15 percentage points, said the person, who asked not to be identified because the details are private.</p>\n<p>A barrage of U.S. bank-earnings beats may herald a splurge of bond issuance from the financial sector before borrowing costs rise too much. Benchmark 10-year Treasury yields reached the highest since mid-year this week. The bond deal comes as risk premiums in corporate debt remain low, increasing the appeal to issuers.</p>\n<p>Morgan Stanley’s investment bankers scored their best quarter ever, boosted by dealmaking. The division hauled in $2.85 billion in the third quarter, a 67% jump that topped analysts’ estimates and helped drive firm-wide profitability higher.</p>\n<p>Morgan Stanley and Goldman Sachs Group Inc. are seeing increased prime brokerage activity after the implosion of Archegos Capital Management and are likely to issue new debt to finance that part of their businesses, according to Bloomberg Intelligence analyst Arnold Kakuda.</p>\n<p>“I see the bond sale as Morgan Stanley helping to finance their prime business,” Kakuda said in a telephone interview Thursday. “They have tight spreads and its businesses are doing pretty well.”</p>\n<p>Bill Hwang’s Archegos collapsed in March as some of its more than $100 billion in positions tumbled, triggering margin calls from banks, which then dumped their holdings. The ensuing rout caused lenders to lose more than $10 billion and forced internal probes and the departures of senior executives. Hwang’s brokers included Credit Suisse Group AG, Nomura Holdings Inc., Goldman Sachs and Morgan Stanley.</p>\n<p>Bigger banks like JPMorgan Chase &amp; Co. and Bank of America Corp. have been issuing more debt since the expiration of the Federal Reserve’s supplementary leverage ratio relief in late March to boost their cash holdings to support ballooning balance sheets, said Kakuda.</p>\n<p>“I wouldn’t be surprised to see JPMorgan issue senior debt and they can also do sub or preferred notes,” he added. “Citi may do one bond deal until year end while Bank of America may start slowing down going forward. Wells Fargo will probably not issue the rest of the year.”</p>\n<p>Financial sector debt spreads tightened on Thursday, pacing a broad-based credit rally. High-grade senior financial sector cash bond spreads tightened 1.2 basis points as of 4:41 p.m. in New York, data compiled by Bloomberg show.</p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Morgan Stanley Leads Big Banks in Selling Bonds Post Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMorgan Stanley Leads Big Banks in Selling Bonds Post Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-15 08:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/morgan-stanley-leads-big-banks-162042301.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- Morgan Stanley became the first big Wall Street bank to bring a new bond deal after reporting third-quarter earnings, setting the stage for other banks to follow.\nThe lender borrowed $5...</p>\n\n<a href=\"https://finance.yahoo.com/news/morgan-stanley-leads-big-banks-162042301.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MS":"摩根士丹利"},"source_url":"https://finance.yahoo.com/news/morgan-stanley-leads-big-banks-162042301.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1150327212","content_text":"(Bloomberg) -- Morgan Stanley became the first big Wall Street bank to bring a new bond deal after reporting third-quarter earnings, setting the stage for other banks to follow.\nThe lender borrowed $5 billion in a two-part bond sale on Thursday, according to a person with knowledge of the matter. The longest maturity, an 11-year portion, yields 1 percentage point above Treasuries, after initial discussions of around 1.15 percentage points, said the person, who asked not to be identified because the details are private.\nA barrage of U.S. bank-earnings beats may herald a splurge of bond issuance from the financial sector before borrowing costs rise too much. Benchmark 10-year Treasury yields reached the highest since mid-year this week. The bond deal comes as risk premiums in corporate debt remain low, increasing the appeal to issuers.\nMorgan Stanley’s investment bankers scored their best quarter ever, boosted by dealmaking. The division hauled in $2.85 billion in the third quarter, a 67% jump that topped analysts’ estimates and helped drive firm-wide profitability higher.\nMorgan Stanley and Goldman Sachs Group Inc. are seeing increased prime brokerage activity after the implosion of Archegos Capital Management and are likely to issue new debt to finance that part of their businesses, according to Bloomberg Intelligence analyst Arnold Kakuda.\n“I see the bond sale as Morgan Stanley helping to finance their prime business,” Kakuda said in a telephone interview Thursday. “They have tight spreads and its businesses are doing pretty well.”\nBill Hwang’s Archegos collapsed in March as some of its more than $100 billion in positions tumbled, triggering margin calls from banks, which then dumped their holdings. The ensuing rout caused lenders to lose more than $10 billion and forced internal probes and the departures of senior executives. Hwang’s brokers included Credit Suisse Group AG, Nomura Holdings Inc., Goldman Sachs and Morgan Stanley.\nBigger banks like JPMorgan Chase & Co. and Bank of America Corp. have been issuing more debt since the expiration of the Federal Reserve’s supplementary leverage ratio relief in late March to boost their cash holdings to support ballooning balance sheets, said Kakuda.\n“I wouldn’t be surprised to see JPMorgan issue senior debt and they can also do sub or preferred notes,” he added. “Citi may do one bond deal until year end while Bank of America may start slowing down going forward. Wells Fargo will probably not issue the rest of the year.”\nFinancial sector debt spreads tightened on Thursday, pacing a broad-based credit rally. High-grade senior financial sector cash bond spreads tightened 1.2 basis points as of 4:41 p.m. in New York, data compiled by Bloomberg show.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1107,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":823726999,"gmtCreate":1633664233140,"gmtModify":1633664233209,"author":{"id":"3580436163482352","authorId":"3580436163482352","name":"JohnLoh00","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580436163482352","authorIdStr":"3580436163482352"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/823726999","repostId":"1150824617","repostType":4,"repost":{"id":"1150824617","pubTimestamp":1633663561,"share":"https://www.laohu8.com/m/news/1150824617?lang=&edition=full","pubTime":"2021-10-08 11:26","market":"us","language":"en","title":"Musk Says Chip and Ship Shortages Top Threats to Tesla Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=1150824617","media":"Bloomberg","summary":"A double-whammy of a global shortage of chips and ships is the only thing standing in the way of Tes","content":"<p>A double-whammy of a global shortage of chips and ships is the only thing standing in the way of&nbsp;Tesla Inc.&nbsp;maintaining sales growth in excess of 50%, according to Chief Executive Officer Elon Musk.</p>\n<p>“We’ve had a fantastic year, we had record vehicle deliveries,” Musk told Tesla’s annual shareholder meeting in Austin, Texas on Thursday. “It looks like we have a good chance of maintaining that. Basically, if we can get the chips we can do it. Hopefully this chip shortage will alleviate soon but I feel confident of being able to maintain something like at least above 50% for quite a while.”</p>\n<p>While the chip shortage has&nbsp;dominated&nbsp;auto-industry headlines this year, Musk said the electric-car pioneer was grappling with “lots” of supply chain challenges.</p>\n<p>“One of the biggest challenges we had in Q3 was can we get enough ships,” he said. “There was a huge ship shortage.”</p>\n<p>The chip shortage doesn’t appear to be slowing Tesla down just yet. The company earlier this week reported&nbsp;record deliveries&nbsp;of 241,300 cars worldwide in the third quarter, beating the previous high of 201,250 vehicles in the second quarter.</p>\n<p>Tesla’s numbers compare favorably with the rest of the auto industry, which saw U.S.&nbsp;vehicle sales slump&nbsp;in the latest three-month period due to limits on production from supply-chain shortages. General Motors Co. took the biggest blow, with sales in its home market dropping by a third in the latest quarter.</p>\n<p><img src=\"https://static.tigerbbs.com/45dcb3f45ff50e0c05b66696154c5c7b\" tg-width=\"832\" tg-height=\"489\" width=\"100%\" height=\"auto\"></p>\n<p>Musk said the “significant cost pressure” in the supply chain had forced Tesla to increase car prices, at least temporarily.</p>\n<p>“The sheer amount of money we’re spending on flying parts around the world isn’t great,” he said.</p>\n<p>And it may be at least 12 months before things start to improve. “We should be through our severe supply chain shortages in ‘23,” he said. “I’m optimistic that will be the case.”</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Musk Says Chip and Ship Shortages Top Threats to Tesla Growth</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMusk Says Chip and Ship Shortages Top Threats to Tesla Growth\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-08 11:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-10-08/musk-says-chip-and-ship-shortage-are-top-threats-to-tesla-growth?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>A double-whammy of a global shortage of chips and ships is the only thing standing in the way of Tesla Inc. maintaining sales growth in excess of 50%, according to Chief Executive Officer Elon Musk.\n“...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-10-08/musk-says-chip-and-ship-shortage-are-top-threats-to-tesla-growth?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.bloomberg.com/news/articles/2021-10-08/musk-says-chip-and-ship-shortage-are-top-threats-to-tesla-growth?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1150824617","content_text":"A double-whammy of a global shortage of chips and ships is the only thing standing in the way of Tesla Inc. maintaining sales growth in excess of 50%, according to Chief Executive Officer Elon Musk.\n“We’ve had a fantastic year, we had record vehicle deliveries,” Musk told Tesla’s annual shareholder meeting in Austin, Texas on Thursday. “It looks like we have a good chance of maintaining that. Basically, if we can get the chips we can do it. Hopefully this chip shortage will alleviate soon but I feel confident of being able to maintain something like at least above 50% for quite a while.”\nWhile the chip shortage has dominated auto-industry headlines this year, Musk said the electric-car pioneer was grappling with “lots” of supply chain challenges.\n“One of the biggest challenges we had in Q3 was can we get enough ships,” he said. “There was a huge ship shortage.”\nThe chip shortage doesn’t appear to be slowing Tesla down just yet. The company earlier this week reported record deliveries of 241,300 cars worldwide in the third quarter, beating the previous high of 201,250 vehicles in the second quarter.\nTesla’s numbers compare favorably with the rest of the auto industry, which saw U.S. vehicle sales slump in the latest three-month period due to limits on production from supply-chain shortages. General Motors Co. took the biggest blow, with sales in its home market dropping by a third in the latest quarter.\n\nMusk said the “significant cost pressure” in the supply chain had forced Tesla to increase car prices, at least temporarily.\n“The sheer amount of money we’re spending on flying parts around the world isn’t great,” he said.\nAnd it may be at least 12 months before things start to improve. “We should be through our severe supply chain shortages in ‘23,” he said. “I’m optimistic that will be the case.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":815,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":868143094,"gmtCreate":1632623252318,"gmtModify":1632650711674,"author":{"id":"3580436163482352","authorId":"3580436163482352","name":"JohnLoh00","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580436163482352","authorIdStr":"3580436163482352"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/868143094","repostId":"2170614921","repostType":4,"repost":{"id":"2170614921","pubTimestamp":1632619060,"share":"https://www.laohu8.com/m/news/2170614921?lang=&edition=full","pubTime":"2021-09-26 09:17","market":"us","language":"en","title":"Renewable Energy Stocks: Is Now a Good Time to Buy?","url":"https://stock-news.laohu8.com/highlight/detail?id=2170614921","media":"Motley Fool","summary":"The renewable energy industry has never been stronger, and that's great news for investors.","content":"<p>Renewable energy stocks have been on a wild ride so far this century as the industry has gone through a number of boom-and-bust cycles. We've seen some stocks soar, some of the largest solar panel manufacturers go out of business, and even finance companies go bankrupt.</p>\n<p>Given what investors have seen take place in renewable energy over the last two decades and where the industry is today, here's why I'm very bullish on renewable energy stocks right now.</p>\n<p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F643582%2Fwind-turbines-on-rocky-hill.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Image source: Getty Images.</p>\n<h2>The growth story</h2>\n<p>Renewable energy is booming around the world. The chart below shows the growth of wind and solar energy production in the U.S. this century; you can see that they continue to grow rapidly. But wind and solar still only account for about 12% of all electricity generated in the U.S.</p>\n<p><img src=\"https://static.tigerbbs.com/660deaded1e8ec6374c4499453a09b49\" tg-width=\"720\" tg-height=\"409\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>US Wind Energy Production data by YCharts</p>\n<p>Wind and solar are now winning against coal, natural gas, and nuclear energy based on the cost of electricity alone, so there's little doubt they'll keep growing. And as wind and solar become more economical, we're likely to see more energy storage and new technologies like hydrogen emerge. The future is bright for renewable energy, as long as the companies you buy can make money on what they produce.</p>\n<h2>The financial picture is getting clearer</h2>\n<p>There are a number of ways to invest in the renewable energy industry, but I'll use solar as a proxy because it has more public companies than wind and a longer history in public markets than something like energy storage or hydrogen.</p>\n<p>The solar industry has gone through a lot of changes in the last decade as costs dropped rapidly, some companies went bankrupt, and new business models emerged. Today, we're entering a more mature phase for the industry in which companies are establishing technology advantages and scale that helps create a competitive moat. The result is steadily rising profitability, which you can see below from <b>First Solar</b> (NASDAQ:FSLR), <b><a href=\"https://laohu8.com/S/ENPH\">Enphase Energy</a></b> (NASDAQ:ENPH), <b>SolarEdge</b> <b>Technologies</b> (NASDAQ:SEDG), and <b><a href=\"https://laohu8.com/S/SPWR\">SunPower</a></b> (NASDAQ:SPWR).</p>\n<p><img src=\"https://static.tigerbbs.com/c055def260e944884c83dea8e7769d1b\" tg-width=\"720\" tg-height=\"387\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>FSLR Net Income (TTM) data by YCharts</p>\n<p>As mature as the solar industry is getting, other segments of renewable energy are not as mature. For example, energy storage, hydrogen, and even emerging nuclear technologies are hardly financially stable and closer to being in the nascent stage of the business cycle than maturity.</p>\n<p>The good news for investors is that we can find profitable companies with a competitive moat in renewable energy, which hasn't always been the case.</p>\n<h2>How to invest in renewable energy today</h2>\n<p>I bucket renewable investments into three categories: financiers, solar stocks, and speculative investments. And there are good opportunities in all three.</p>\n<p>Financiers are the companies that build or buy renewable energy projects, usually with long-term contracts to sell electricity to a utility. They generate very stable cash flows and often come with a dividend. <b>Brookfield Renewable Partners</b> (NYSE:BEP) and <b>NextEra Energy Partners</b> (NYSE:NEP) are both leaders in this space and have exposure to wind and solar energy projects. They're also starting to acquire new technology projects like energy storage, which can provide a service to the grid. The reality of the energy business is that a lot of money needs to be invested to build projects and generate renewable electricity -- and Brookfield Renewable Partners and NextEra Energy Partners are keys to making clean energy a reality.</p>\n<p>I focus on the solar industry in part because there are very few wind-focused companies publicly traded in the U.S. But in solar energy there are some leaders with clear differentiation, like First Solar in solar panel manufacturing, SunPower in deploying residential and commercial solar, and Enphase Energy in module-level power electronics. All three companies are riding the wave of solar energy growth and have emerged as industry leaders as competitors have declined.</p>\n<p>On the speculative side, I see a huge opportunity in hydrogen. <b>Bloom Energy</b> (NYSE:BE) is an industry leader in solid-oxide fuel cells; it's also built a nearly $1 billion business in backup power with new markets like electrolysis and marine power on the horizon. If costs continue to drop, Bloom Energy could be a big winner in the hydrogen industry.</p>\n<p>Whether you want to take a risky bet on Bloom Energy, a safer investment in Brookfield Renewable Partners, or something in between, there's something for everyone in the renewable energy industry. And as the industry matures we should see profitability rise as well, which is good news for investors who can buy and hold the industry's best companies long-term.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Renewable Energy Stocks: Is Now a Good Time to Buy?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRenewable Energy Stocks: Is Now a Good Time to Buy?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-26 09:17 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/25/renewable-energy-stocks-is-now-a-good-time-to-buy/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Renewable energy stocks have been on a wild ride so far this century as the industry has gone through a number of boom-and-bust cycles. We've seen some stocks soar, some of the largest solar panel ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/25/renewable-energy-stocks-is-now-a-good-time-to-buy/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/09/25/renewable-energy-stocks-is-now-a-good-time-to-buy/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2170614921","content_text":"Renewable energy stocks have been on a wild ride so far this century as the industry has gone through a number of boom-and-bust cycles. We've seen some stocks soar, some of the largest solar panel manufacturers go out of business, and even finance companies go bankrupt.\nGiven what investors have seen take place in renewable energy over the last two decades and where the industry is today, here's why I'm very bullish on renewable energy stocks right now.\n\nImage source: Getty Images.\nThe growth story\nRenewable energy is booming around the world. The chart below shows the growth of wind and solar energy production in the U.S. this century; you can see that they continue to grow rapidly. But wind and solar still only account for about 12% of all electricity generated in the U.S.\n\nUS Wind Energy Production data by YCharts\nWind and solar are now winning against coal, natural gas, and nuclear energy based on the cost of electricity alone, so there's little doubt they'll keep growing. And as wind and solar become more economical, we're likely to see more energy storage and new technologies like hydrogen emerge. The future is bright for renewable energy, as long as the companies you buy can make money on what they produce.\nThe financial picture is getting clearer\nThere are a number of ways to invest in the renewable energy industry, but I'll use solar as a proxy because it has more public companies than wind and a longer history in public markets than something like energy storage or hydrogen.\nThe solar industry has gone through a lot of changes in the last decade as costs dropped rapidly, some companies went bankrupt, and new business models emerged. Today, we're entering a more mature phase for the industry in which companies are establishing technology advantages and scale that helps create a competitive moat. The result is steadily rising profitability, which you can see below from First Solar (NASDAQ:FSLR), Enphase Energy (NASDAQ:ENPH), SolarEdge Technologies (NASDAQ:SEDG), and SunPower (NASDAQ:SPWR).\n\nFSLR Net Income (TTM) data by YCharts\nAs mature as the solar industry is getting, other segments of renewable energy are not as mature. For example, energy storage, hydrogen, and even emerging nuclear technologies are hardly financially stable and closer to being in the nascent stage of the business cycle than maturity.\nThe good news for investors is that we can find profitable companies with a competitive moat in renewable energy, which hasn't always been the case.\nHow to invest in renewable energy today\nI bucket renewable investments into three categories: financiers, solar stocks, and speculative investments. And there are good opportunities in all three.\nFinanciers are the companies that build or buy renewable energy projects, usually with long-term contracts to sell electricity to a utility. They generate very stable cash flows and often come with a dividend. Brookfield Renewable Partners (NYSE:BEP) and NextEra Energy Partners (NYSE:NEP) are both leaders in this space and have exposure to wind and solar energy projects. They're also starting to acquire new technology projects like energy storage, which can provide a service to the grid. The reality of the energy business is that a lot of money needs to be invested to build projects and generate renewable electricity -- and Brookfield Renewable Partners and NextEra Energy Partners are keys to making clean energy a reality.\nI focus on the solar industry in part because there are very few wind-focused companies publicly traded in the U.S. But in solar energy there are some leaders with clear differentiation, like First Solar in solar panel manufacturing, SunPower in deploying residential and commercial solar, and Enphase Energy in module-level power electronics. All three companies are riding the wave of solar energy growth and have emerged as industry leaders as competitors have declined.\nOn the speculative side, I see a huge opportunity in hydrogen. Bloom Energy (NYSE:BE) is an industry leader in solid-oxide fuel cells; it's also built a nearly $1 billion business in backup power with new markets like electrolysis and marine power on the horizon. If costs continue to drop, Bloom Energy could be a big winner in the hydrogen industry.\nWhether you want to take a risky bet on Bloom Energy, a safer investment in Brookfield Renewable Partners, or something in between, there's something for everyone in the renewable energy industry. And as the industry matures we should see profitability rise as well, which is good news for investors who can buy and hold the industry's best companies long-term.","news_type":1},"isVote":1,"tweetType":1,"viewCount":294,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":860401147,"gmtCreate":1632193476289,"gmtModify":1632802148971,"author":{"id":"3580436163482352","authorId":"3580436163482352","name":"JohnLoh00","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580436163482352","authorIdStr":"3580436163482352"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/860401147","repostId":"1159687756","repostType":4,"repost":{"id":"1159687756","pubTimestamp":1632190724,"share":"https://www.laohu8.com/m/news/1159687756?lang=&edition=full","pubTime":"2021-09-21 10:18","market":"us","language":"en","title":"Got $1,000? Buy These Hot Growth Stocks Before They Take Off","url":"https://stock-news.laohu8.com/highlight/detail?id=1159687756","media":"Motley Fool","summary":"You don't need a lot of money to make a difference with the right growth stocks.","content":"<p><b>Key Points</b></p>\n<ul>\n <li>A little money can go a long way when volatility turns stocks you want to buy into even bigger bargains.</li>\n <li>Crocs is a name on this list, a surprising winner that is still sneaking up on investors with its masterful turnaround.</li>\n <li>The other two names are growing fast in a booming streaming video market.</li>\n</ul>\n<p>The market's off to a shaky start this week, but there's opportunity in the volatility. Now is a good time to size up some of the stocks on your shopping to list, asking yourself if the stories are getting better even as the stocks are going nowhere.</p>\n<p>You don't need a lot of money to take advantage of the ups and downs of Wall Street. Just $1,000 can go a long way if you are buying the right growth stocks, and right now I like&nbsp;<b>Crocs</b>&nbsp;(NASDAQ:CROX),<b>fuboTV</b>(NYSE:FUBO), and&nbsp;<b>Roku</b>(NASDAQ:ROKU). The first one is a surprising winner in 2021. The other two are surprising laggards. Even though $1,000 will buy you just a couple of shares in some of these names, let's get into why I see these as growth stocks that are about to take off.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5eb5fb95534102c76d3a38d3bea8ad5b\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"><span>IMAGE SOURCE: GETTY IMAGES.</span></p>\n<p><b>1. Crocs</b></p>\n<p>If you haven't been following Crocs lately you may be surprised at how well the stock has been doing. The maker of hole-filled resin shoes has more than doubled in 2021, nearly quadrupling since the start of last year.</p>\n<p>Crocs has had its ups and downs over the years, but it's clearly on an upswing now. The revival started in 2017 when a new CEO came in just as the maker of unique footwear was posting its third straight year of declining sales. Revenue growth turned slightly positive in 2018 with a 6% increase, followed by back-to-back years of 13% top-line upticks. This year Crocs is running on an entirely different level.</p>\n<p>Back in February Crocs was targeting 20% to 25% revenue gains for all of 2021, a great achievement as it would be nearly doubling its growth from the prior year. In late April the guidance was bumped to 40% to 50% in top-line growth, and this summer it got boosted again. Crocs now sees a 60% to 65% increase in revenue in 2021.</p>\n<p>The pandemic made us appreciate Crocs again. We chose comfort over fashion during the shelter-in-place phase of the pandemic. Now that we're out and about again we're not giving up our Crocs. We're seeing celebrities strutting in Crocs at media events and out in the wild. Crocs are showing up in movies like this summer's&nbsp;<i>Suicide Squad</i>. The stock may have hit&nbsp;an all-time high last week, but with a lot of people still skeptical on the turnaround the bullish argument here is that the rally is just beginning.</p>\n<p><b>2. fuboTV</b></p>\n<p>When you size up the IPO class of 2020, fuboTV should be the teacher's pet. Some debutantes appear to be peaking just before their stock offerings, but the live TV streaming service is&nbsp;stepping on the gas. Let's just go over the top-line performance in fuboTV's first four quarters as a public company.</p>\n<ul>\n <li>Q3 2020: 71% revenue growth.</li>\n <li>Q4 2020: 98% revenue growth.</li>\n <li>Q1 2021: 135% revenue growth.</li>\n <li>Q2 2021: 196% revenue growth.</li>\n</ul>\n<p>A 138% increase in subscribers over the past year coupled with a 30% pop in average revenue per user is why fuboTV's revenue has nearly tripled. The near-term outlook is even more exciting. As a sports-minded streaming service -- with more than three dozen of its over 100 channels dedicated to live sporting events -- it knows its audience. It introduced free-to-play predictive games and live layered stats this summer, and it expects to roll out a sportsbook to allow viewers to place cash bets on the games they're watching before the end of the year.</p>\n<p>Despite the perpetual improvement at fuboTV the stock is roughly where it was when the year began. With sports season heating up, fuboTV's engaged audience will help it win this game.</p>\n<p><b>3. Roku</b></p>\n<p>There are worse things than standing in place, and right now Roku is trading slightly lower in 2021. It doesn't seem fair. Roku continues to be the platform of choice for folks streaming from home, with 38% of all smart TVs rolling out with Roku's operating system as the default factory-installed operating system. If you don't happen to buy a Roku-ready TV you can buy a dongle for as little as $20 to $30 that will plug into one of your TV's HDMI ports.</p>\n<p>This is a growing market, and even if viewing hours slipped this summer as we began to venture outside again the long-term trend is undeniable. We love streaming video entertainment from home. Sunday's Emmy Awards is another reminder that the best shows on TV these days are largely on premium streaming services.</p>\n<p>Despite the slight dip in sequential consumption in its latest quarter and the&nbsp;recent challenge&nbsp;of a competitor introducing its own TVs, Roku has never been better. The record 55.1 million active accounts on the platform at the end of June was a 28% increase from where it was a year ago, and like fuboTV we're seeing average revenue per user advance at a double-digit percentage clip. Roku is a worthy leader among&nbsp;streaming service stocks. The stock taking a small step back in 2021 at a time when the fundamentals continue to move forward makes this a strong candidate to take off once the dust settles.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Got $1,000? Buy These Hot Growth Stocks Before They Take Off</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGot $1,000? Buy These Hot Growth Stocks Before They Take Off\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-21 10:18 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/20/got-1000-buy-these-hot-growth-stocks-before-they-t/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Key Points\n\nA little money can go a long way when volatility turns stocks you want to buy into even bigger bargains.\nCrocs is a name on this list, a surprising winner that is still sneaking up on ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/20/got-1000-buy-these-hot-growth-stocks-before-they-t/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"FUBO":"fuboTV Inc.","CROX":"卡骆驰","ROKU":"Roku Inc"},"source_url":"https://www.fool.com/investing/2021/09/20/got-1000-buy-these-hot-growth-stocks-before-they-t/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159687756","content_text":"Key Points\n\nA little money can go a long way when volatility turns stocks you want to buy into even bigger bargains.\nCrocs is a name on this list, a surprising winner that is still sneaking up on investors with its masterful turnaround.\nThe other two names are growing fast in a booming streaming video market.\n\nThe market's off to a shaky start this week, but there's opportunity in the volatility. Now is a good time to size up some of the stocks on your shopping to list, asking yourself if the stories are getting better even as the stocks are going nowhere.\nYou don't need a lot of money to take advantage of the ups and downs of Wall Street. Just $1,000 can go a long way if you are buying the right growth stocks, and right now I like Crocs (NASDAQ:CROX),fuboTV(NYSE:FUBO), and Roku(NASDAQ:ROKU). The first one is a surprising winner in 2021. The other two are surprising laggards. Even though $1,000 will buy you just a couple of shares in some of these names, let's get into why I see these as growth stocks that are about to take off.\nIMAGE SOURCE: GETTY IMAGES.\n1. Crocs\nIf you haven't been following Crocs lately you may be surprised at how well the stock has been doing. The maker of hole-filled resin shoes has more than doubled in 2021, nearly quadrupling since the start of last year.\nCrocs has had its ups and downs over the years, but it's clearly on an upswing now. The revival started in 2017 when a new CEO came in just as the maker of unique footwear was posting its third straight year of declining sales. Revenue growth turned slightly positive in 2018 with a 6% increase, followed by back-to-back years of 13% top-line upticks. This year Crocs is running on an entirely different level.\nBack in February Crocs was targeting 20% to 25% revenue gains for all of 2021, a great achievement as it would be nearly doubling its growth from the prior year. In late April the guidance was bumped to 40% to 50% in top-line growth, and this summer it got boosted again. Crocs now sees a 60% to 65% increase in revenue in 2021.\nThe pandemic made us appreciate Crocs again. We chose comfort over fashion during the shelter-in-place phase of the pandemic. Now that we're out and about again we're not giving up our Crocs. We're seeing celebrities strutting in Crocs at media events and out in the wild. Crocs are showing up in movies like this summer's Suicide Squad. The stock may have hit an all-time high last week, but with a lot of people still skeptical on the turnaround the bullish argument here is that the rally is just beginning.\n2. fuboTV\nWhen you size up the IPO class of 2020, fuboTV should be the teacher's pet. Some debutantes appear to be peaking just before their stock offerings, but the live TV streaming service is stepping on the gas. Let's just go over the top-line performance in fuboTV's first four quarters as a public company.\n\nQ3 2020: 71% revenue growth.\nQ4 2020: 98% revenue growth.\nQ1 2021: 135% revenue growth.\nQ2 2021: 196% revenue growth.\n\nA 138% increase in subscribers over the past year coupled with a 30% pop in average revenue per user is why fuboTV's revenue has nearly tripled. The near-term outlook is even more exciting. As a sports-minded streaming service -- with more than three dozen of its over 100 channels dedicated to live sporting events -- it knows its audience. It introduced free-to-play predictive games and live layered stats this summer, and it expects to roll out a sportsbook to allow viewers to place cash bets on the games they're watching before the end of the year.\nDespite the perpetual improvement at fuboTV the stock is roughly where it was when the year began. With sports season heating up, fuboTV's engaged audience will help it win this game.\n3. Roku\nThere are worse things than standing in place, and right now Roku is trading slightly lower in 2021. It doesn't seem fair. Roku continues to be the platform of choice for folks streaming from home, with 38% of all smart TVs rolling out with Roku's operating system as the default factory-installed operating system. If you don't happen to buy a Roku-ready TV you can buy a dongle for as little as $20 to $30 that will plug into one of your TV's HDMI ports.\nThis is a growing market, and even if viewing hours slipped this summer as we began to venture outside again the long-term trend is undeniable. We love streaming video entertainment from home. Sunday's Emmy Awards is another reminder that the best shows on TV these days are largely on premium streaming services.\nDespite the slight dip in sequential consumption in its latest quarter and the recent challenge of a competitor introducing its own TVs, Roku has never been better. The record 55.1 million active accounts on the platform at the end of June was a 28% increase from where it was a year ago, and like fuboTV we're seeing average revenue per user advance at a double-digit percentage clip. Roku is a worthy leader among streaming service stocks. The stock taking a small step back in 2021 at a time when the fundamentals continue to move forward makes this a strong candidate to take off once the dust settles.","news_type":1},"isVote":1,"tweetType":1,"viewCount":74,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":821750357,"gmtCreate":1633794872595,"gmtModify":1633794872595,"author":{"id":"3580436163482352","authorId":"3580436163482352","name":"JohnLoh00","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580436163482352","authorIdStr":"3580436163482352"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/821750357","repostId":"1163103525","repostType":4,"repost":{"id":"1163103525","pubTimestamp":1633760681,"share":"https://www.laohu8.com/m/news/1163103525?lang=&edition=full","pubTime":"2021-10-09 14:24","market":"us","language":"en","title":"With U.S. Credit Default No Longer a Likely Threat, Eyes Turn Back Toward the Fed","url":"https://stock-news.laohu8.com/highlight/detail?id=1163103525","media":"Benzinga","summary":"After the United States Senate recently voted to temporarily raise the nation's debt limit, a sigh o","content":"<p>After the United States Senate recently&nbsp;voted to temporarily raise the nation's debt limit, a sigh of relief was likely emitted by many. However, it's now right back to the Federal Reserve as one of the primary players to watch in the current state of the U.S. and global economic system. While&nbsp;behemoths like&nbsp;<b>Apple</b>,&nbsp;<b>CocaCola</b>, and&nbsp;<b>Western Union</b>&nbsp;may be focused on a recent increase in international&nbsp;corporate taxes, for many it seems&nbsp;waiting for the next statement from Fed chair&nbsp;Jerome Powell is the common thread.</p>\n<p>In response to the economic impact of the coronavirus pandemic, global governments have embarked on a massive spending spree that has pushed total debt to GDP ratios from 88% to a staggering 105% (according to the Institute of International Finance). The U.S. Treasury has been front and center in this initiative as domestic national debt rose from an already alarming $23 trillion to a current level of $29 trillion.</p>\n<p>The purpose of this increased borrowing and spending was to take the edge off the resultant recession and provide a cushion for those most affected by the slowdowns. Artificially propping up demand with government spending in times of crisis is basic Keynesian theory, and its efficacy is agreed upon by many economists, provided it’s used with discipline and for short periods of time. Those same economists would probably have a spirited debate as to the definition of “short term” and whether 18 months and counting falls under that.</p>\n<p>But does this spending come without a cost? Some traditional inflation indicators, like the Producer Price Index and raw commodity prices, have been flashing a warning for months that inflation is taking root. The Federal Reserve has repeatedly stated that the inflation is transitory, but as time passes, many believe that this may not be true.</p>\n<p>There are a couple of things that make the current situation unique. The same economic crises and pandemic fears that caused the government’s spending spree has also caused global supply chain disruptions that have made a multitude of products and raw materials much more scarce. It’s no surprise that government-fueled demand, coupled with a significant decrease in supplies, has caused inflation. The supply versus demand equation and its effect on inflation is one of the few things that is considered “settled science” in the economic world.</p>\n<p>Secondly, the Federal Reserve has played a significant role in the government’s spending spree. On March 23, 2020, the Fed announced a huge increase in its asset purchase program known as quantitative easing. This was done to facilitate the Treasury’s debt issuance and keep interest rates from moving significantly higher under the anticipated increase in the amount of bonds to be sold by the U.S. Treasury. All these emergency economic measures were taken under the belief that they were both necessary and, more importantly, temporary. A common belief now is that the clock is ticking and that normalization of policy must come soon or else it could lead to uncontrollable inflation.</p>\n<p>CME Group Senior Economist Erik Norland seems optimistic that increased vaccination rates will play a significant role in distancing us from the pandemic and the consequent emergency spending levels and aggressive Fed policy. This, combined with additional tax revenue, had Norland conclude that “it looks like government deficits will begin to shrink going forward.” Norland also believes that the Fed may begin to taper asset purchases soon, and that could allow long-end rates to rise. “In 2013, when the Fed tapered, it caused a huge bear market in bonds, and 10-Year yields went from 1.4% to north of 3%,” said Norland.</p>\n<p>There’s little question that rising rates, increased taxes, and less government spending could help to slow inflation. But will it be enough? Dan Deming, managing director at KKM Financial, believes that inflation could remain an issue as “supply chains continue to be a challenge” and that “the current flattening of the yield curve could be a signal that growth prospects are under pressure” due, in part, to those supply shortages.</p>\n<p>The inflation debate seems to have three moving parts that will be watched closely by traders going forward: the size of a new government spending package being debated in Washington, D.C.; the Fed’s timeline for tapering; and proposals for tax increases going forward.</p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>With U.S. Credit Default No Longer a Likely Threat, Eyes Turn Back Toward the Fed</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWith U.S. Credit Default No Longer a Likely Threat, Eyes Turn Back Toward the Fed\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-09 14:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/government/21/10/23307031/with-u-s-credit-default-no-longer-a-likely-threat-eyes-turn-back-toward-the-fed><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After the United States Senate recently voted to temporarily raise the nation's debt limit, a sigh of relief was likely emitted by many. However, it's now right back to the Federal Reserve as one of ...</p>\n\n<a href=\"https://www.benzinga.com/government/21/10/23307031/with-u-s-credit-default-no-longer-a-likely-threat-eyes-turn-back-toward-the-fed\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"KO":"可口可乐","WU":"西联汇款","AAPL":"苹果"},"source_url":"https://www.benzinga.com/government/21/10/23307031/with-u-s-credit-default-no-longer-a-likely-threat-eyes-turn-back-toward-the-fed","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1163103525","content_text":"After the United States Senate recently voted to temporarily raise the nation's debt limit, a sigh of relief was likely emitted by many. However, it's now right back to the Federal Reserve as one of the primary players to watch in the current state of the U.S. and global economic system. While behemoths like Apple, CocaCola, and Western Union may be focused on a recent increase in international corporate taxes, for many it seems waiting for the next statement from Fed chair Jerome Powell is the common thread.\nIn response to the economic impact of the coronavirus pandemic, global governments have embarked on a massive spending spree that has pushed total debt to GDP ratios from 88% to a staggering 105% (according to the Institute of International Finance). The U.S. Treasury has been front and center in this initiative as domestic national debt rose from an already alarming $23 trillion to a current level of $29 trillion.\nThe purpose of this increased borrowing and spending was to take the edge off the resultant recession and provide a cushion for those most affected by the slowdowns. Artificially propping up demand with government spending in times of crisis is basic Keynesian theory, and its efficacy is agreed upon by many economists, provided it’s used with discipline and for short periods of time. Those same economists would probably have a spirited debate as to the definition of “short term” and whether 18 months and counting falls under that.\nBut does this spending come without a cost? Some traditional inflation indicators, like the Producer Price Index and raw commodity prices, have been flashing a warning for months that inflation is taking root. The Federal Reserve has repeatedly stated that the inflation is transitory, but as time passes, many believe that this may not be true.\nThere are a couple of things that make the current situation unique. The same economic crises and pandemic fears that caused the government’s spending spree has also caused global supply chain disruptions that have made a multitude of products and raw materials much more scarce. It’s no surprise that government-fueled demand, coupled with a significant decrease in supplies, has caused inflation. The supply versus demand equation and its effect on inflation is one of the few things that is considered “settled science” in the economic world.\nSecondly, the Federal Reserve has played a significant role in the government’s spending spree. On March 23, 2020, the Fed announced a huge increase in its asset purchase program known as quantitative easing. This was done to facilitate the Treasury’s debt issuance and keep interest rates from moving significantly higher under the anticipated increase in the amount of bonds to be sold by the U.S. Treasury. All these emergency economic measures were taken under the belief that they were both necessary and, more importantly, temporary. A common belief now is that the clock is ticking and that normalization of policy must come soon or else it could lead to uncontrollable inflation.\nCME Group Senior Economist Erik Norland seems optimistic that increased vaccination rates will play a significant role in distancing us from the pandemic and the consequent emergency spending levels and aggressive Fed policy. This, combined with additional tax revenue, had Norland conclude that “it looks like government deficits will begin to shrink going forward.” Norland also believes that the Fed may begin to taper asset purchases soon, and that could allow long-end rates to rise. “In 2013, when the Fed tapered, it caused a huge bear market in bonds, and 10-Year yields went from 1.4% to north of 3%,” said Norland.\nThere’s little question that rising rates, increased taxes, and less government spending could help to slow inflation. But will it be enough? Dan Deming, managing director at KKM Financial, believes that inflation could remain an issue as “supply chains continue to be a challenge” and that “the current flattening of the yield curve could be a signal that growth prospects are under pressure” due, in part, to those supply shortages.\nThe inflation debate seems to have three moving parts that will be watched closely by traders going forward: the size of a new government spending package being debated in Washington, D.C.; the Fed’s timeline for tapering; and proposals for tax increases going forward.","news_type":1},"isVote":1,"tweetType":1,"viewCount":735,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820579133,"gmtCreate":1633408441246,"gmtModify":1633408441318,"author":{"id":"3580436163482352","authorId":"3580436163482352","name":"JohnLoh00","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580436163482352","authorIdStr":"3580436163482352"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/820579133","repostId":"1121300578","repostType":4,"repost":{"id":"1121300578","pubTimestamp":1633395123,"share":"https://www.laohu8.com/m/news/1121300578?lang=&edition=full","pubTime":"2021-10-05 08:52","market":"us","language":"en","title":"SoFi Technologies stock dips after offering $1.1B of convertible notes","url":"https://stock-news.laohu8.com/highlight/detail?id=1121300578","media":"Seekingalpha","summary":"SoFi Technologies(NASDAQ:SOFI)shares fall 5.2% since the fintech announced a convertible debt offeri","content":"<ul>\n <li>SoFi Technologies(NASDAQ:SOFI)shares fall 5.2% since the fintech announced a convertible debt offering last week.</li>\n <li>In today's trading alone, the stock&nbsp;dips 1.8%&nbsp;in early afternoon trading.</li>\n <li>On Sept. 29, the company boosted the size of its debt offering to $1.1B from $750M. The notes can be converted into SoFi (SOFI) shares on or after April 15, 2026 until the trading day preceding Oct. 15, 2026.</li>\n <li>Shares of companies that issue convertible debt often decline as the conversion of the debt to shares would increase the number of shares outstanding, potentially diluting existing stockholders' stakes.</li>\n <li>Previously (Sept. 29),SoFi Technologies prices $1.1B of convertible notes offering</li>\n</ul>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SoFi Technologies stock dips after offering $1.1B of convertible notes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSoFi Technologies stock dips after offering $1.1B of convertible notes\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-05 08:52 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3748268-sofi-technologies-stock-dips-after-offering-11b-of-convertible-notes><strong>Seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SoFi Technologies(NASDAQ:SOFI)shares fall 5.2% since the fintech announced a convertible debt offering last week.\nIn today's trading alone, the stock dips 1.8% in early afternoon trading.\nOn Sept. 29,...</p>\n\n<a href=\"https://seekingalpha.com/news/3748268-sofi-technologies-stock-dips-after-offering-11b-of-convertible-notes\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SOFI":"SoFi Technologies Inc."},"source_url":"https://seekingalpha.com/news/3748268-sofi-technologies-stock-dips-after-offering-11b-of-convertible-notes","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1121300578","content_text":"SoFi Technologies(NASDAQ:SOFI)shares fall 5.2% since the fintech announced a convertible debt offering last week.\nIn today's trading alone, the stock dips 1.8% in early afternoon trading.\nOn Sept. 29, the company boosted the size of its debt offering to $1.1B from $750M. The notes can be converted into SoFi (SOFI) shares on or after April 15, 2026 until the trading day preceding Oct. 15, 2026.\nShares of companies that issue convertible debt often decline as the conversion of the debt to shares would increase the number of shares outstanding, potentially diluting existing stockholders' stakes.\nPreviously (Sept. 29),SoFi Technologies prices $1.1B of convertible notes offering","news_type":1},"isVote":1,"tweetType":1,"viewCount":833,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":860067721,"gmtCreate":1632108948463,"gmtModify":1632802775095,"author":{"id":"3580436163482352","authorId":"3580436163482352","name":"JohnLoh00","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580436163482352","authorIdStr":"3580436163482352"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/860067721","repostId":"2168505605","repostType":4,"isVote":1,"tweetType":1,"viewCount":113,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":887097920,"gmtCreate":1631940583860,"gmtModify":1632805171963,"author":{"id":"3580436163482352","authorId":"3580436163482352","name":"JohnLoh00","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580436163482352","authorIdStr":"3580436163482352"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/887097920","repostId":"2168574191","repostType":4,"repost":{"id":"2168574191","pubTimestamp":1631928823,"share":"https://www.laohu8.com/m/news/2168574191?lang=&edition=full","pubTime":"2021-09-18 09:33","market":"us","language":"en","title":"Pfizer Covid-19 shot's protection against hospitalisation wanes in study","url":"https://stock-news.laohu8.com/highlight/detail?id=2168574191","media":"The Straits Times","summary":"WASHINGTON (BLOOMBERG) - Pfizer's Covid-19 vaccine declined in protection against hospitalisation af","content":"<div>\n<p>WASHINGTON (BLOOMBERG) - Pfizer's Covid-19 vaccine declined in protection against hospitalisation after four months, while Moderna's remained stable, US researchers found in an analysis of data from ...</p>\n\n<a href=\"http://www.straitstimes.com/world/united-states/pfizer-covid-19-shots-protection-against-hospitalisation-wanes-in-study\">Web Link</a>\n\n</div>\n","source":"straits_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Covid-19 shot's protection against hospitalisation wanes in study</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Covid-19 shot's protection against hospitalisation wanes in study\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-18 09:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://www.straitstimes.com/world/united-states/pfizer-covid-19-shots-protection-against-hospitalisation-wanes-in-study><strong>The Straits Times</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>WASHINGTON (BLOOMBERG) - Pfizer's Covid-19 vaccine declined in protection against hospitalisation after four months, while Moderna's remained stable, US researchers found in an analysis of data from ...</p>\n\n<a href=\"http://www.straitstimes.com/world/united-states/pfizer-covid-19-shots-protection-against-hospitalisation-wanes-in-study\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"http://www.straitstimes.com/world/united-states/pfizer-covid-19-shots-protection-against-hospitalisation-wanes-in-study","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2168574191","content_text":"WASHINGTON (BLOOMBERG) - Pfizer's Covid-19 vaccine declined in protection against hospitalisation after four months, while Moderna's remained stable, US researchers found in an analysis of data from 21 US hospitals across 18 states.\nTwo doses of either vaccine provided more protection against hospitalisation than the one-dose Johnson & Johnson vaccine, the study found, though Pfizer's advantage over J&J narrowed over time, according to the study published on Friday (Sept 17) by the Centres for Disease Control and Prevention with collaborators across the country.\nAll three vaccines provided substantial protection after four months - Moderna's was 92 per cent effective against hospitalisation by then, with Pfizer's at 77 per cent and J&J at 68 per cent.\nThe data, published on Friday, may influence the debate over whether Americans should receive a third dose of vaccine to ward off the virus.\nAdvisers to the Food and Drug Administration are expected to vote on Friday on whether to recommend a booster shot, and they've mostly had to rely on data from Israel and the UK on whether the shots' effectiveness wanes over time.\nThe US is facing a surge of Covid-19 infections fuelled by the highly transmissible Delta variant, particularly among unvaccinated parts of the country, and breakthrough infections among vaccinated people have become more common.\nThe CDC study looked at 3,689 non-immunocompromised adults from March to August. The researchers noted that the vaccine effectiveness differences between Moderna and Pfizer's shots, which both use a mechanism called messenger RNA, could be due to differences in timings between doses.\nThe second dose of the Pfizer vaccine is typically delivered after three weeks, while Moderna patients wait four weeks.\nThey also noted several limitations to the study, including the fact that a relatively small number of patients had received the J&J vaccine compared with the mRNA vaccines.\nPrevious studies have found that Moderna's vaccine appears to generate more antibodies than Pfizer's, though it's not clear if antibodies are even the most important component in immunity over the long term.","news_type":1},"isVote":1,"tweetType":1,"viewCount":120,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":885045088,"gmtCreate":1631748377144,"gmtModify":1632806492621,"author":{"id":"3580436163482352","authorId":"3580436163482352","name":"JohnLoh00","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580436163482352","authorIdStr":"3580436163482352"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/885045088","repostId":"2167559884","repostType":4,"repost":{"id":"2167559884","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1631721822,"share":"https://www.laohu8.com/m/news/2167559884?lang=&edition=full","pubTime":"2021-09-16 00:03","market":"us","language":"en","title":"Procept BioRobotics spikes 40% on its first day of trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2167559884","media":"Dow Jones","summary":"Procept BioRobotics spikes 40% on its first day of trading.\n\nProcept BioRobotics Corp. is set to go ","content":"<p>Procept BioRobotics spikes 40% on its first day of trading.</p>\n<p><img src=\"https://static.tigerbbs.com/70f6e6c88567a43f408cd96f913f6476\" tg-width=\"1404\" tg-height=\"888\" width=\"100%\" height=\"auto\"></p>\n<p>Procept BioRobotics Corp.&nbsp;is set to go public Wednesday, as the California-based surgical robotics company's upsized initial public offering priced above the expected range at $25.00 per share. The company sold 6.56 million shares in the IPO to raise $163.9 million. Procept had previously expected to offer 5.5 million shares in the IPO, which was projected to price between $22 and $24 per share. The stock is expected to begin trading Wednesday on the Nasdaq under the ticker symbol \"PRCT.\" With 41.21 million shares outstanding after the IPO, the pricing values Procept at $1.03 billion. BofA Securities and Goldman Sachs are the joint lead bookrunning managers. The company had recorded a net loss of $27.4 million on revenue of $15.7 million in the six months ended June 30, after a loss of $25.7 million on revenue of $2.4 million in the same period a year ago. The company is going public at a time that the <a href=\"https://laohu8.com/S/IPO\">Renaissance IPO ETF</a>&nbsp;has gained 7.4% over the past three months while the S&amp;P 500 has tacked on 4.6%.</p>\n<p><b>Company and Technology</b></p>\n<p>Redwood City, California-based Procept was founded to develop advanced surgical robotic devices for use in minimally invasive procedures.</p>\n<p>Management is headed by President and CEO Reza Zadno, Ph.D., who has been with the firm since February 2020 and was previously president and CEO of Avedro, a healthcare company.</p>\n<p>The company's first instrument is the AquaBeam Robotic System for use in urologic surgery with an initial focus on treating benign prostate hyperplasia.</p>\n<p>Procept has received at least $328 million in equity investment from investors including CPMG, Viking Global, Fidelity and individuals.</p>\n<p>Customer Acquisition</p>\n<p>The firm sells its product to hospitals who in turn charge various third party payors for each service rendered.</p>\n<p>The company is targeting 860 high-volume hospitals which account for 70% of all hospital-based resective procedures.</p>\n<p>Selling, G&amp;A expenses as a percentage of total revenue have dropped substantially as revenues have increased, as the figures below indicate:</p>\n<table>\n <colgroup></colgroup>\n <tbody>\n  <tr>\n   <td><p><b>Selling, G&amp;A</b></p></td>\n   <td><p><b>Expenses vs. Revenue</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Percentage</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>144.5%</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>392.3%</p></td>\n  </tr>\n  <tr>\n   <td><p>2019</p></td>\n   <td><p>462.3%</p></td>\n  </tr>\n </tbody>\n</table>\n<p>The Selling, G&amp;A efficiency rate, defined as how many dollars of additional new revenue are generated by each dollar of Selling, G&amp;A spend, rose to 0.6x in the most recent reporting period, as shown in the table below:</p>\n<table>\n <colgroup></colgroup>\n <tbody>\n  <tr>\n   <td><p><b>Selling, G&amp;A</b></p></td>\n   <td><p><b>Efficiency Rate</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Multiple</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>0.6</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>0.1</p></td>\n  </tr>\n </tbody>\n</table>\n<p><b>Market &amp; Competition</b></p>\n<p>According to a 2018 marketresearch reportby Allied Market Research, the global market for treating benign prostatic hyperplasia was an estimated $10.7 billion in 2017 and is forecast to reach $20.1 billion by 2025.</p>\n<p>This represents a forecast CAGR of 8.1% from 2018 to 2025.</p>\n<p>The main drivers for this expected growth are an increase in disease incidence to the aging of the global population of males.</p>\n<p>Also, alpha-blocker drugs are likely to be a major competitor, as they help in relaxing the muscle of the prostate and the bladder neck, allowing urination to occur more easily.</p>\n<p>Major competitive or other industry participants include:</p>\n<ul>\n <li>Boehringer Ingelheim</li>\n <li>Allergan</li>\n <li>GlaxoSmithKline(NYSE:GSK)</li>\n <li>Merck(NYSE:MRK)</li>\n <li>Teleflex(NYSE:TFX)</li>\n <li>Boston Scientific(NYSE:BSX)</li>\n <li>Others</li>\n</ul>\n<p><b>Financial Performance</b></p>\n<p>Procept’s recent financial results can be summarized as follows:</p>\n<ul>\n <li>Sharply growing top-line revenue from a small base</li>\n <li>A swing to gross profit and positive gross margin</li>\n <li>High and increasing operating losses</li>\n <li>High and increasing cash used in operations</li>\n</ul>\n<p>Below are relevant financial results derived from the firm’s registration statement:</p>\n<p><img src=\"https://static.tigerbbs.com/6fb31b91e96ed681b39c952c72b32105\" tg-width=\"904\" tg-height=\"439\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/94b04bc1fd096b33535887c4c77d17a5\" tg-width=\"906\" tg-height=\"442\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/72b3c6e00fbb7d021141642eb8f69104\" tg-width=\"907\" tg-height=\"441\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/43410c6bd6487d96c4424db32f9c94e7\" tg-width=\"907\" tg-height=\"438\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/0457da194f7ee652bf4bad3deb6fbf40\" tg-width=\"908\" tg-height=\"441\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/12ac204e8226347ff04eb9ca845142aa\" tg-width=\"902\" tg-height=\"439\" referrerpolicy=\"no-referrer\"></p>\n<p>As of June 30, 2021, Procept had $159.2 million in cash and $68.3 million in total liabilities.</p>\n<p>Free cash flow during the twelve months ended June 30, 2021, was negative ($52.7 million).</p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Procept BioRobotics spikes 40% on its first day of trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nProcept BioRobotics spikes 40% on its first day of trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-09-16 00:03</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Procept BioRobotics spikes 40% on its first day of trading.</p>\n<p><img src=\"https://static.tigerbbs.com/70f6e6c88567a43f408cd96f913f6476\" tg-width=\"1404\" tg-height=\"888\" width=\"100%\" height=\"auto\"></p>\n<p>Procept BioRobotics Corp.&nbsp;is set to go public Wednesday, as the California-based surgical robotics company's upsized initial public offering priced above the expected range at $25.00 per share. The company sold 6.56 million shares in the IPO to raise $163.9 million. Procept had previously expected to offer 5.5 million shares in the IPO, which was projected to price between $22 and $24 per share. The stock is expected to begin trading Wednesday on the Nasdaq under the ticker symbol \"PRCT.\" With 41.21 million shares outstanding after the IPO, the pricing values Procept at $1.03 billion. BofA Securities and Goldman Sachs are the joint lead bookrunning managers. The company had recorded a net loss of $27.4 million on revenue of $15.7 million in the six months ended June 30, after a loss of $25.7 million on revenue of $2.4 million in the same period a year ago. The company is going public at a time that the <a href=\"https://laohu8.com/S/IPO\">Renaissance IPO ETF</a>&nbsp;has gained 7.4% over the past three months while the S&amp;P 500 has tacked on 4.6%.</p>\n<p><b>Company and Technology</b></p>\n<p>Redwood City, California-based Procept was founded to develop advanced surgical robotic devices for use in minimally invasive procedures.</p>\n<p>Management is headed by President and CEO Reza Zadno, Ph.D., who has been with the firm since February 2020 and was previously president and CEO of Avedro, a healthcare company.</p>\n<p>The company's first instrument is the AquaBeam Robotic System for use in urologic surgery with an initial focus on treating benign prostate hyperplasia.</p>\n<p>Procept has received at least $328 million in equity investment from investors including CPMG, Viking Global, Fidelity and individuals.</p>\n<p>Customer Acquisition</p>\n<p>The firm sells its product to hospitals who in turn charge various third party payors for each service rendered.</p>\n<p>The company is targeting 860 high-volume hospitals which account for 70% of all hospital-based resective procedures.</p>\n<p>Selling, G&amp;A expenses as a percentage of total revenue have dropped substantially as revenues have increased, as the figures below indicate:</p>\n<table>\n <colgroup></colgroup>\n <tbody>\n  <tr>\n   <td><p><b>Selling, G&amp;A</b></p></td>\n   <td><p><b>Expenses vs. Revenue</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Percentage</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>144.5%</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>392.3%</p></td>\n  </tr>\n  <tr>\n   <td><p>2019</p></td>\n   <td><p>462.3%</p></td>\n  </tr>\n </tbody>\n</table>\n<p>The Selling, G&amp;A efficiency rate, defined as how many dollars of additional new revenue are generated by each dollar of Selling, G&amp;A spend, rose to 0.6x in the most recent reporting period, as shown in the table below:</p>\n<table>\n <colgroup></colgroup>\n <tbody>\n  <tr>\n   <td><p><b>Selling, G&amp;A</b></p></td>\n   <td><p><b>Efficiency Rate</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Multiple</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>0.6</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>0.1</p></td>\n  </tr>\n </tbody>\n</table>\n<p><b>Market &amp; Competition</b></p>\n<p>According to a 2018 marketresearch reportby Allied Market Research, the global market for treating benign prostatic hyperplasia was an estimated $10.7 billion in 2017 and is forecast to reach $20.1 billion by 2025.</p>\n<p>This represents a forecast CAGR of 8.1% from 2018 to 2025.</p>\n<p>The main drivers for this expected growth are an increase in disease incidence to the aging of the global population of males.</p>\n<p>Also, alpha-blocker drugs are likely to be a major competitor, as they help in relaxing the muscle of the prostate and the bladder neck, allowing urination to occur more easily.</p>\n<p>Major competitive or other industry participants include:</p>\n<ul>\n <li>Boehringer Ingelheim</li>\n <li>Allergan</li>\n <li>GlaxoSmithKline(NYSE:GSK)</li>\n <li>Merck(NYSE:MRK)</li>\n <li>Teleflex(NYSE:TFX)</li>\n <li>Boston Scientific(NYSE:BSX)</li>\n <li>Others</li>\n</ul>\n<p><b>Financial Performance</b></p>\n<p>Procept’s recent financial results can be summarized as follows:</p>\n<ul>\n <li>Sharply growing top-line revenue from a small base</li>\n <li>A swing to gross profit and positive gross margin</li>\n <li>High and increasing operating losses</li>\n <li>High and increasing cash used in operations</li>\n</ul>\n<p>Below are relevant financial results derived from the firm’s registration statement:</p>\n<p><img src=\"https://static.tigerbbs.com/6fb31b91e96ed681b39c952c72b32105\" tg-width=\"904\" tg-height=\"439\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/94b04bc1fd096b33535887c4c77d17a5\" tg-width=\"906\" tg-height=\"442\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/72b3c6e00fbb7d021141642eb8f69104\" tg-width=\"907\" tg-height=\"441\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/43410c6bd6487d96c4424db32f9c94e7\" tg-width=\"907\" tg-height=\"438\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/0457da194f7ee652bf4bad3deb6fbf40\" tg-width=\"908\" tg-height=\"441\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/12ac204e8226347ff04eb9ca845142aa\" tg-width=\"902\" tg-height=\"439\" referrerpolicy=\"no-referrer\"></p>\n<p>As of June 30, 2021, Procept had $159.2 million in cash and $68.3 million in total liabilities.</p>\n<p>Free cash flow during the twelve months ended June 30, 2021, was negative ($52.7 million).</p>\n<p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PRCT":"PROCEPT BioRobotics"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2167559884","content_text":"Procept BioRobotics spikes 40% on its first day of trading.\n\nProcept BioRobotics Corp. is set to go public Wednesday, as the California-based surgical robotics company's upsized initial public offering priced above the expected range at $25.00 per share. The company sold 6.56 million shares in the IPO to raise $163.9 million. Procept had previously expected to offer 5.5 million shares in the IPO, which was projected to price between $22 and $24 per share. The stock is expected to begin trading Wednesday on the Nasdaq under the ticker symbol \"PRCT.\" With 41.21 million shares outstanding after the IPO, the pricing values Procept at $1.03 billion. BofA Securities and Goldman Sachs are the joint lead bookrunning managers. The company had recorded a net loss of $27.4 million on revenue of $15.7 million in the six months ended June 30, after a loss of $25.7 million on revenue of $2.4 million in the same period a year ago. The company is going public at a time that the Renaissance IPO ETF has gained 7.4% over the past three months while the S&P 500 has tacked on 4.6%.\nCompany and Technology\nRedwood City, California-based Procept was founded to develop advanced surgical robotic devices for use in minimally invasive procedures.\nManagement is headed by President and CEO Reza Zadno, Ph.D., who has been with the firm since February 2020 and was previously president and CEO of Avedro, a healthcare company.\nThe company's first instrument is the AquaBeam Robotic System for use in urologic surgery with an initial focus on treating benign prostate hyperplasia.\nProcept has received at least $328 million in equity investment from investors including CPMG, Viking Global, Fidelity and individuals.\nCustomer Acquisition\nThe firm sells its product to hospitals who in turn charge various third party payors for each service rendered.\nThe company is targeting 860 high-volume hospitals which account for 70% of all hospital-based resective procedures.\nSelling, G&A expenses as a percentage of total revenue have dropped substantially as revenues have increased, as the figures below indicate:\n\n\n\n\nSelling, G&A\nExpenses vs. Revenue\n\n\nPeriod\nPercentage\n\n\nSix Mos. Ended June 30, 2021\n144.5%\n\n\n2020\n392.3%\n\n\n2019\n462.3%\n\n\n\nThe Selling, G&A efficiency rate, defined as how many dollars of additional new revenue are generated by each dollar of Selling, G&A spend, rose to 0.6x in the most recent reporting period, as shown in the table below:\n\n\n\n\nSelling, G&A\nEfficiency Rate\n\n\nPeriod\nMultiple\n\n\nSix Mos. Ended June 30, 2021\n0.6\n\n\n2020\n0.1\n\n\n\nMarket & Competition\nAccording to a 2018 marketresearch reportby Allied Market Research, the global market for treating benign prostatic hyperplasia was an estimated $10.7 billion in 2017 and is forecast to reach $20.1 billion by 2025.\nThis represents a forecast CAGR of 8.1% from 2018 to 2025.\nThe main drivers for this expected growth are an increase in disease incidence to the aging of the global population of males.\nAlso, alpha-blocker drugs are likely to be a major competitor, as they help in relaxing the muscle of the prostate and the bladder neck, allowing urination to occur more easily.\nMajor competitive or other industry participants include:\n\nBoehringer Ingelheim\nAllergan\nGlaxoSmithKline(NYSE:GSK)\nMerck(NYSE:MRK)\nTeleflex(NYSE:TFX)\nBoston Scientific(NYSE:BSX)\nOthers\n\nFinancial Performance\nProcept’s recent financial results can be summarized as follows:\n\nSharply growing top-line revenue from a small base\nA swing to gross profit and positive gross margin\nHigh and increasing operating losses\nHigh and increasing cash used in operations\n\nBelow are relevant financial results derived from the firm’s registration statement:\n\nAs of June 30, 2021, Procept had $159.2 million in cash and $68.3 million in total liabilities.\nFree cash flow during the twelve months ended June 30, 2021, was negative ($52.7 million).","news_type":1},"isVote":1,"tweetType":1,"viewCount":144,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":864468714,"gmtCreate":1633139611877,"gmtModify":1633139611948,"author":{"id":"3580436163482352","authorId":"3580436163482352","name":"JohnLoh00","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580436163482352","authorIdStr":"3580436163482352"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/864468714","repostId":"2172618951","repostType":4,"repost":{"id":"2172618951","pubTimestamp":1633101555,"share":"https://www.laohu8.com/m/news/2172618951?lang=&edition=full","pubTime":"2021-10-01 23:19","market":"us","language":"en","title":"Here are the most anticipated IPOs and new listings for Q4 2021 and early 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=2172618951","media":"Yahoo Finance","summary":"It has been a record-breaking year for new public company listings — including IPOs, direct listings","content":"<p>It has been a record-breaking year for new public company listings — including IPOs, direct listings and SPACs — with total U.S. issuance standing at $257 billion. Though most unicorns that grew up over the last decade have found their way to the public markets, a few large holdouts remain in the pipeline for the coming quarters.</p>\n<p>A new wrinkle is popping up as well, which potentially threatens to introduce delays. Only a day after the latest consumer-facing unicorn, Warby Parker (WRBY), came public on the New York Stock Exchange (ending the day with a $6.1 billion valuation), Wall Street is bracing for a nail-biting resolution to the budget crisis.</p>\n<p>If the government were to shut down, it would include the Securities and Exchange Commission, which would delay the review process for new listings. The last government shutdown on December 22, 2018, which lasted until January 25, 2019, delayed the Uber (UBER) and Lyft (LYFT) IPOs by at least a month — maybe longer.</p>\n<p>Delays or not, investors await some of the hottest names yet to go public — and they're not all expected to be traditional IPOs. Investing app Acorns Grow will likely enter a reverse merger with a Special Purpose Acquisition Company (SPAC). While payments platform Stripe is mulling a direct listing where no money is raised from the public but insiders are allowed to sell their shares.</p>\n<p>Here are some of the larger names:</p>\n<h2>Stripe</h2>\n<h2></h2>\n<p>Listing type: IPO or direct listing</p>\n<p>Listing Timeline: 2022</p>\n<p>Valuation: $100 billion</p>\n<p>The most valuable U.S. startup, which is already competing head-to-head in the payments space with Square (SQ) and <a href=\"https://laohu8.com/S/PYPL\">PayPal</a> (PYPL), is reportedly seeking a 2022 IPO or direct listing. The 11-year-old company founded by two brothers, John and Patrick Collison, may be <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the largest listings on record. The last funding round in March valued the company at $95 billion, but sales in the private market suggest a valuation as high as $152 billion. Given the 2022 timetable, its valuation could be materially different by then.</p>\n<h2>Rivian Automotive</h2>\n<h2></h2>\n<p>Listing type: IPO</p>\n<p>Listing Timeline: October or November</p>\n<p>Valuation: $80 billion</p>\n<p>Only weeks ago, the electric pickup truck maker finally got the green light from three regulatory agencies to sell its R1T battery-electric pickup to customers. Rivian, which is backed by Amazon (AMZN), Ford (F), T Rowe Price (TROW) and Fidelity, is looking to launch its R1S SUV sometime this fall. Rivian hopes to raise between $5 billion and $8 billion in its IPO, which would peg its valuation at about $80 billion. U.K. prime minister Boris Johnson lobbied Amazon Chairman Jeff Bezos to coax Rivian into building a new $1.39 billion (£1 billion) factory near Bristol, Sky News recently reported.</p>\n<h2><b>InstaCart</b></h2>\n<h2></h2>\n<p>Listing type: IPO</p>\n<p>Listing Timeline: 2021</p>\n<p>Valuation: $39 billion</p>\n<p>One of the few delivery services not to go public yet or get scooped up in a merger play (though DoorDash (DASH) did hold talks with the the company earlier this year), InstaCart is also one of the few remaining mega-unicorns. The largest grocery delivery agent in the U.S. was last valued at $39 billion from a $265 million funding round in March — up 120% from its previous funding round five months earlier. As it beefs up its corporate headcount, it's also engaging in new projects. In mid-September, InstaCart partnered with Kroger to launch their \"Kroger Delivery Now\" program nationwide with delivery times as low as 30 minutes.</p>\n<h2><b>Reddit</b></h2>\n<h2></h2>\n<p>Listing type: IPO</p>\n<p>Listing Timeline: Early 2022</p>\n<p>Valuation: $15 billion</p>\n<p>The Robinhood Markets (HOOD) IPO in July was only a foretaste of the feast to come for the Reddit army, which is looking forward to the IPO of its namesake early next year. In August, Reddit raised $700 million in part to build its business and attract new users. That round valued the social media network at $10 billion, but since then, Reuters has reported the company is looking for a $15 billion valuation. Whether the stock goes to the moon or leaves early investors unfortunate bag holders, meme stock aficionados will be keeping a close eye on this listing.</p>\n<h2>Acorns Grow</h2>\n<h2></h2>\n<p>Listing type: SPAC</p>\n<p>Listing Timeline: 2021</p>\n<p>Valuation: $2.2 billion</p>\n<p>This nine-year-old company that brings micro-investing and robo-investing to the masses is set to list on the Nasdaq under the ticker OAKS. Once Acorns completes its planned reverse merger with <a href=\"https://laohu8.com/S/PACXU\">Pioneer Merger Corp.</a>, a SPAC that went public itself in March, Acorns CEO Noah Kerner will continue to lead the company along with his management team. Acorns is looking to grow its user base to 8 million users by 2023 and generate revenue of $309 million that year, which would be up 335% from its 2020 reported revenue of $71 million.</p>\n<p><b><i>Jared Blikre is an anchor and reporter focused on the markets on Yahoo Finance Live. Follow him @SPYJared</i></b></p>\n<ul>\n <li><p><b>Read the latest financial and business news from Yahoo Finance</b></p></li>\n</ul>\n<p><b><i>Follow Yahoo Finance on <a href=\"https://laohu8.com/S/TWTR\">Twitter</a>, <a href=\"https://laohu8.com/S/FB\">Facebook</a>, Instagram, Flipboard, LinkedIn, YouTube, and reddit</i></b></p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here are the most anticipated IPOs and new listings for Q4 2021 and early 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere are the most anticipated IPOs and new listings for Q4 2021 and early 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-01 23:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/here-are-the-most-anticipated-ip-os-and-new-listings-for-q-4-2021-and-early-2022-190938224.html><strong>Yahoo Finance</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It has been a record-breaking year for new public company listings — including IPOs, direct listings and SPACs — with total U.S. issuance standing at $257 billion. Though most unicorns that grew up ...</p>\n\n<a href=\"https://finance.yahoo.com/news/here-are-the-most-anticipated-ip-os-and-new-listings-for-q-4-2021-and-early-2022-190938224.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/1fe90f56c29ba1fe75cd676f7616d563","relate_stocks":{"PYPL":"PayPal","HOOD":"Robinhood","TROW":"普信集团","SQ":"Block","LYFT":"Lyft, Inc.","UBER":"优步","WRBY":"Warby Parker Inc.","DASH":"DoorDash, Inc."},"source_url":"https://finance.yahoo.com/news/here-are-the-most-anticipated-ip-os-and-new-listings-for-q-4-2021-and-early-2022-190938224.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2172618951","content_text":"It has been a record-breaking year for new public company listings — including IPOs, direct listings and SPACs — with total U.S. issuance standing at $257 billion. Though most unicorns that grew up over the last decade have found their way to the public markets, a few large holdouts remain in the pipeline for the coming quarters.\nA new wrinkle is popping up as well, which potentially threatens to introduce delays. Only a day after the latest consumer-facing unicorn, Warby Parker (WRBY), came public on the New York Stock Exchange (ending the day with a $6.1 billion valuation), Wall Street is bracing for a nail-biting resolution to the budget crisis.\nIf the government were to shut down, it would include the Securities and Exchange Commission, which would delay the review process for new listings. The last government shutdown on December 22, 2018, which lasted until January 25, 2019, delayed the Uber (UBER) and Lyft (LYFT) IPOs by at least a month — maybe longer.\nDelays or not, investors await some of the hottest names yet to go public — and they're not all expected to be traditional IPOs. Investing app Acorns Grow will likely enter a reverse merger with a Special Purpose Acquisition Company (SPAC). While payments platform Stripe is mulling a direct listing where no money is raised from the public but insiders are allowed to sell their shares.\nHere are some of the larger names:\nStripe\n\nListing type: IPO or direct listing\nListing Timeline: 2022\nValuation: $100 billion\nThe most valuable U.S. startup, which is already competing head-to-head in the payments space with Square (SQ) and PayPal (PYPL), is reportedly seeking a 2022 IPO or direct listing. The 11-year-old company founded by two brothers, John and Patrick Collison, may be one of the largest listings on record. The last funding round in March valued the company at $95 billion, but sales in the private market suggest a valuation as high as $152 billion. Given the 2022 timetable, its valuation could be materially different by then.\nRivian Automotive\n\nListing type: IPO\nListing Timeline: October or November\nValuation: $80 billion\nOnly weeks ago, the electric pickup truck maker finally got the green light from three regulatory agencies to sell its R1T battery-electric pickup to customers. Rivian, which is backed by Amazon (AMZN), Ford (F), T Rowe Price (TROW) and Fidelity, is looking to launch its R1S SUV sometime this fall. Rivian hopes to raise between $5 billion and $8 billion in its IPO, which would peg its valuation at about $80 billion. U.K. prime minister Boris Johnson lobbied Amazon Chairman Jeff Bezos to coax Rivian into building a new $1.39 billion (£1 billion) factory near Bristol, Sky News recently reported.\nInstaCart\n\nListing type: IPO\nListing Timeline: 2021\nValuation: $39 billion\nOne of the few delivery services not to go public yet or get scooped up in a merger play (though DoorDash (DASH) did hold talks with the the company earlier this year), InstaCart is also one of the few remaining mega-unicorns. The largest grocery delivery agent in the U.S. was last valued at $39 billion from a $265 million funding round in March — up 120% from its previous funding round five months earlier. As it beefs up its corporate headcount, it's also engaging in new projects. In mid-September, InstaCart partnered with Kroger to launch their \"Kroger Delivery Now\" program nationwide with delivery times as low as 30 minutes.\nReddit\n\nListing type: IPO\nListing Timeline: Early 2022\nValuation: $15 billion\nThe Robinhood Markets (HOOD) IPO in July was only a foretaste of the feast to come for the Reddit army, which is looking forward to the IPO of its namesake early next year. In August, Reddit raised $700 million in part to build its business and attract new users. That round valued the social media network at $10 billion, but since then, Reuters has reported the company is looking for a $15 billion valuation. Whether the stock goes to the moon or leaves early investors unfortunate bag holders, meme stock aficionados will be keeping a close eye on this listing.\nAcorns Grow\n\nListing type: SPAC\nListing Timeline: 2021\nValuation: $2.2 billion\nThis nine-year-old company that brings micro-investing and robo-investing to the masses is set to list on the Nasdaq under the ticker OAKS. Once Acorns completes its planned reverse merger with Pioneer Merger Corp., a SPAC that went public itself in March, Acorns CEO Noah Kerner will continue to lead the company along with his management team. Acorns is looking to grow its user base to 8 million users by 2023 and generate revenue of $309 million that year, which would be up 335% from its 2020 reported revenue of $71 million.\nJared Blikre is an anchor and reporter focused on the markets on Yahoo Finance Live. Follow him @SPYJared\n\nRead the latest financial and business news from Yahoo Finance\n\nFollow Yahoo Finance on Twitter, Facebook, Instagram, Flipboard, LinkedIn, YouTube, and reddit","news_type":1},"isVote":1,"tweetType":1,"viewCount":687,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":869838777,"gmtCreate":1632271331099,"gmtModify":1632801612990,"author":{"id":"3580436163482352","authorId":"3580436163482352","name":"JohnLoh00","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580436163482352","authorIdStr":"3580436163482352"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/869838777","repostId":"2169637141","repostType":4,"isVote":1,"tweetType":1,"viewCount":143,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":885045807,"gmtCreate":1631748395909,"gmtModify":1632806492193,"author":{"id":"3580436163482352","authorId":"3580436163482352","name":"JohnLoh00","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580436163482352","authorIdStr":"3580436163482352"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/885045807","repostId":"1121883775","repostType":4,"isVote":1,"tweetType":1,"viewCount":47,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":882896308,"gmtCreate":1631671667604,"gmtModify":1632806890425,"author":{"id":"3580436163482352","authorId":"3580436163482352","name":"JohnLoh00","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580436163482352","authorIdStr":"3580436163482352"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/882896308","repostId":"1194314814","repostType":4,"repost":{"id":"1194314814","pubTimestamp":1631669942,"share":"https://www.laohu8.com/m/news/1194314814?lang=&edition=full","pubTime":"2021-09-15 09:39","market":"us","language":"en","title":"SPRT Stock Plunges 30% Ahead of Greenidge Generation’s (GREE) Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1194314814","media":"investorplace","summary":"Today marks the final catalyst that we predicted for shareholders of SPRT as Support.com(NASDAQ:SPRT","content":"<p>Today marks the&nbsp;final catalyst&nbsp;that we predicted for shareholders of SPRT as&nbsp;<b>Support.com</b>(NASDAQ:<b><u>SPRT</u></b>) and&nbsp;<b>Greenidge Generation Holdings</b>&nbsp;complete&nbsp;their long-awaited merger. As of tomorrow, Greenidge Class A common stock shares will begin trading on the&nbsp;<b>Nasdaq</b>&nbsp;under the ticker GREE. This morning, though, saw shares of SPRT stock continue the trend of plunging further, despite the merger’s continuous development.</p>\n<p>As we’ve noted previously, SPRT stock has continued to decline over the past week, despite a spike during the week before. Investors chased up shares earlier in September upon news that shareholders would soon vote to approve the merger. The actual vote, though, did not have the same affect, as shares began to decline. Since then, this trend hasn’t stopped.</p>\n<p>As of this writing, shares of SPRT stock are down 30.8% for the day. After briefly surging late in the day on Sept. 9, they have only kept declining. Yesterday saw the stock fall by 9%.</p>\n<p>What It Means</p>\n<p>The deal received overwhelming support from shareholders when it came time to vote, but in the days since, some analysts have expressed concern for the company’s long-term future.</p>\n<p>Some concerns are certainly justified, although part of SPRT stock’s poor performance of late can be attributed to pure uncertainty. The deal is a bit unorthodox given the two companies it involves and how different their dealings are. Nonetheless, this area which has some concerned can also prove beneficial to Support.com and likewise, its shareholders.</p>\n<p>It should be noted that a company like Suport.com saw merging with a company like Greenidge as its best chance at staying relevant in an ever-changing market. The latter is poised to become the first publicly traded<b>Bitcoin</b>(CCC:<b><u>BTC-USD</u></b>) mining company with its own power plant, an area that could allow them to grow considerably. The move has beencalleda Hail Mary pass for Support.com but if that’s true, it’s certainly a well-calculated pass that makes sense at this point in the game.</p>\n<p>Let’s also not forget that while this merger dragged out, Support.com was able to garner meme stock status, a rare feat for a company with a business model as boring as providing digital human resource tools. Say what you will about Greenidge, but merging with it makes Support.com unquestionably more interesting.</p>\n<p>What’s Next for These Companies?</p>\n<p>Support.com stock has seen plenty of volatility and it may not be over yet, but that doesn’t mean that the company won’t have plenty of opportunity to grow once GREE begins trading and markets can move forward. Tomorrow will hopefully mean the end of this uncertainty, allowing us to finally assess how SPRT stock will perform in a post-merger world.</p>\n<p>The stock is drawing a lot of criticism right now, but we shouldn’t be so quick to write it off until we see what GREE will do. Support.com’s new partner has plenty of potential.</p>\n<p>As<i>InvestorPlace</i>contributor Tom Kerr recently&nbsp;assessed“One thing can be said for certain: now the upside for SPRT stock depends a heck of a lot more on the price of Bitcoin (CCC:<b><u>BTC-USD</u></b>).”</p>\n<p>With that in mind, we should continue to watch and wait.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SPRT Stock Plunges 30% Ahead of Greenidge Generation’s (GREE) Debut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSPRT Stock Plunges 30% Ahead of Greenidge Generation’s (GREE) Debut\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-15 09:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/09/sprt-stock-plunges-30-ahead-of-greenidge-generations-gree-debut/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Today marks the final catalyst that we predicted for shareholders of SPRT as Support.com(NASDAQ:SPRT) and Greenidge Generation Holdings complete their long-awaited merger. As of tomorrow, Greenidge ...</p>\n\n<a href=\"https://investorplace.com/2021/09/sprt-stock-plunges-30-ahead-of-greenidge-generations-gree-debut/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://investorplace.com/2021/09/sprt-stock-plunges-30-ahead-of-greenidge-generations-gree-debut/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1194314814","content_text":"Today marks the final catalyst that we predicted for shareholders of SPRT as Support.com(NASDAQ:SPRT) and Greenidge Generation Holdings complete their long-awaited merger. As of tomorrow, Greenidge Class A common stock shares will begin trading on the Nasdaq under the ticker GREE. This morning, though, saw shares of SPRT stock continue the trend of plunging further, despite the merger’s continuous development.\nAs we’ve noted previously, SPRT stock has continued to decline over the past week, despite a spike during the week before. Investors chased up shares earlier in September upon news that shareholders would soon vote to approve the merger. The actual vote, though, did not have the same affect, as shares began to decline. Since then, this trend hasn’t stopped.\nAs of this writing, shares of SPRT stock are down 30.8% for the day. After briefly surging late in the day on Sept. 9, they have only kept declining. Yesterday saw the stock fall by 9%.\nWhat It Means\nThe deal received overwhelming support from shareholders when it came time to vote, but in the days since, some analysts have expressed concern for the company’s long-term future.\nSome concerns are certainly justified, although part of SPRT stock’s poor performance of late can be attributed to pure uncertainty. The deal is a bit unorthodox given the two companies it involves and how different their dealings are. Nonetheless, this area which has some concerned can also prove beneficial to Support.com and likewise, its shareholders.\nIt should be noted that a company like Suport.com saw merging with a company like Greenidge as its best chance at staying relevant in an ever-changing market. The latter is poised to become the first publicly tradedBitcoin(CCC:BTC-USD) mining company with its own power plant, an area that could allow them to grow considerably. The move has beencalleda Hail Mary pass for Support.com but if that’s true, it’s certainly a well-calculated pass that makes sense at this point in the game.\nLet’s also not forget that while this merger dragged out, Support.com was able to garner meme stock status, a rare feat for a company with a business model as boring as providing digital human resource tools. Say what you will about Greenidge, but merging with it makes Support.com unquestionably more interesting.\nWhat’s Next for These Companies?\nSupport.com stock has seen plenty of volatility and it may not be over yet, but that doesn’t mean that the company won’t have plenty of opportunity to grow once GREE begins trading and markets can move forward. Tomorrow will hopefully mean the end of this uncertainty, allowing us to finally assess how SPRT stock will perform in a post-merger world.\nThe stock is drawing a lot of criticism right now, but we shouldn’t be so quick to write it off until we see what GREE will do. Support.com’s new partner has plenty of potential.\nAsInvestorPlacecontributor Tom Kerr recently assessed“One thing can be said for certain: now the upside for SPRT stock depends a heck of a lot more on the price of Bitcoin (CCC:BTC-USD).”\nWith that in mind, we should continue to watch and wait.","news_type":1},"isVote":1,"tweetType":1,"viewCount":3,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":885042243,"gmtCreate":1631748359982,"gmtModify":1632806492946,"author":{"id":"3580436163482352","authorId":"3580436163482352","name":"JohnLoh00","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580436163482352","authorIdStr":"3580436163482352"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/885042243","repostId":"2167559884","repostType":4,"repost":{"id":"2167559884","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1631721822,"share":"https://www.laohu8.com/m/news/2167559884?lang=&edition=full","pubTime":"2021-09-16 00:03","market":"us","language":"en","title":"Procept BioRobotics spikes 40% on its first day of trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2167559884","media":"Dow Jones","summary":"Procept BioRobotics spikes 40% on its first day of trading.\n\nProcept BioRobotics Corp. is set to go ","content":"<p>Procept BioRobotics spikes 40% on its first day of trading.</p>\n<p><img src=\"https://static.tigerbbs.com/70f6e6c88567a43f408cd96f913f6476\" tg-width=\"1404\" tg-height=\"888\" width=\"100%\" height=\"auto\"></p>\n<p>Procept BioRobotics Corp.&nbsp;is set to go public Wednesday, as the California-based surgical robotics company's upsized initial public offering priced above the expected range at $25.00 per share. The company sold 6.56 million shares in the IPO to raise $163.9 million. Procept had previously expected to offer 5.5 million shares in the IPO, which was projected to price between $22 and $24 per share. The stock is expected to begin trading Wednesday on the Nasdaq under the ticker symbol \"PRCT.\" With 41.21 million shares outstanding after the IPO, the pricing values Procept at $1.03 billion. BofA Securities and Goldman Sachs are the joint lead bookrunning managers. The company had recorded a net loss of $27.4 million on revenue of $15.7 million in the six months ended June 30, after a loss of $25.7 million on revenue of $2.4 million in the same period a year ago. The company is going public at a time that the <a href=\"https://laohu8.com/S/IPO\">Renaissance IPO ETF</a>&nbsp;has gained 7.4% over the past three months while the S&amp;P 500 has tacked on 4.6%.</p>\n<p><b>Company and Technology</b></p>\n<p>Redwood City, California-based Procept was founded to develop advanced surgical robotic devices for use in minimally invasive procedures.</p>\n<p>Management is headed by President and CEO Reza Zadno, Ph.D., who has been with the firm since February 2020 and was previously president and CEO of Avedro, a healthcare company.</p>\n<p>The company's first instrument is the AquaBeam Robotic System for use in urologic surgery with an initial focus on treating benign prostate hyperplasia.</p>\n<p>Procept has received at least $328 million in equity investment from investors including CPMG, Viking Global, Fidelity and individuals.</p>\n<p>Customer Acquisition</p>\n<p>The firm sells its product to hospitals who in turn charge various third party payors for each service rendered.</p>\n<p>The company is targeting 860 high-volume hospitals which account for 70% of all hospital-based resective procedures.</p>\n<p>Selling, G&amp;A expenses as a percentage of total revenue have dropped substantially as revenues have increased, as the figures below indicate:</p>\n<table>\n <colgroup></colgroup>\n <tbody>\n  <tr>\n   <td><p><b>Selling, G&amp;A</b></p></td>\n   <td><p><b>Expenses vs. Revenue</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Percentage</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>144.5%</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>392.3%</p></td>\n  </tr>\n  <tr>\n   <td><p>2019</p></td>\n   <td><p>462.3%</p></td>\n  </tr>\n </tbody>\n</table>\n<p>The Selling, G&amp;A efficiency rate, defined as how many dollars of additional new revenue are generated by each dollar of Selling, G&amp;A spend, rose to 0.6x in the most recent reporting period, as shown in the table below:</p>\n<table>\n <colgroup></colgroup>\n <tbody>\n  <tr>\n   <td><p><b>Selling, G&amp;A</b></p></td>\n   <td><p><b>Efficiency Rate</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Multiple</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>0.6</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>0.1</p></td>\n  </tr>\n </tbody>\n</table>\n<p><b>Market &amp; Competition</b></p>\n<p>According to a 2018 marketresearch reportby Allied Market Research, the global market for treating benign prostatic hyperplasia was an estimated $10.7 billion in 2017 and is forecast to reach $20.1 billion by 2025.</p>\n<p>This represents a forecast CAGR of 8.1% from 2018 to 2025.</p>\n<p>The main drivers for this expected growth are an increase in disease incidence to the aging of the global population of males.</p>\n<p>Also, alpha-blocker drugs are likely to be a major competitor, as they help in relaxing the muscle of the prostate and the bladder neck, allowing urination to occur more easily.</p>\n<p>Major competitive or other industry participants include:</p>\n<ul>\n <li>Boehringer Ingelheim</li>\n <li>Allergan</li>\n <li>GlaxoSmithKline(NYSE:GSK)</li>\n <li>Merck(NYSE:MRK)</li>\n <li>Teleflex(NYSE:TFX)</li>\n <li>Boston Scientific(NYSE:BSX)</li>\n <li>Others</li>\n</ul>\n<p><b>Financial Performance</b></p>\n<p>Procept’s recent financial results can be summarized as follows:</p>\n<ul>\n <li>Sharply growing top-line revenue from a small base</li>\n <li>A swing to gross profit and positive gross margin</li>\n <li>High and increasing operating losses</li>\n <li>High and increasing cash used in operations</li>\n</ul>\n<p>Below are relevant financial results derived from the firm’s registration statement:</p>\n<p><img src=\"https://static.tigerbbs.com/6fb31b91e96ed681b39c952c72b32105\" tg-width=\"904\" tg-height=\"439\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/94b04bc1fd096b33535887c4c77d17a5\" tg-width=\"906\" tg-height=\"442\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/72b3c6e00fbb7d021141642eb8f69104\" tg-width=\"907\" tg-height=\"441\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/43410c6bd6487d96c4424db32f9c94e7\" tg-width=\"907\" tg-height=\"438\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/0457da194f7ee652bf4bad3deb6fbf40\" tg-width=\"908\" tg-height=\"441\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/12ac204e8226347ff04eb9ca845142aa\" tg-width=\"902\" tg-height=\"439\" referrerpolicy=\"no-referrer\"></p>\n<p>As of June 30, 2021, Procept had $159.2 million in cash and $68.3 million in total liabilities.</p>\n<p>Free cash flow during the twelve months ended June 30, 2021, was negative ($52.7 million).</p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Procept BioRobotics spikes 40% on its first day of trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nProcept BioRobotics spikes 40% on its first day of trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-09-16 00:03</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Procept BioRobotics spikes 40% on its first day of trading.</p>\n<p><img src=\"https://static.tigerbbs.com/70f6e6c88567a43f408cd96f913f6476\" tg-width=\"1404\" tg-height=\"888\" width=\"100%\" height=\"auto\"></p>\n<p>Procept BioRobotics Corp.&nbsp;is set to go public Wednesday, as the California-based surgical robotics company's upsized initial public offering priced above the expected range at $25.00 per share. The company sold 6.56 million shares in the IPO to raise $163.9 million. Procept had previously expected to offer 5.5 million shares in the IPO, which was projected to price between $22 and $24 per share. The stock is expected to begin trading Wednesday on the Nasdaq under the ticker symbol \"PRCT.\" With 41.21 million shares outstanding after the IPO, the pricing values Procept at $1.03 billion. BofA Securities and Goldman Sachs are the joint lead bookrunning managers. The company had recorded a net loss of $27.4 million on revenue of $15.7 million in the six months ended June 30, after a loss of $25.7 million on revenue of $2.4 million in the same period a year ago. The company is going public at a time that the <a href=\"https://laohu8.com/S/IPO\">Renaissance IPO ETF</a>&nbsp;has gained 7.4% over the past three months while the S&amp;P 500 has tacked on 4.6%.</p>\n<p><b>Company and Technology</b></p>\n<p>Redwood City, California-based Procept was founded to develop advanced surgical robotic devices for use in minimally invasive procedures.</p>\n<p>Management is headed by President and CEO Reza Zadno, Ph.D., who has been with the firm since February 2020 and was previously president and CEO of Avedro, a healthcare company.</p>\n<p>The company's first instrument is the AquaBeam Robotic System for use in urologic surgery with an initial focus on treating benign prostate hyperplasia.</p>\n<p>Procept has received at least $328 million in equity investment from investors including CPMG, Viking Global, Fidelity and individuals.</p>\n<p>Customer Acquisition</p>\n<p>The firm sells its product to hospitals who in turn charge various third party payors for each service rendered.</p>\n<p>The company is targeting 860 high-volume hospitals which account for 70% of all hospital-based resective procedures.</p>\n<p>Selling, G&amp;A expenses as a percentage of total revenue have dropped substantially as revenues have increased, as the figures below indicate:</p>\n<table>\n <colgroup></colgroup>\n <tbody>\n  <tr>\n   <td><p><b>Selling, G&amp;A</b></p></td>\n   <td><p><b>Expenses vs. Revenue</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Percentage</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>144.5%</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>392.3%</p></td>\n  </tr>\n  <tr>\n   <td><p>2019</p></td>\n   <td><p>462.3%</p></td>\n  </tr>\n </tbody>\n</table>\n<p>The Selling, G&amp;A efficiency rate, defined as how many dollars of additional new revenue are generated by each dollar of Selling, G&amp;A spend, rose to 0.6x in the most recent reporting period, as shown in the table below:</p>\n<table>\n <colgroup></colgroup>\n <tbody>\n  <tr>\n   <td><p><b>Selling, G&amp;A</b></p></td>\n   <td><p><b>Efficiency Rate</b></p></td>\n  </tr>\n  <tr>\n   <td><p>Period</p></td>\n   <td><p>Multiple</p></td>\n  </tr>\n  <tr>\n   <td><p>Six Mos. Ended June 30, 2021</p></td>\n   <td><p>0.6</p></td>\n  </tr>\n  <tr>\n   <td><p>2020</p></td>\n   <td><p>0.1</p></td>\n  </tr>\n </tbody>\n</table>\n<p><b>Market &amp; Competition</b></p>\n<p>According to a 2018 marketresearch reportby Allied Market Research, the global market for treating benign prostatic hyperplasia was an estimated $10.7 billion in 2017 and is forecast to reach $20.1 billion by 2025.</p>\n<p>This represents a forecast CAGR of 8.1% from 2018 to 2025.</p>\n<p>The main drivers for this expected growth are an increase in disease incidence to the aging of the global population of males.</p>\n<p>Also, alpha-blocker drugs are likely to be a major competitor, as they help in relaxing the muscle of the prostate and the bladder neck, allowing urination to occur more easily.</p>\n<p>Major competitive or other industry participants include:</p>\n<ul>\n <li>Boehringer Ingelheim</li>\n <li>Allergan</li>\n <li>GlaxoSmithKline(NYSE:GSK)</li>\n <li>Merck(NYSE:MRK)</li>\n <li>Teleflex(NYSE:TFX)</li>\n <li>Boston Scientific(NYSE:BSX)</li>\n <li>Others</li>\n</ul>\n<p><b>Financial Performance</b></p>\n<p>Procept’s recent financial results can be summarized as follows:</p>\n<ul>\n <li>Sharply growing top-line revenue from a small base</li>\n <li>A swing to gross profit and positive gross margin</li>\n <li>High and increasing operating losses</li>\n <li>High and increasing cash used in operations</li>\n</ul>\n<p>Below are relevant financial results derived from the firm’s registration statement:</p>\n<p><img src=\"https://static.tigerbbs.com/6fb31b91e96ed681b39c952c72b32105\" tg-width=\"904\" tg-height=\"439\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/94b04bc1fd096b33535887c4c77d17a5\" tg-width=\"906\" tg-height=\"442\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/72b3c6e00fbb7d021141642eb8f69104\" tg-width=\"907\" tg-height=\"441\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/43410c6bd6487d96c4424db32f9c94e7\" tg-width=\"907\" tg-height=\"438\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/0457da194f7ee652bf4bad3deb6fbf40\" tg-width=\"908\" tg-height=\"441\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/12ac204e8226347ff04eb9ca845142aa\" tg-width=\"902\" tg-height=\"439\" referrerpolicy=\"no-referrer\"></p>\n<p>As of June 30, 2021, Procept had $159.2 million in cash and $68.3 million in total liabilities.</p>\n<p>Free cash flow during the twelve months ended June 30, 2021, was negative ($52.7 million).</p>\n<p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PRCT":"PROCEPT BioRobotics"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2167559884","content_text":"Procept BioRobotics spikes 40% on its first day of trading.\n\nProcept BioRobotics Corp. is set to go public Wednesday, as the California-based surgical robotics company's upsized initial public offering priced above the expected range at $25.00 per share. The company sold 6.56 million shares in the IPO to raise $163.9 million. Procept had previously expected to offer 5.5 million shares in the IPO, which was projected to price between $22 and $24 per share. The stock is expected to begin trading Wednesday on the Nasdaq under the ticker symbol \"PRCT.\" With 41.21 million shares outstanding after the IPO, the pricing values Procept at $1.03 billion. BofA Securities and Goldman Sachs are the joint lead bookrunning managers. The company had recorded a net loss of $27.4 million on revenue of $15.7 million in the six months ended June 30, after a loss of $25.7 million on revenue of $2.4 million in the same period a year ago. The company is going public at a time that the Renaissance IPO ETF has gained 7.4% over the past three months while the S&P 500 has tacked on 4.6%.\nCompany and Technology\nRedwood City, California-based Procept was founded to develop advanced surgical robotic devices for use in minimally invasive procedures.\nManagement is headed by President and CEO Reza Zadno, Ph.D., who has been with the firm since February 2020 and was previously president and CEO of Avedro, a healthcare company.\nThe company's first instrument is the AquaBeam Robotic System for use in urologic surgery with an initial focus on treating benign prostate hyperplasia.\nProcept has received at least $328 million in equity investment from investors including CPMG, Viking Global, Fidelity and individuals.\nCustomer Acquisition\nThe firm sells its product to hospitals who in turn charge various third party payors for each service rendered.\nThe company is targeting 860 high-volume hospitals which account for 70% of all hospital-based resective procedures.\nSelling, G&A expenses as a percentage of total revenue have dropped substantially as revenues have increased, as the figures below indicate:\n\n\n\n\nSelling, G&A\nExpenses vs. Revenue\n\n\nPeriod\nPercentage\n\n\nSix Mos. Ended June 30, 2021\n144.5%\n\n\n2020\n392.3%\n\n\n2019\n462.3%\n\n\n\nThe Selling, G&A efficiency rate, defined as how many dollars of additional new revenue are generated by each dollar of Selling, G&A spend, rose to 0.6x in the most recent reporting period, as shown in the table below:\n\n\n\n\nSelling, G&A\nEfficiency Rate\n\n\nPeriod\nMultiple\n\n\nSix Mos. Ended June 30, 2021\n0.6\n\n\n2020\n0.1\n\n\n\nMarket & Competition\nAccording to a 2018 marketresearch reportby Allied Market Research, the global market for treating benign prostatic hyperplasia was an estimated $10.7 billion in 2017 and is forecast to reach $20.1 billion by 2025.\nThis represents a forecast CAGR of 8.1% from 2018 to 2025.\nThe main drivers for this expected growth are an increase in disease incidence to the aging of the global population of males.\nAlso, alpha-blocker drugs are likely to be a major competitor, as they help in relaxing the muscle of the prostate and the bladder neck, allowing urination to occur more easily.\nMajor competitive or other industry participants include:\n\nBoehringer Ingelheim\nAllergan\nGlaxoSmithKline(NYSE:GSK)\nMerck(NYSE:MRK)\nTeleflex(NYSE:TFX)\nBoston Scientific(NYSE:BSX)\nOthers\n\nFinancial Performance\nProcept’s recent financial results can be summarized as follows:\n\nSharply growing top-line revenue from a small base\nA swing to gross profit and positive gross margin\nHigh and increasing operating losses\nHigh and increasing cash used in operations\n\nBelow are relevant financial results derived from the firm’s registration statement:\n\nAs of June 30, 2021, Procept had $159.2 million in cash and $68.3 million in total liabilities.\nFree cash flow during the twelve months ended June 30, 2021, was negative ($52.7 million).","news_type":1},"isVote":1,"tweetType":1,"viewCount":45,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}